细胞株Cell Lines 97及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV97
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作微信:1843439339 (QQ同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID UKRV-Mel-20f
AC CVCL_C404
DR Cosmic; 1846713
DR ESTDAB; ESTDAB-236
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D3S1358: 17
ST D5S818: 12,14
ST D7S820: 10,12
ST FGA: 21,25
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A721 ! UKRV-Mel-20a
OI CVCL_C401 ! UKRV-Mel-20b
OI CVCL_C402 ! UKRV-Mel-20c
OI CVCL_C403 ! UKRV-Mel-20e
OI CVCL_C405 ! UKRV-Mel-20h
SX Male
CA Cancer cell line
//
ID UKRV-Mel-20h
AC CVCL_C405
DR ESTDAB; ESTDAB-237
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D3S1358: 16,17
ST D5S818: 12,14
ST D7S820: 10,12
ST FGA: 21,25
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A721 ! UKRV-Mel-20a
OI CVCL_C401 ! UKRV-Mel-20b
OI CVCL_C402 ! UKRV-Mel-20c
OI CVCL_C403 ! UKRV-Mel-20e
OI CVCL_C404 ! UKRV-Mel-20f
SX Male
CA Cancer cell line
//
ID UKRV-Mel-21a
AC CVCL_A722
DR BTO; BTO:0005348
DR Cosmic; 1846715
DR ESTDAB; ESTDAB-063
RX PubMed=10594685;
CC Derived from metastatic site: Lymph node.
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 13,14
ST D3S1358: 14,17
ST D5S818: 12
ST D7S820: 10,11
ST FGA: 22
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UKRV-Mel-22
AC CVCL_A723
SY UKRV MEL22
DR Cosmic; 972281
DR Cosmic; 1846716
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKRV-Mel-22a
AC CVCL_C661
DR Cosmic; 1846717
DR Cosmic; 2163860
DR ESTDAB; ESTDAB-182
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 9
ST FGA: 21,24
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C662 ! UKRV-Mel-22b
SX Male
CA Cancer cell line
//
ID UKRV-Mel-22b
AC CVCL_C662
DR Cosmic; 1846718
DR ESTDAB; ESTDAB-183
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: Not_detected
ST FGA: 24
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C661 ! UKRV-Mel-22a
SX Male
CA Cancer cell line
//
ID UKRV-Mel-23
AC CVCL_A724
RX PubMed=10594685;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKRV-Mel-24
AC CVCL_A725
DR ESTDAB; ESTDAB-099
RX PubMed=17311103;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UKRV-Mel-25
AC CVCL_C406
DR Cosmic; 1846720
DR Cosmic; 2163861
DR ESTDAB; ESTDAB-184
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 8,11
ST FGA: 22
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UKRV-Mel-27
AC CVCL_A726
DR BTO; BTO:0005349
DR Cosmic; 1846721
DR ESTDAB; ESTDAB-238
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 7,11
ST D13S317: 10,12
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 10,13
ST FGA: 22,23.2
ST TH01: 7
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKRV-Mel-29
AC CVCL_A727
DR Cosmic; 1846722
RX PubMed=10594685;
RX PubMed=17311103;
CC Derived from metastatic site: Cutaneous/subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UKRV-Mel-30
AC CVCL_C407
DR Cosmic; 1846723
DR Cosmic; 2163836
DR ESTDAB; ESTDAB-146
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D3S1358: 14
ST D5S818: 12,14
ST D7S820: 10,12
ST FGA: 21,24
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UKRV-Mel-31
AC CVCL_A728
DR BTO; BTO:0005350
DR Cosmic; 1846724
DR ESTDAB; ESTDAB-101
RX PubMed=17311103;
CC Derived from metastatic site: Cutaneous/subcutaneous.
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9,12
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 10,11
ST FGA: 24
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UKRV-Mel-37
AC CVCL_A729
DR Cosmic; 1846726
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UKRV-Mel-38
AC CVCL_A730
DR Cosmic; 2163823
DR ESTDAB; ESTDAB-112
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,13
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 9,10
ST FGA: 23
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UKTS8049
AC CVCL_K960
DR ECACC; 91032120
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS8660
AC CVCL_K961
DR ECACC; 91032121
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 91032121; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS8670
AC CVCL_K962
DR ECACC; 91031441
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS8695
AC CVCL_K963
DR ECACC; 91021102
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UKTS8713
AC CVCL_K964
DR ECACC; 91031446
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS8727
AC CVCL_K965
DR ECACC; 91021107
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS8740
AC CVCL_K966
DR ECACC; 91031437
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS8754
AC CVCL_K967
DR ECACC; 91070908
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UKTS8768
AC CVCL_K968
DR ECACC; 91031439
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UKTS8770
AC CVCL_K969
DR ECACC; 91070910
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 91070910; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS8791
AC CVCL_K970
DR ECACC; 91032122
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS8792
AC CVCL_K971
DR ECACC; 91032123
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UKTS8796
AC CVCL_K972
DR ECACC; 91032124
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS8797
AC CVCL_K973
DR ECACC; 91032125
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS8802
AC CVCL_K974
DR ECACC; 91032126
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS8825
AC CVCL_K975
DR ECACC; 91030444
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS8837
AC CVCL_K976
DR ECACC; 91021101
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS8840
AC CVCL_K977
DR ECACC; 91031438
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS8878
AC CVCL_K978
DR ECACC; 91032127
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS8964
AC CVCL_K979
DR ECACC; 91070916
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 91070916; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS8966
AC CVCL_K980
DR ECACC; 91021106
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS8989
AC CVCL_K981
DR ECACC; 91031443
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS8992
AC CVCL_K982
DR ECACC; 91030401
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9002
AC CVCL_K983
DR ECACC; 91031447
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9003
AC CVCL_K984
DR ECACC; 91031436
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9019
AC CVCL_K985
DR ECACC; 91032128
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9020
AC CVCL_K986
DR ECACC; 91070903
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9025
AC CVCL_K987
DR ECACC; 91021104
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9034
AC CVCL_K988
DR ECACC; 91070905
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS9046
AC CVCL_K989
DR ECACC; 91030402
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9050
AC CVCL_K990
DR ECACC; 91030403
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS9051
AC CVCL_K991
DR ECACC; 91032129
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9074
AC CVCL_K992
DR ECACC; 91021103
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9082
AC CVCL_K993
DR ECACC; 91031445
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS9087
AC CVCL_K994
DR ECACC; 91070901
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 91070901; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS9109
AC CVCL_K995
DR ECACC; 91032130
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UKTS9110
AC CVCL_K996
DR ECACC; 91032131
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UKTS9114
AC CVCL_K997
DR ECACC; 91031442
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UKTS9115
AC CVCL_K998
DR ECACC; 91032132
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS9142
AC CVCL_K999
DR ECACC; 91070909
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9160
AC CVCL_L000
DR ECACC; 91032133
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 91032133; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS9161
AC CVCL_L001
DR ECACC; 91032134
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 91032134; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS9175
AC CVCL_L002
DR ECACC; 91021105
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UKTS9201
AC CVCL_L003
DR ECACC; 91070902
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9204
AC CVCL_L004
DR ECACC; 91070906
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 91070906; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS9213
AC CVCL_L005
DR ECACC; 91070904
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID UKTS9225
AC CVCL_L006
SY UKTS9225?
DR ECACC; 91032135
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UKTS9242
AC CVCL_L007
DR ECACC; 91031440
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UKTS9260
AC CVCL_L008
DR ECACC; 91070907
CC Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UL-1
AC CVCL_L421
RX PubMed=23196801;
CC Doubling time: 20.9 hours (PubMed=23196801).
CC Breed/subspecies: Labrador Retriever mix.
DI NCIt; C128121; Canine lymphoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID Ul-F
AC CVCL_6F96
SY ULF; Umbra limi Fin
RX PubMed=6541753;
CC Group: Fish cell line.
OX NCBI_TaxID=75935; ! Umbra limi
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Ul-H
AC CVCL_6F97
SY ULH; Umbra limi Heart
RX PubMed=6541753;
CC Group: Fish cell line.
OX NCBI_TaxID=75935; ! Umbra limi
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ULA
AC CVCL_1854
SY Uppsala Lymphoma Ascites-fluid
DR BioSample; SAMN03473508
DR DSMZ; ACC-627
DR GEO; GSM1374977
RX PubMed=17487752;
CC Doubling time: ~40-60 hours (DSMZ).
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 9,10
ST D13S317: 9,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17,18
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
//
ID ULF-23
AC CVCL_5641
SY Umbra Limi Fin-23
DR CLO; CLO_0050006
DR RCB; RCB0568
RX CelloPub=CLPUB00124;
CC Group: Fish cell line.
OX NCBI_TaxID=75935; ! Umbra limi
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ULF-23HU
AC CVCL_5642
RX DOI=10.1007/BF02624131;
CC Group: Fish cell line.
OX NCBI_TaxID=75935; ! Umbra limi
HI CVCL_5641 ! ULF-23
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ULK1 KO MEF (SIM)
AC CVCL_5A52
SY ULK1-/-ULK2+/+
DR ECACC; 14050806
DR Ximbio; 151715
RX PubMed=23291478;
CC Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID ULK1 KO MEF (SV40)
AC CVCL_5A53
DR ECACC; 14050807
DR Ximbio; 152609
RX PubMed=23291478;
CC Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID ULK1/2 WT MEF (SIM)
AC CVCL_5A50
DR ECACC; 14050808
DR Ximbio; 151714
RX PubMed=23291478;
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID ULK1/2 WT MEF (SV40)
AC CVCL_5A51
DR ECACC; 14050804
DR Ximbio; 152607
RX PubMed=23291478;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID ULK1+ULK2 DKO MEF (SIM)
AC CVCL_5A56
SY MEF Ulk1 -/- Ulk2 -/- (DKO) (SIM)
DR ECACC; 14050803
DR Ximbio; 151774
RX PubMed=23291478;
CC Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.
CC Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID ULK1+ULK2 DKO MEF (SV40)
AC CVCL_5A57
SY MEF Ulk1 -/- Ulk2 -/- (DKO) (SV40)
DR ECACC; 14050802
DR Ximbio; 152608
RX PubMed=23291478;
CC Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.
CC Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID ULK2 KO MEF (SIM)
AC CVCL_5A54
SY ULK1+/+ULK2-/-
DR ECACC; 14050810
DR Ximbio; 151776
RX PubMed=23291478;
CC Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID ULK2 KO MEF (SV40)
AC CVCL_5A55
DR ECACC; 14050805
DR Ximbio; 152610
RX PubMed=23291478;
CC Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID ULT-1
AC CVCL_L784
RX PubMed=22273270;
CC Characteristics: Ultra long-lived cell line with a life span of 166 PDL.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0560 ! TIG-1
SX Female
CA Finite cell line
//
ID ULTR
AC CVCL_8138
RX PubMed=1311088;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ULTR-hT
AC CVCL_8139
SY ULTRhT
RX PubMed=19767538;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8138 ! ULTR
SX Female
CA Transformed cell line
//
ID UM-1
AC CVCL_W392
RX PubMed=10087940;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-2
AC CVCL_W393
RX PubMed=10087940;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-3
AC CVCL_W394
SY UM3
RX PubMed=10087940;
RX PubMed=10936422;
RX PubMed=15257707;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-6
AC CVCL_W395
RX PubMed=10087940;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-AVE1
AC CVCL_Z825
RX PubMed=1367156;
CC Group: Insect cell line.
OX NCBI_TaxID=7163; ! Aedes vexans
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UM-BGE-1
AC CVCL_Z332
RX DOI=10.1016/B978-0-12-470270-7.50008-2;
RX PubMed=192663;
CC Group: Insect cell line.
CC Doubling time: 4.8 days (PubMed=192663).
OX NCBI_TaxID=6973; ! Blattella germanica
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UM-BGE-2
AC CVCL_Z333
SY UMN-BGE-2
RX DOI=10.1016/B978-0-12-470270-7.50008-2;
RX PubMed=192663;
RX PubMed=16593348;
CC Group: Insect cell line.
OX NCBI_TaxID=6973; ! Blattella germanica
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UM-BGE-4
AC CVCL_Z334
SY UMBGE-4
RX DOI=10.1016/B978-0-12-470270-7.50008-2;
RX PubMed=192663;
CC Group: Insect cell line.
OX NCBI_TaxID=6973; ! Blattella germanica
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UM-BGE-5 alpha
AC CVCL_Z335
RX DOI=10.1016/B978-0-12-470270-7.50008-2;
RX PubMed=192663;
CC Group: Insect cell line.
OX NCBI_TaxID=6973; ! Blattella germanica
OI CVCL_Z336 ! UM-BGE-5 beta
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UM-BGE-5 beta
AC CVCL_Z336
SY UMN-BGE-5beta
RX DOI=10.1016/B978-0-12-470270-7.50008-2;
RX PubMed=192663;
RX PubMed=16593348;
CC Group: Insect cell line.
OX NCBI_TaxID=6973; ! Blattella germanica
OI CVCL_Z335 ! UM-BGE-5 alpha
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UM-CCS-1
AC CVCL_0J37
SY UM-CCS1
RX PubMed=12237889;
DI NCIt; C3745; Clear cell sarcoma of soft tissue
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-Chor1
AC CVCL_1D68
SY UM-CHOR-1; University of Michigan-Chordoma-1
RX PubMed=27102572;
WW https://www.chordomafoundation.org/reagents-data/cell-line-repository/um-chor1/
WW http://ahns.jnabstracts.com/2014/Detail.aspx?ID=57728
WW http://epostersonline.com/ifhnos2014/node/3423?view=true
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced.
ST Source(s): PubMed=27102572
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 14
ST D19S433: 14,16
ST D21S11: 27,31
ST D2S1338: 18,20
ST D3S1358: 18
ST D5S818: 9,13
ST D7S820: 11
ST D8S1179: 12,13
ST FGA: 19,23
ST Penta D: 8,9
ST Penta E: 7
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 15
DI NCIt; C5412; Clivus chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-Chor2
AC CVCL_5T81
SY UM-CHOR-2; University of Michigan-Chordoma-2
WW http://ahns.jnabstracts.com/2014/Detail.aspx?ID=57728
WW http://epostersonline.com/ifhnos2014/node/3423?view=true
DI NCIt; C5156; Spinal chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-EC-1
AC CVCL_5972
SY University of Michigan-Endometrial Carcinoma-1
RX PubMed=1541432;
RX PubMed=3349465;
RX PubMed=8123477;
RX PubMed=17178626;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-EC-2
AC CVCL_X001
SY University of Michigan-Endometrial Carcinoma-2
RX PubMed=1541432;
RX PubMed=2344964;
RX PubMed=8123477;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-EC-3
AC CVCL_X002
SY University of Michigan-Endometrial carcinoma-3
RX PubMed=1541432;
RX PubMed=8123477;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-FSC-1
AC CVCL_W199
RX PubMed=3855324;
DI NCIt; C6604; Bone fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-GCC-1
AC CVCL_HX25
SY University of Michigan-Glassy cell Cervix Carcinoma-1
RX PubMed=1958593;
RX PubMed=7751322;
DI NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-HMC-1
AC CVCL_Y473
RX PubMed=24035723;
DI NCIt; C5908; Salivary gland mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-HMC-2
AC CVCL_Y474
RX PubMed=24035723;
DI NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-HMC-3A
AC CVCL_Y471
RX PubMed=24035723;
DI NCIt; C6214; Hard palate mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y472 ! UM-HMC-3B
SX Female
CA Cancer cell line
//
ID UM-HMC-3B
AC CVCL_Y472
RX PubMed=24035723;
CC Derived from metastatic site: Lymph node.
DI NCIt; C6214; Hard palate mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y471 ! UM-HMC-3A
SX Female
CA Cancer cell line
//
ID UM-HPA-1
AC CVCL_Y475
RX PubMed=24035723;
DI NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-Ly(ebv)-17
AC CVCL_5G90
SY UM-Lyebv-17
RX PubMed=2790823;
RX PubMed=6417595;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7724 ! UM-SCC-17A
OI CVCL_7725 ! UM-SCC-17B
SX Female
CA Transformed cell line
//
ID UM-RC-11
AC CVCL_B226
SY UMRC-11; UMRC11; University of Michigan-Renal Carcinoma-11
DR Cosmic; 972915
RX PubMed=7915601;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-RC-2
AC CVCL_2739
SY UMRC-2; UMRC2; University of Michigan-Renal Carcinoma-2
DR CCLE; UMRC2_KIDNEY
DR Cosmic; 972910
DR ECACC; 08090511
DR GEO; GSM374476
RX PubMed=4038766;
RX PubMed=7915601;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~24 hours (PubMed=4038766).
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-RC-3
AC CVCL_2740
SY UMRC-3; UMRC3; University of Michigan-Renal Carcinoma-3
DR Cosmic; 972911
DR ECACC; 08090512
DR PRIDE; PXD003105
RX PubMed=4038766;
RX PubMed=7915601;
RX PubMed=26972028;
RX PubMed=27141528;
CC Doubling time: ~29 hours (PubMed=4038766).
CC Omics: GPI-anchored proteins analysis by proteomics.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 9
ST D5S818: 9,12
ST D7S820: 9
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-RC-5
AC CVCL_B227
SY UMRC-5; UMRC5; University of Michigan-Renal Carcinoma-5
DR Cosmic; 972872
DR Cosmic; 972912
RX PubMed=4038766;
RX PubMed=7915601;
CC Doubling time: ~43 hours (PubMed=4038766).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-RC-6
AC CVCL_2741
SY UMRC-6; UMRC6; University of Michigan-Renal Carcinoma-6
DR BioSample; SAMN03470958
DR CCLE; UMRC6_KIDNEY
DR Cosmic; 972873
DR Cosmic; 972913
DR Cosmic; 1779196
DR ECACC; 08090513
DR GEO; GSM374477
RX PubMed=4038766;
RX PubMed=7915601;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-317.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~43 hours (PubMed=4038766).
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 8,12
ST D13S317: 12
ST D16S539: 9,10
ST D18S51: 18
ST D19S433: 14,18.2
ST D21S11: 28
ST D2S1338: 19,22
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 12,13
ST FGA: 22
ST Penta D: 7
ST Penta E: 8
ST TH01: 6
ST TPOX: 10
ST vWA: 18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-RC-7
AC CVCL_2742
SY UMRC-7; UMRC7; University of Michigan-Renal Carcinoma-7
DR BioSample; SAMN03470957
DR Cosmic; 972914
DR ECACC; 08090514
RX PubMed=4038766;
RX PubMed=7915601;
CC Doubling time: ~53 hours (PubMed=4038766).
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 11
ST D18S51: 13,14,19
ST D19S433: 14,15,16.2
ST D21S11: 31.2,33.2
ST D2S1338: 17,25
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 24,25
ST Penta D: 9,12
ST Penta E: 7,9
ST TH01: 8,9
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-1
AC CVCL_7707
SY UMSCC-1; UM-SCC1; UMSCC1; SCC-1; SCC1
DR BTO; BTO:0003138
DR Cosmic; 1483455
DR Cosmic; 1530751
DR Cosmic; 2131858
DR Millipore; SCC070
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X,Y (PubMed=19760794_passage_4)
ST Amelogenin: X (PubMed=19760794_passage_150; PubMed=21868764)
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 12,13
ST D18S51: 18
ST D21S11: 27
ST D3S1358: 18
ST D5S818: 10,13
ST D7S820: 9,12
ST D8S1179: 13,16 (PubMed=19760794_passage_4)
ST D8S1179: 16 (PubMed=19760794_passage_150)
ST FGA: 18,22 (PubMed=19760794_passage_4)
ST FGA: 18 (PubMed=19760794_passage_150)
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-100
AC CVCL_7708
SY UMSCC-100; UMSCC100
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-101A
AC CVCL_7709
SY UMSCC-101A; UMSCC101A
RX PubMed=15287027;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7710 ! UM-SCC-101B
SX Female
CA Cancer cell line
//
ID UM-SCC-101B
AC CVCL_7710
SY UMSCC-101B; UMSCC101B
RX PubMed=15287027;
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7709 ! UM-SCC-101A
SX Female
CA Cancer cell line
//
ID UM-SCC-103
AC CVCL_7711
SY UMSCC-103; UMSCC103
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-SCC-104
AC CVCL_7712
SY UMSCC-104; UMSCC104; University of Michigan-Squamous Cell Carcinoma-104
DR Millipore; SCC072
RX PubMed=22162267;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-105
AC CVCL_0C69
RX PubMed=25677579;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-106
AC CVCL_0C70
RX PubMed=25677579;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-108
AC CVCL_0C71
RX PubMed=25677579;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-109
AC CVCL_0C72
RX PubMed=25677579;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-10A
AC CVCL_7713
SY UM-SCC 10A; UMSCC-10A; UMSCC10A
DR Cosmic; 948025
DR Cosmic; 2131859
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=8679156;
RX PubMed=15287027;
RX PubMed=19760794;
RX PubMed=20947470;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9
ST D16S539: 11
ST D18S51: 15
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 9
ST D8S1179: 13,14
ST FGA: 22,26
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7714 ! UM-SCC-10B
SX Male
CA Cancer cell line
//
ID UM-SCC-10B
AC CVCL_7714
SY UM-SCC 10B; UMSCC-10B; UMSCC10B; UM-SCC10B
DR Cosmic; 932287
DR Cosmic; 948026
DR Cosmic; 2439751
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=8679156;
RX PubMed=15287027;
RX PubMed=19760794;
RX PubMed=20947470;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Submental lymph node.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9
ST D16S539: 11
ST D18S51: 15
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 9
ST D8S1179: 13,14
ST FGA: 22
ST TH01: 6
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7713 ! UM-SCC-10A
SX Male
CA Cancer cell line
//
ID UM-SCC-110
AC CVCL_0C73
RX PubMed=25677579;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-111
AC CVCL_0C74
RX PubMed=25677579;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-11A
AC CVCL_7715
SY UMSCC-11A; UMSCC11A
DR Cosmic; 948027
DR Cosmic; 2131860
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=1958593;
RX PubMed=3855324;
RX PubMed=15287027;
RX PubMed=19760794;
RX PubMed=16785414;
RX PubMed=21868764;
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 7
ST D13S317: 14
ST D16S539: 12,14
ST D18S51: 16
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 12,15
ST FGA: 19,24
ST TH01: 7
ST TPOX: 8
ST vWA: 16,17,18
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7716 ! UM-SCC-11B
SX Male
CA Cancer cell line
//
ID UM-SCC-11B
AC CVCL_7716
SY UM-SCC 11B; UMSCC-11B; UMSCC11B; UM-SCC11B; SCC11B
DR BTO; BTO:0005995
DR Cosmic; 932288
DR Cosmic; 948028
DR Cosmic; 1130354
DR Cosmic; 1317414
DR Cosmic; 1351517
DR Cosmic; 2296306
DR Cosmic; 2131861
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=1958593;
RX PubMed=3855324;
RX PubMed=8679156;
RX PubMed=15287027;
RX PubMed=16785414;
RX PubMed=19760794;
RX PubMed=20947470;
RX PubMed=21868764;
RX PubMed=25275298;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
ST Source(s): PubMed=19760794; PubMed=21868764; PubMed=25275298
ST Amelogenin: X
ST CSF1PO: 7
ST D13S317: 14
ST D16S539: 12,14
ST D18S51: 16
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 15
ST FGA: 19
ST Penta D: 2.2
ST Penta E: 8,13
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,17,18
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7715 ! UM-SCC-11A
SX Male
CA Cancer cell line
//
ID UM-SCC-12
AC CVCL_7717
SY UMSCC-12; UMSCC12
DR BTO; BTO:0003139
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 13
ST D18S51: 12,16
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 14,15
ST FGA: 23,25
ST vWA: 16
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-13
AC CVCL_7718
SY UMSCC-13; UMSCC13
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 12
ST D18S51: 14,16
ST D21S11: 27,28
ST D3S1358: 16,18
ST D5S818: 13
ST D7S820: 8,12
ST D8S1179: 12,14
ST FGA: 19,24
ST vWA: 17
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-14A
AC CVCL_7719
SY UM-SCC 14A; UMSCC-14A; UMSCC14A
DR BTO; BTO:0003140
DR Cosmic; 948029
DR Cosmic; 1483458
DR Lonza; 40
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=8679156;
RX PubMed=9041179;
RX PubMed=15287027;
RX PubMed=19760794;
RX PubMed=20947470;
RX PubMed=21868764;
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 15
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 11,14
ST D7S820: 9,10
ST D8S1179: 8,13
ST FGA: 20,21
ST TH01: 6,8
ST vWA: 14,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7720 ! UM-SCC-14B
OI CVCL_7721 ! UM-SCC-14C
SX Female
CA Cancer cell line
//
ID UM-SCC-14B
AC CVCL_7720
SY UM-SCC 14B; UMSCC-14B; UMSCC14B
DR BTO; BTO:0002710
DR Cosmic; 948030
DR Cosmic; 2513912
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=8679156;
RX PubMed=9041179;
RX PubMed=15287027;
RX PubMed=19760794;
RX PubMed=20947470;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 15
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 11,14
ST D7S820: 9,10 (PubMed=19760794)
ST D7S820: 9,10,11 (PubMed=21868764)
ST D8S1179: 8,13
ST FGA: 20,21
ST TH01: 6,8
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7719 ! UM-SCC-14A
OI CVCL_7721 ! UM-SCC-14C
SX Female
CA Cancer cell line
//
ID UM-SCC-14C
AC CVCL_7721
SY UM-SCC 14C; UMSCC-14C; UMSCC14C; UM-SCC14C
DR CLS; 300370/p795_UM-SCC-14C
DR Cosmic; 932289
RX PubMed=8679156;
RX PubMed=9041179;
RX PubMed=15287027;
RX PubMed=19760794;
RX PubMed=20947470;
CC Derived from metastatic site: Skin.
ST Source(s): CLS; PubMed=19760794
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 12
ST D18S51: 15
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 11,14
ST D7S820: 9,10
ST D8S1179: 8,13
ST FGA: 20,21
ST Penta D: 12,16
ST Penta E: 7
ST TH01: 6,8
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7719 ! UM-SCC-14A
OI CVCL_7720 ! UM-SCC-14B
SX Female
CA Cancer cell line
//
ID UM-SCC-15
AC CVCL_7722
SY UMSCC-15; UMSCC15
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 12
ST D18S51: 14
ST D21S11: 31,31.2
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 9
ST D8S1179: 13,14
ST FGA: 23
ST vWA: 17
DI NCIt; C102872; Pharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-16
AC CVCL_7723
SY UMSCC-16; UMSCC16
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 8,10
ST D18S51: 15
ST D21S11: 28,29.2
ST D3S1358: 14
ST D5S818: 10,12
ST D7S820: 10,12
ST D8S1179: 10,14
ST FGA: 21,24
ST vWA: 15,17
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-17A
AC CVCL_7724
SY UM-SCC 17A; UMSCC-17A; UMSCC17A; UM-SCC17A; SCC17A
DR BTO; BTO:0004022
DR Cosmic; 932290
DR Cosmic; 948031
DR Cosmic; 1130355
DR Millipore; SCC074
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=1958593;
RX PubMed=2790823;
RX PubMed=3855324;
RX PubMed=6417595;
RX PubMed=8679156;
RX PubMed=15287027;
RX PubMed=16785414;
RX PubMed=19760794;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 10,11
ST D18S51: 17,22
ST D21S11: 28
ST D3S1358: 15,18
ST D5S818: 11
ST D7S820: 13
ST D8S1179: 12,13
ST FGA: 20,22
ST TH01: 6,8
ST TPOX: 10,11
ST vWA: 14,17
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5G90 ! UM-Ly(ebv)-17
OI CVCL_7725 ! UM-SCC-17B
SX Female
CA Cancer cell line
//
ID UM-SCC-17As
AC CVCL_9T71
RX PubMed=1958593;
RX PubMed=15287027;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7724 ! UM-SCC-17A
SX Female
CA Cancer cell line
//
ID UM-SCC-17B
AC CVCL_7725
SY UMSCC-17B; UMSCC17B
DR BTO; BTO:0002711
DR Cosmic; 948032
DR Cosmic; 2296307
DR Millipore; SCC075
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=1958593;
RX PubMed=2790823;
RX PubMed=3855324;
RX PubMed=6417595;
RX PubMed=15287027;
RX PubMed=16785414;
RX PubMed=19760794;
RX PubMed=21868764;
RX PubMed=25275298;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Neck lymph node.
ST Source(s): PubMed=19760794; PubMed=21868764; PubMed=25275298
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 10,11
ST D18S51: 22
ST D21S11: 28
ST D3S1358: 15,18
ST D5S818: 11
ST D7S820: 13
ST D8S1179: 12,13
ST FGA: 20,22
ST Penta D: 10
ST Penta E: 5,19
ST TH01: 6,8
ST TPOX: 10,11
ST vWA: 14,17
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5G90 ! UM-Ly(ebv)-17
OI CVCL_7724 ! UM-SCC-17A
SX Female
CA Cancer cell line
//
ID UM-SCC-18
AC CVCL_7726
SY UMSCC-18; UMSCC18
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 9,12
ST D18S51: 14
ST D21S11: 29,30
ST D3S1358: 13,14
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 14,15
ST FGA: 19,20
ST vWA: 15,19
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-19
AC CVCL_7727
SY UMSCC-19; UMSCC19; UMC19; UMC-19; umc-19
DR Cosmic; 844589
DR Cosmic; 877398
DR Cosmic; 1152493
DR Cosmic; 2043900
DR Cosmic; 2439755
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9,13
ST D18S51: 10,16
ST D21S11: 28,30
ST D3S1358: 14
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 10,12
ST FGA: 24
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,19
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-2
AC CVCL_7728
SY UMSCC-2; UMSCC2
DR BTO; BTO:0003315
DR Cosmic; 2043890
DR Cosmic; 2296304
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
RX PubMed=21868764;
RX PubMed=25275298;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 11,13
ST D18S51: 18
ST D21S11: 30,33.2
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8,12
ST D8S1179: 12,14
ST FGA: 19
ST vWA: 16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-20
AC CVCL_7729
SY UMSCC-20; UMSCC20
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=19760794;
CC Derived from metastatic site: Neck.
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 8,10
ST D18S51: 13,15
ST D21S11: 28,30.2
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 12,15
ST FGA: 18,22.2
ST vWA: 16,18
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-21A
AC CVCL_7730
SY UMSCC-21A; UMSCC21A
DR BTO; BTO:0002713
RX PubMed=1958593;
RX PubMed=15287027;
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 8,9
ST D18S51: 14
ST D21S11: 29,32.2
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 21
ST vWA: 16,18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L143 ! UM-SCC-21B
SX Male
CA Cancer cell line
//
ID UM-SCC-21B
AC CVCL_L143
SY UMSCC-21B; UMSCC21B
RX PubMed=1958593;
RX PubMed=15287027;
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7730 ! UM-SCC-21A
SX Male
CA Cancer cell line
//
ID UM-SCC-22A
AC CVCL_7731
SY UMSCC-22A; UMSCC22A; SCC22A; UMC-22a; UMC22a; UM-22A
DR BTO; BTO:0002714
DR Cosmic; 948033
DR Cosmic; 1130357
DR Cosmic; 2439752
DR Cosmic; 2513913
DR Millipore; SCC076
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=1958593;
RX PubMed=15287027;
RX PubMed=19760794;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,12
ST D16S539: 9,11
ST D18S51: 18
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8,9
ST D8S1179: 11,13
ST FGA: 22,24
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,18 (PubMed=19760794_passage_16)
ST vWA: 18 (PubMed=19760794_passage_138; PubMed=21868764)
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7732 ! UM-SCC-22B
SX Female
CA Cancer cell line
//
ID UM-SCC-22B
AC CVCL_7732
SY UM-SCC 22B; UMSCC-22B; UMSCC22B; UM-SCC22B; SCC22B; UMC-22b; UMC22b; UMC22B; UM-22B
DR ChEMBL-Cells; CHEMBL3307244
DR ChEMBL-Targets; CHEMBL612798
DR Cosmic; 932291
DR Cosmic; 948034
DR Cosmic; 1130358
DR Cosmic; 1483459
DR Cosmic; 2131862
DR Cosmic; 2513914
DR Millipore; SCC077
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=1958593;
RX PubMed=8679156;
RX PubMed=15287027;
RX PubMed=19760794;
RX PubMed=20145189;
RX PubMed=20947470;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Neck lymph node.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,12
ST D16S539: 9,11
ST D18S51: 18
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8,9
ST D8S1179: 11,13
ST FGA: 22,24
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7731 ! UM-SCC-22A
SX Female
CA Cancer cell line
//
ID UM-SCC-23
AC CVCL_7733
SY UMSCC-23; UMSCC23
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=1958593;
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 8
ST D18S51: 10
ST D21S11: 29
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 8,13
ST D8S1179: 10,15
ST FGA: 20
ST vWA: 17
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-24
AC CVCL_7734
SY UMSCC-24; UMSCC24
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 11,12
ST D18S51: 15
ST D21S11: 32.2
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 9
ST D8S1179: 13
ST FGA: 18,25
ST vWA: 16,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-25
AC CVCL_7735
SY UMSCC-25; UMSCC25; SCC25; UMC-25; UMC25
DR Cosmic; 1130359
DR Cosmic; 2131863
RX PubMed=19760794;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 10,15
ST D13S317: 11
ST D16S539: 10,12
ST D18S51: 19
ST D21S11: 27
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 12,13
ST D8S1179: 13,14
ST FGA: 21
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 19
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-26
AC CVCL_7736
SY UMSCC-26; UMSCC26
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 11
ST D18S51: 14
ST D21S11: 32.2
ST D3S1358: 16
ST D5S818: 10,11
ST D7S820: 7,12
ST D8S1179: 13,15
ST FGA: 21,24
ST vWA: 16,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-27
AC CVCL_7737
SY UMSCC-27; UMSCC27
DR Cosmic; 1483460
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 8
ST D18S51: 14,16
ST D21S11: 29,32.2
ST D3S1358: 14
ST D5S818: 12,13
ST D7S820: 8,11
ST D8S1179: 12,13
ST FGA: 19
ST vWA: 17,18
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-28
AC CVCL_7738
SY UMSCC-28; UMSCC28
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 12
ST D18S51: 14
ST D21S11: 30,32.2
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 13,15
ST FGA: 23,25
ST vWA: 18,19
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-29
AC CVCL_7739
SY UMSCC-29; UMSCC29
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 8,11
ST D18S51: 15
ST D21S11: 28
ST D3S1358: 14
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 15
ST FGA: 23,25
ST vWA: 18,19
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-SCC-3
AC CVCL_7740
SY UMSCC-3; UMSCC3; SCC3
DR Cosmic; 1130350
DR Cosmic; 1483456
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
RX PubMed=21868764;
CC Derived from metastatic site: Lymph node.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 11,12
ST D18S51: 12,15
ST D21S11: 31.2
ST D3S1358: 17
ST D5S818: 11,13
ST D7S820: 9,10
ST D8S1179: 14
ST FGA: 20,27
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-30
AC CVCL_7741
SY UMSCC-30; UMSCC30
DR Cosmic; 2513915
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 13
ST D18S51: 14
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 14,15
ST FGA: 21
ST vWA: 16,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-31
AC CVCL_7742
SY UMSCC-31; UMSCC31; UMC-31; UMC31
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 10,12
ST D18S51: 13,18
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8
ST D8S1179: 14
ST FGA: 24
ST vWA: 17,18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-32
AC CVCL_7743
SY UMSCC-32; UMSCC32
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-33
AC CVCL_7744
SY UMSCC-33; UMSCC33
RX PubMed=19760794;
RX PubMed=21868764;
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 10
ST D18S51: 18
ST D21S11: 31
ST D3S1358: 17
ST D5S818: 10
ST D7S820: 10
ST D8S1179: 12
ST FGA: 19
ST TH01: 9.3
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-34
AC CVCL_7745
SY UMSCC-34; UMSCC34
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 12,13
ST D18S51: 13
ST D21S11: 30,31
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 10,12
ST D8S1179: 9,14
ST FGA: 23
ST vWA: 15,18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-35
AC CVCL_7746
SY UMSCC-35; UMSCC35
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 11
ST D18S51: 15
ST D21S11: 36
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 9,11
ST D8S1179: 11,15,16
ST FGA: 18.2,26
ST vWA: 15,18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-36
AC CVCL_7747
SY UMSCC-36; UMSCC36; UMC-36; UMC36
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 11,12
ST D18S51: 20
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 9,11
ST D8S1179: 12,13
ST FGA: 21
ST vWA: 17,18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-37
AC CVCL_7748
SY UMSCC-37; UMSCC37
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 10
ST D18S51: 14,17
ST D21S11: 30
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 11,14
ST FGA: 20,22
ST vWA: 18,19
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-38
AC CVCL_7749
SY UMSCC-38; UMSCC38
DR BTO; BTO:0002715
DR Cosmic; 948035
DR Cosmic; 2513916
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=1958593;
RX PubMed=19760794;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 10,11
ST D18S51: 19
ST D21S11: 27,29
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 14,15
ST FGA: 28
ST vWA: 17,18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-39
AC CVCL_7750
SY UMSCC-39; UMSCC39
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 13
ST D18S51: 16,17
ST D21S11: 32.2
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 14
ST FGA: 24
ST vWA: 17,18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-4
AC CVCL_7751
SY UMSCC-4; UMSCC4; SCC4
DR Cosmic; 1130351
DR Cosmic; 1483457
DR Cosmic; 2131864
DR Cosmic; 2296305
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
RX PubMed=21868764;
RX PubMed=25275298;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12
ST D18S51: 16
ST D21S11: 28
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 9,10
ST D8S1179: 13,15
ST FGA: 26
ST TH01: 7
ST TPOX: 9,10
ST vWA: 17,18
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-40
AC CVCL_7752
SY UMSCC-40; UMSCC40
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 10
ST D18S51: 12
ST D21S11: 28,30
ST D3S1358: 14
ST D5S818: 10
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 21,22
ST vWA: 14,16
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-41
AC CVCL_7753
SY UMSCC-41; UMSCC41
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 11
ST D18S51: 18
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 14
ST FGA: 25
ST vWA: 18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-42
AC CVCL_7754
SY UMSCC-42; UMSCC42
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 13
ST D18S51: 12
ST D21S11: 29,30
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 10,14
ST FGA: 19,20
ST vWA: 18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-43
AC CVCL_7755
SY UMSCC-43; UMSCC43
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 11,13
ST D18S51: 14,16
ST D21S11: 32.2
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 13,15
ST FGA: 20,22
ST vWA: 14,15
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-44
AC CVCL_7756
SY UMSCC-44; UMSCC44
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 12
ST D18S51: 12,13
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 9,13
ST D8S1179: 13
ST FGA: 24
ST vWA: 16,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-45
AC CVCL_7757
SY UMSCC-45; UMSCC45
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 10
ST D18S51: 19
ST D21S11: 28,30
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 11,14
ST FGA: 21
ST vWA: 14,16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-46
AC CVCL_7758
SY UMSCC-46; UMSCC46
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 10
ST D18S51: 19
ST D21S11: 30,31.2
ST D3S1358: 15
ST D5S818: 10,11
ST D7S820: 12,14
ST D8S1179: 13,15
ST FGA: 21
ST vWA: 14,18
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-47
AC CVCL_7759
SY UMSCC-47; UMSCC47; UM-SCC47; UMSCC047
DR Cosmic; 1122677
DR Cosmic; 2131865
DR Cosmic; 2296309
DR Millipore; SCC071
RX PubMed=19760794;
RX PubMed=21868764;
RX PubMed=25275298;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Omics: Deep exome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794; PubMed=21868764; PubMed=25275298
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8,11
ST D16S539: 8,13
ST D18S51: 18
ST D21S11: 29,30
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 15
ST FGA: 23,25
ST Penta D: 9,10
ST Penta E: 12,13
ST TH01: 7,9.3
ST TPOX: 10,11
ST vWA: 18
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-48
AC CVCL_7760
SY UMSCC-48; UMSCC48
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 12
ST D18S51: 15
ST D21S11: 29,31.2
ST D3S1358: 14
ST D5S818: 12,13
ST D7S820: 8,11
ST D8S1179: 13,14
ST FGA: 18,21
ST vWA: 17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-49
AC CVCL_7761
SY UMSCC-49; UMSCC49
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 12,13
ST D18S51: 15
ST D21S11: 27
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 8,9
ST D8S1179: 12
ST FGA: 23,26
ST vWA: 16,20
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-5
AC CVCL_7762
SY UMSCC-5; UMSCC5
DR BTO; BTO:0004023
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 8,11
ST D18S51: 12,16
ST D21S11: 31
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 9
ST D8S1179: 11,13
ST FGA: 25
ST vWA: 18
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-50
AC CVCL_7763
SY UMSCC-50; UMSCC50
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 11
ST D18S51: 17
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 9,12
ST D7S820: 10,12
ST D8S1179: 13,15
ST FGA: 21,22
ST vWA: 16,18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-51
AC CVCL_7764
SY UMSCC-51; UMSCC51
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 11
ST D18S51: 14
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 13
ST D8S1179: 9,12
ST FGA: 20,21
ST vWA: 14,15
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-52
AC CVCL_7765
SY UMSCC-52; UMSCC52
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 13
ST D18S51: 12
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 9,12
ST D8S1179: 13,16,17
ST FGA: 19
ST vWA: 16,18,19
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-53
AC CVCL_7766
SY UMSCC-53; UMSCC53
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 8
ST D18S51: 14,21
ST D21S11: 27,30
ST D3S1358: 14
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 12,15
ST FGA: 24
ST vWA: 17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-54
AC CVCL_7767
SY UMSCC-54; UMSCC54; UMC-54; UMC54
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 10,11
ST D18S51: 14,15
ST D21S11: 29
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 12,14
ST FGA: 24,25
ST vWA: 14,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-55
AC CVCL_7768
SY UMSCC-55; UMSCC55
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 8,13
ST D18S51: 16
ST D21S11: 30,31
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 10
ST D8S1179: 12,14
ST FGA: 22,24
ST vWA: 17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-56
AC CVCL_7769
SY UMSCC-56; UMSCC56
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-SCC-57
AC CVCL_7770
SY UMSCC-57; UMSCC57
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 9,12
ST D18S51: 17,18
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 12
ST FGA: 23,24
ST vWA: 16,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-58
AC CVCL_7771
SY UMSCC-58; UMSCC58
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 9,13
ST D18S51: 13
ST D21S11: 30,32.2
ST D3S1358: 14
ST D5S818: 11
ST D7S820: 9,11
ST D8S1179: 13,15
ST FGA: 22,25
ST vWA: 15,16,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-59
AC CVCL_7772
SY UMSCC-59; UMSCC59
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 10
ST D18S51: 12
ST D21S11: 28,29
ST D3S1358: 14
ST D5S818: 10
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 22
ST vWA: 15
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-6
AC CVCL_7773
SY UMSCC-6; UMSCC6; SCC-6
DR Cosmic; 1530755
DR Millipore; SCC073
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794; PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 13
ST D16S539: 9,12
ST D18S51: 11,19
ST D21S11: 28
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 11,14
ST FGA: 23
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 15,16
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-60
AC CVCL_7774
SY UMSCC-60; UMSCC60
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 14
ST D18S51: 12
ST D21S11: 32
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 9,10
ST D8S1179: 11
ST FGA: 19,26
ST vWA: 14,15
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-62
AC CVCL_L129
SY UMSCC-62; UMSCC62
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-63
AC CVCL_L130
SY UMSCC-63; UMSCC63
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-65
AC CVCL_L131
SY UMSCC-65; UMSCC65
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-66
AC CVCL_L132
SY UMSCC-66; UMSCC66
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-67
AC CVCL_L133
SY UMSCC-67; UMSCC67
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-68A
AC CVCL_L134
SY UMSCC-68A; UMSCC68A
RX PubMed=15287027;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L135 ! UM-SCC-68B
SX Male
CA Cancer cell line
//
ID UM-SCC-68B
AC CVCL_L135
SY UMSCC-68B; UMSCC68B
RX PubMed=15287027;
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L134 ! UM-SCC-68A
SX Male
CA Cancer cell line
//
ID UM-SCC-69
AC CVCL_7775
SY UMSCC-69; UMSCC69
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 11
ST D18S51: 15,16
ST D21S11: 30,32.2
ST D3S1358: 17,18
ST D5S818: 11,12
ST D7S820: 11,13
ST D8S1179: 10,14
ST FGA: 20,24
ST vWA: 16,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-7
AC CVCL_7776
SY UMSCC-7; UMSCC7
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 10
ST D18S51: 14,15
ST D21S11: 33.2
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 12,15
ST FGA: 20,22
ST vWA: 16
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-70
AC CVCL_7777
SY UMSCC-70; UMSCC70
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 11
ST D18S51: 18
ST D21S11: 30
ST D3S1358: 14
ST D5S818: 11
ST D7S820: 12
ST D8S1179: 14
ST FGA: 20
ST vWA: 16,17
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-71
AC CVCL_L136
SY UMSCC-71; UMSCC71
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-72
AC CVCL_L137
SY UMSCC-72; UMSCC72
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-73A
AC CVCL_9T70
RX PubMed=15287027;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7778 ! UM-SCC-73B
SX Male
CA Cancer cell line
//
ID UM-SCC-73B
AC CVCL_7778
SY UMSCC-73B; UMSCC73B
RX PubMed=15287027;
RX PubMed=19760794;
CC Derived from metastatic site: Neck lymph node.
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 11
ST D18S51: 12,14
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8,9
ST D8S1179: 13,15
ST FGA: 21
ST vWA: 16,19
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T70 ! UM-SCC-73A
SX Male
CA Cancer cell line
//
ID UM-SCC-74A
AC CVCL_7779
SY UMSCC-74A; UMSCC74A
RX PubMed=15287027;
RX PubMed=19760794;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 12
ST D18S51: 17
ST D21S11: 30,34.2
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 12,13
ST FGA: 21,26
ST vWA: 15,16
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7780 ! UM-SCC-74B
SX Male
CA Cancer cell line
//
ID UM-SCC-74B
AC CVCL_7780
SY UMSCC-74B; UMSCC74B
RX PubMed=15287027;
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 12
ST D18S51: 17
ST D21S11: 30,34.2
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 12,13
ST FGA: 21,26
ST vWA: 15,16
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7779 ! UM-SCC-74A
SX Male
CA Cancer cell line
//
ID UM-SCC-75
AC CVCL_L138
SY UMSCC-75; UMSCC75
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-76
AC CVCL_L139
SY UMSCC-76; UMSCC76
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-77
AC CVCL_L140
SY UMSCC-77; UMSCC77
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-78A
AC CVCL_L141
SY UMSCC-78A; UMSCC78A
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L142 ! UM-SCC-78B
SX Male
CA Cancer cell line
//
ID UM-SCC-78B
AC CVCL_L142
SY UMSCC-78B; UMSCC78B
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L141 ! UM-SCC-78A
SX Male
CA Cancer cell line
//
ID UM-SCC-79
AC CVCL_L299
SY UMSCC-79; UMSCC79
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-8
AC CVCL_7781
SY UMSCC-8; UMSCC8; SCC8
DR Cosmic; 1130352
DR Cosmic; 2043898
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=1958593;
RX PubMed=3855324;
RX PubMed=19760794;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 12
ST D18S51: 13,15
ST D21S11: 29,31.2
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 10,13
ST FGA: 22,23
ST vWA: 16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-80
AC CVCL_7782
SY UMSCC-80; UMSCC80
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 11
ST D18S51: 24
ST D21S11: 31.2
ST D3S1358: 17
ST D5S818: 9
ST D7S820: 10
ST D8S1179: 13
ST FGA: 22
ST vWA: 14,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-81A
AC CVCL_7783
SY UMSCC-81A; UMSCC81A
RX PubMed=9041179;
RX PubMed=15287027;
RX PubMed=16785414;
RX PubMed=19760794;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 9
ST D18S51: 14,19
ST D21S11: 33.2
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 10
ST FGA: 22
ST vWA: 17
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7784 ! UM-SCC-81B
SX Male
CA Cancer cell line
//
ID UM-SCC-81B
AC CVCL_7784
SY UMSCC-81B; UMSCC81B
RX PubMed=9041179;
RX PubMed=15287027;
RX PubMed=16785414;
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X,Y
ST D13S317: 9,11
ST D18S51: 14
ST D21S11: 29
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 10,13
ST FGA: 20,22
ST vWA: 17
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7783 ! UM-SCC-81A
SX Male
CA Cancer cell line
//
ID UM-SCC-82A
AC CVCL_L127
SY UMSCC-82A; UMSCC82A
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L128 ! UM-SCC-82B
SX Female
CA Cancer cell line
//
ID UM-SCC-82B
AC CVCL_L128
SY UMSCC-82B; UMSCC82B
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L127 ! UM-SCC-82A
SX Female
CA Cancer cell line
//
ID UM-SCC-83A
AC CVCL_7785
SY UMSCC-83A; UMSCC83A
RX PubMed=9041179;
RX PubMed=15287027;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7786 ! UM-SCC-83B
SX Male
CA Cancer cell line
//
ID UM-SCC-83B
AC CVCL_7786
SY UMSCC-83B; UMSCC83B
RX PubMed=9041179;
RX PubMed=15287027;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7785 ! UM-SCC-83A
SX Male
CA Cancer cell line
//
ID UM-SCC-84
AC CVCL_7787
SY UMSCC-84; UMSCC84
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-85
AC CVCL_7788
SY UMSCC-85; UMSCC85
RX PubMed=21868764;
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 9
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C8192; Nasal cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-86
AC CVCL_7789
SY UMSCC-86; UMSCC86
RX PubMed=9041179;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-87
AC CVCL_7790
SY UMSCC-87; UMSCC87
RX PubMed=9041179;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-88
AC CVCL_7791
SY UMSCC-88; UMSCC88
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-89
AC CVCL_7792
SY UMSCC-89; UMSCC89
RX PubMed=9041179;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-9
AC CVCL_7793
SY UMSCC-9; UMSCC9; UM-SCC9; SCC9
DR Cosmic; 1130353
DR Cosmic; 1317413
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=3855324;
RX PubMed=19760794;
CC Derived from metastatic site: Lymph node.
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 11,14
ST D18S51: 13,15
ST D21S11: 30,31.2
ST D3S1358: 14
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 9,13
ST FGA: 22
ST vWA: 17,18
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-90
AC CVCL_7794
SY UMSCC-90; UMSCC90
RX PubMed=9041179;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-91
AC CVCL_7795
SY UMSCC-91; UMSCC91
RX PubMed=9041179;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-92
AC CVCL_7796
SY UMSCC-92; UMSCC92
RX PubMed=19760794;
ST Source(s): PubMed=19760794
ST Amelogenin: X
ST D13S317: 12,14
ST D18S51: 14,15
ST D21S11: 29,31
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 11,12
ST D8S1179: 10,13
ST FGA: 19,21
ST vWA: 17,20
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-93
AC CVCL_7797
SY UMSCC-93; UMSCC93
RX PubMed=9041179;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-94
AC CVCL_7798
SY UMSCC-94; UMSCC94
RX PubMed=9041179;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-95
AC CVCL_7799
SY UMSCC-95; UMSCC95
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-96
AC CVCL_7800
SY UMSCC-96; UMSCC96
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-97
AC CVCL_7801
SY UMSCC-97; UMSCC97
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCC-98
AC CVCL_7802
SY UMSCC-98; UMSCC98
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCC-99
AC CVCL_7803
SY UMSCC-99; UMSCC99
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCP-1
AC CVCL_4906
RX PubMed=6378378;
RX PubMed=14518029;
WW http://capcelllines.ca/details.asp?id=81
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-SCV-1A
AC CVCL_0568
SY UMSCV-1A; University of Michigan-Squamous cell Carcinoma of the Vulva-1A
DR MCCL; MCC:0000473
RX PubMed=1777413;
RX PubMed=1958593;
RX PubMed=2335395;
RX PubMed=2758419;
RX PubMed=8646696;
RX PubMed=15047230;
CC Doubling time: 32 hours (PubMed=15047230).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5973 ! UM-SCV-1B
SX Female
CA Cancer cell line
//
ID UM-SCV-1B
AC CVCL_5973
SY UMSCV-1B; University of Michigan-Squamous cell Carcinoma of the Vulva-1B
RX PubMed=1777413;
RX PubMed=1958593;
RX PubMed=2335395;
RX PubMed=2758419;
RX PubMed=7599042;
RX PubMed=8646696;
RX PubMed=15047230;
CC Doubling time: 34 hours (PubMed=15047230).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0568 ! UM-SCV-1A
SX Female
CA Cancer cell line
//
ID UM-SCV-2
AC CVCL_5974
SY UMSCV-2; University of Michigan-Squamous cell Carcinoma of the Vulva-2
RX PubMed=1777413;
RX PubMed=1958593;
RX PubMed=2758419;
RX PubMed=7599042;
RX PubMed=8646696;
RX PubMed=15047230;
RX PubMed=17178626;
CC Doubling time: 58 hours (PubMed=15047230).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCV-3
AC CVCL_5975
SY UMSCV-3; University of Michigan-Squamous cell Carcinoma of the Vulva-3
RX PubMed=1777413;
RX PubMed=1958593;
RX PubMed=7599042;
RX PubMed=15047230;
CC Doubling time: 76 hours (PubMed=15047230).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCV-4
AC CVCL_5976
SY UMSCV-4; University of Michigan-Squamous cell Carcinoma of the Vulva-4
RX PubMed=1777413;
RX PubMed=1958593;
RX PubMed=7599042;
RX PubMed=8646696;
RX PubMed=15047230;
CC Doubling time: 56 hours (PubMed=15047230).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCV-5
AC CVCL_HX24
SY UMSCV-5; University of Michigan-Squamous cell Carcinoma of the Vulva-5
RX PubMed=1777413;
RX PubMed=7599042;
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCV-6
AC CVCL_0569
SY UMSCV-6; University of Michigan-Squamous cell Carcinoma of the Vulva-6
DR MCCL; MCC:0000474
RX PubMed=1777413;
RX PubMed=7599042;
RX PubMed=15047230;
CC Characteristics: Contains an integrated HPV16 genome.
CC Doubling time: 53 hours (PubMed=15047230).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCV-7
AC CVCL_5977
SY UMSCV-7; University of Michigan-Squamous cell Carcinoma of the Vulva-7
RX PubMed=7599042;
RX PubMed=15047230;
RX PubMed=17178626;
CC Doubling time: 37 hours (PubMed=15047230).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-SCVa-1
AC CVCL_HX28
SY UM-SCVA-1 University of Michigan-Squamous cell Carcinoma of the Vagina-1
RX PubMed=1958593;
RX PubMed=7599042;
DI NCIt; C7736; Vaginal squamous cell carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-UC-1
AC CVCL_2743
SY UMUC1; University of Michigan-Urothelial Carcinoma-1
DR EFO; EFO_0006770
DR BioSample; SAMN03473231
DR CCLE; UMUC1_URINARY_TRACT
DR Cosmic; 1927293
DR Cosmic; 1938699
DR ECACC; 06080301
DR GEO; GSM888823
DR GEO; GSM1574557
RX PubMed=3761468;
RX PubMed=6471236;
RX PubMed=16469639;
RX PubMed=18812553;
RX PubMed=19375735;
RX PubMed=22460905;
RX PubMed=23401075;
RX PubMed=25485619;
RX PubMed=25997541;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Doubling time: ~26 hours (ECACC).
CC Omics: CNV analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,11
ST D18S51: 15
ST D21S11: 28,29
ST D3S1358: 17,18
ST D5S818: 13
ST D7S820: 8,11
ST D8S1179: 12,14
ST FGA: 22,24
ST Penta D: 2.2
ST Penta E: 7,17
ST TH01: 8
ST TPOX: 8
ST vWA: 14,15
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-UC-10
AC CVCL_2744
SY UMUC10; University of Michigan-Urothelial Carcinoma-10
DR BTO; BTO:0004992
DR Cosmic; 1082651
DR Cosmic; 1927297
DR Cosmic; 1938705
DR Cosmic; 2037962
DR ECACC; 08090506
RX PubMed=16469639;
RX PubMed=18812553;
RX PubMed=19375735;
RX PubMed=23401075;
RX PubMed=24018021;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-UC-11
AC CVCL_2745
SY UM-UC11; UMUC11; UC-11; University of Michigan-Urothelial Carcinoma-11
DR Cosmic; 846279
DR Cosmic; 1927298
DR Cosmic; 1938706
DR Cosmic; 2037963
DR ECACC; 08090507
DR GEO; GSM1574591
RX PubMed=16469639;
RX PubMed=18812553;
RX PubMed=19375735;
RX PubMed=23401075;
RX PubMed=24018021;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-UC-12
AC CVCL_S992
SY UMUC12; University of Michigan-Urothelial Carcinoma-12
DR Cosmic; 1938707
DR GEO; GSM1574592
RX PubMed=25997541;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-UC-13
AC CVCL_2746
SY UMUC13; UC-13; University of Michigan-Urothelial Carcinoma-13
DR Cosmic; 846280
DR Cosmic; 1082652
DR Cosmic; 1938708
DR Cosmic; 2037964
DR ECACC; 08090508
DR GEO; GSM1574560
RX PubMed=16469639;
RX PubMed=18812553;
RX PubMed=19375735;
RX PubMed=24018021;
RX PubMed=25997541;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-UC-14
AC CVCL_2747
SY UMUC-14; UM-UC14; UMUC14; University of Michigan-Urothelial Carcinoma-14
DR BTO; BTO:0004991
DR Cosmic; 1082653
DR Cosmic; 1302360
DR Cosmic; 1938709
DR Cosmic; 2037965
DR Cosmic; 2050469
DR Cosmic; 2057447
DR Cosmic; 2212695
DR Cosmic; 2444231
DR ECACC; 08090509
DR GEO; GSM1574586
DR GEO; GSM1574587
RX PubMed=16469639;
RX PubMed=18812553;
RX PubMed=19375735;
RX PubMed=24018021;
RX PubMed=25997541;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C6142; Renal pelvis carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-UC-15
AC CVCL_R742
SY UMUC15; University of Michigan-Urothelial Carcinoma-15
DR Cosmic; 1927299
DR Cosmic; 1938710
DR Cosmic; 2037966
RX PubMed=18812553;
RX PubMed=23401075;
RX PubMed=24018021;
RX PubMed=25997541;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-UC-16
AC CVCL_2748
SY UMUC16; University of Michigan-Urothelial Carcinoma-16
DR Cosmic; 1082654
DR Cosmic; 1938711
DR ECACC; 08090510
RX PubMed=16469639;
RX PubMed=19375735;
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 6
ST TPOX: 8,10
ST vWA: 15,18
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-UC-17
AC CVCL_R743
SY UMUC17; University of Michigan-Urothelial Carcinoma-17
DR Cosmic; 1927300
DR Cosmic; 1938481
DR Cosmic; 1938712
DR GEO; GSM1574541
DR GEO; GSM1574590
RX PubMed=18812553;
RX PubMed=23401075;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-UC-18
AC CVCL_R744
SY UMUC18; University of Michigan-Urothelial Carcinoma-18
DR Cosmic; 2037967
DR GEO; GSM1574561
RX PubMed=18812553;
RX PubMed=24018021;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM-UC-2
AC CVCL_8155
SY UM-UC2; UMUC2; UC-2; University of Michigan-Urothelial Carcinoma-2
DR BioSample; SAMN03151953
DR Cosmic; 846277
DR Cosmic; 1302357
DR Cosmic; 2037968
RX PubMed=3761468;
RX PubMed=6471236;
RX PubMed=16469639;
RX PubMed=18812553;
RX PubMed=19375735;
RX PubMed=20143388;
RX PubMed=24018021;
RX PubMed=25997541;
RX PubMed=26621286;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=19375735, PubMed=20143388).
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID UM-UC-3
AC CVCL_1783
SY UMUC-3; UM-UC3; UMUC3; UC-3; University of Michigan-Urothelial Carcinoma-3
DR BTO; BTO:0003723
DR CLO; CLO_0009487
DR EFO; EFO_0006771
DR ATCC; CRL-1749
DR BioSample; SAMN03471418
DR BioSample; SAMN03473229
DR CCLE; UMUC3_URINARY_TRACT
DR CCRID; 3131C0001001200023
DR ChEMBL-Cells; CHEMBL3307245
DR ChEMBL-Targets; CHEMBL612799
DR Cosmic; 715827
DR Cosmic; 724838
DR Cosmic; 760478
DR Cosmic; 845568
DR Cosmic; 846273
DR Cosmic; 928818
DR Cosmic; 943744
DR Cosmic; 1046684
DR Cosmic; 1082647
DR Cosmic; 1285132
DR Cosmic; 1285995
DR Cosmic; 1302358
DR Cosmic; 1927294
DR Cosmic; 1938480
DR Cosmic; 1938700
DR Cosmic; 2050468
DR Cosmic; 2057446
DR Cosmic; 2212694
DR Cosmic; 2444238
DR Cosmic-CLP; 724838
DR ECACC; 96020936
DR GDSC; 724838
DR GEO; GSM887729
DR GEO; GSM888824
DR GEO; GSM1374978
DR GEO; GSM1574568
DR GEO; GSM1670567
DR IGRhCellID; UMUC3
DR KCB; KCB 2014053YJ
DR PRIDE; PXD003105
RX PubMed=8873383;
RX PubMed=12127398;
RX PubMed=16469639;
RX PubMed=18812553;
RX PubMed=19375735;
RX PubMed=22460905;
RX PubMed=23401075;
RX PubMed=24367658;
RX PubMed=25485619;
RX PubMed=25997541;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27397505;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11 (ATCC; Cosmic-CLP)
ST CSF1PO: 10 (ECACC; PubMed=25877200)
ST D13S317: 8
ST D16S539: 8,9
ST D18S51: 14
ST D21S11: 31
ST D3S1358: 17,18
ST D5S818: 12
ST D7S820: 8,9
ST D8S1179: 13
ST FGA: 20,21
ST Penta D: 13
ST Penta E: 12
ST TH01: 6,9
ST TPOX: 10
ST vWA: 17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-UC-3-GFP
AC CVCL_1R40
DR BioSample; SAMN03152036
RX PubMed=19375735;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified/contaminated. Shown not to be derived from UM-UC-3, its origin is unknow (PubMed=19375735, PubMed=20143388).
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Undefined cell line type
//
ID UM-UC-4
AC CVCL_2749
SY UMUC4; University of Michigan-Urothelial Carcinoma-4
DR Cosmic; 1938701
DR ECACC; 08090501
DR GEO; GSM1574566
DR GEO; GSM1574569
RX PubMed=3761468;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Doubling time: ~32 hours (ECACC).
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-UC-5
AC CVCL_2750
SY UMUC5; University of Michigan-Urothelial Carcinoma-5
DR BTO; BTO:0004993
DR Cosmic; 1082648
DR Cosmic; 1938702
DR Cosmic; 2037969
DR ECACC; 08090502
DR GEO; GSM1574558
RX PubMed=3761468;
RX PubMed=24018021;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Doubling time: ~19 hours (ECACC).
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UM-UC-6
AC CVCL_2751
SY UM-UC6; UMUC6; UC-6; University of Michigan-Urothelial Carcinoma-6
DR Cosmic; 846278
DR Cosmic; 1082649
DR Cosmic; 1302359
DR Cosmic; 1927295
DR Cosmic; 1938703
DR ECACC; 08090503
DR GEO; GSM1574559
RX PubMed=3761468;
RX PubMed=16469639;
RX PubMed=18812553;
RX PubMed=19375735;
RX PubMed=23401075;
RX PubMed=25997541;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Doubling time: ~38 hours (ECACC).
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-UC-7
AC CVCL_2752
SY UMUC7; University of Michigan-Urothelial Carcinoma-7
DR Cosmic; 1927296
DR Cosmic; 1938704
DR Cosmic; 2037970
DR ECACC; 08090504
DR GEO; GSM1574564
RX PubMed=3761468;
RX PubMed=18812553;
RX PubMed=23401075;
RX PubMed=24018021;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Doubling time: ~19 hours (ECACC).
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UM-UC-9
AC CVCL_2753
SY UMUC9; UC-9; University of Michigan-Urothelial Carcinoma-9
DR BTO; BTO:0004990
DR Cosmic; 846274
DR Cosmic; 1082650
DR Cosmic; 2037971
DR ECACC; 08090505
DR GEO; GSM1574565
RX PubMed=16469639;
RX PubMed=18812553;
RX PubMed=19375735;
RX PubMed=24018021;
RX PubMed=25997541;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UM103-1 PGD
AC CVCL_HF75
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM11-1 PGD
AC CVCL_B837
SY UM11-1PGD
DR ISCR; 2242
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=497
WW http://www.ur.umich.edu/update/archives/120614/stemcell
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0153.
DI NCIt; C75468; Charcot-Marie-Tooth disease type 1A
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM112-1 PGD
AC CVCL_X369
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=703
WW http://www.freep.com/story/news/local/2015/01/18/embryo-donation-disease-cure/21921281/
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0285.
DI NCIt; C61252; Adrenoleukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM112-2 PGD
AC CVCL_Z077
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=826
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0307.
DI NCIt; C61252; Adrenoleukodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM114-10
AC CVCL_X368
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=710
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0290.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM121-7
AC CVCL_X367
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=711
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0291.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM126-2
AC CVCL_5H74
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=840
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0356.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM134-1 PGD
AC CVCL_X365
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=704
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0286.
DI NCIt; C82341; Spinocerebellar ataxia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM139-2 PGD
AC CVCL_X366
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=712
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0292.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM14-1
AC CVCL_B914
DR ISCR; 2243
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=569
WW http://www.ur.umich.edu/update/archives/120614/stemcell
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0162.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM14-2
AC CVCL_B915
DR ISCR; 2244
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=570
WW http://www.ur.umich.edu/update/archives/120614/stemcell
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0163.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM14-3
AC CVCL_5H73
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=839
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0355.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM141-6 PGD
AC CVCL_5H72
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=844
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0360.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM15-4 PGD
AC CVCL_B838
DR ISCR; 2245
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=529
WW http://www.ur.umich.edu/update/archives/120614/stemcell
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0161.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM150-1 PGD
AC CVCL_HF76
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM150-3 PGD
AC CVCL_IS75
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM153-1 PGD
AC CVCL_IS76
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM17-1 PGD
AC CVCL_B913
DR ISCR; 2246
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=571
WW http://www.ur.umich.edu/update/archives/120614/stemcell
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0160.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM22-2
AC CVCL_E087
DR ISCR; 2247
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=587
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0209.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM25-2
AC CVCL_Z076
SY UM25-2 PGD
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=824
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0305.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM29-2 PGD
AC CVCL_B916
DR ISCR; 2248
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=574
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0164.
DI NCIt; C84563; Aniridia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM29-3 PGD
AC CVCL_B917
DR ISCR; 2249
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=575
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0165.
DI NCIt; C84563; Aniridia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM33-4
AC CVCL_R781
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=688
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0279.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM38-2 PGD
AC CVCL_B839
SY UM38-2PGD
DR ISCR; 2250
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=534
WW http://www.ur.umich.edu/update/archives/120614/stemcell
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0155.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM4-11
AC CVCL_5H75
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=837
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0353.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM4-12
AC CVCL_5H76
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=838
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0354.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM4-6
AC CVCL_B840
DR ISCR; 2251
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=490
WW http://www.ur.umich.edu/update/archives/120614/stemcell
WW http://www.uofmhealth.org/news/human-embryonic-stem-cell-line-placed-on-national-registry
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0147.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM4-9
AC CVCL_5H77
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=836
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0352.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM57-1 PGD
AC CVCL_E088
DR ISCR; 2252
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=586
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0208.
DI NCIt; C3226; Multiple endocrine neoplasia type 2A
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM57-3 PGD
AC CVCL_HF77
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM59-2 PGD
AC CVCL_N808
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=685
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0275.
DI NCIt; C75468; Charcot-Marie-Tooth disease type 1A
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM59-4 PGD
AC CVCL_5H78
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=841
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0357.
DI NCIt; C75467; Charcot-Marie-Tooth disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM63-1
AC CVCL_R782
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=686
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0277.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM66-3 PGD
AC CVCL_HF78
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM76-1 PGS
AC CVCL_X362
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=709
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0289.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID UM76-2
AC CVCL_5H68
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=855
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0361.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM77-2
AC CVCL_R783
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=687
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0278.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM78-2
AC CVCL_X363
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=706
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0288.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM89-1 PGD
AC CVCL_N809
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=684
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0276.
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM89-2
AC CVCL_5H69
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=856
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0362.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM89-3 PGD
AC CVCL_5H70
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=842
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0358.
DI NCIt; C75467; Charcot-Marie-Tooth disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM89-4 PGD
AC CVCL_5H71
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=843
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0359.
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM89-5 PGD
AC CVCL_HF79
WW http://grants.nih.gov/stem_cells/registry/pending.htm
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; pending review.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM9-1 PGD
AC CVCL_B841
SY UM9-1PGD
DR ISCR; 2253
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=496
WW http://www.ur.umich.edu/update/archives/120614/stemcell
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0154.
DI NCIt; C26721; Hemophilia B
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM90-12 PGS
AC CVCL_X364
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=705
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0287.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UM90-14 PGD
AC CVCL_Z075
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=825
CC From: University of Michigan; Ann Arbor; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0306.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID UMB-SCC-745
AC CVCL_A093
DR Cosmic; 1483461
RX PubMed=16035614;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UMB-SCC-864
AC CVCL_A094
DR Cosmic; 1483462
RX PubMed=16035614;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UMB-SCC-969
AC CVCL_A095
DR Cosmic; 1483463
RX PubMed=16035614;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UMB1949
AC CVCL_C471
SY UMBSVtel
DR ATCC; CRL-4004
DR BioSample; SAMN03471715
RX PubMed=17592550;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 12
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 6,8
ST TPOX: 12
ST vWA: 18
DI NCIt; C3888; Renal angiomyolipoma
DI NCIt; C75331; Tuberous sclerosis 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UMC-11
AC CVCL_1784
SY UMC11; NCI-UMC-11
DR CLO; CLO_0009483
DR EFO; EFO_0002386
DR ATCC; CRL-5975
DR BioSample; SAMN03473023
DR ChEMBL-Cells; CHEMBL3308343
DR ChEMBL-Targets; CHEMBL1075606
DR Cosmic; 687835
DR Cosmic; 909779
DR Cosmic; 1879414
DR Cosmic; 1995662
DR Cosmic-CLP; 909779
DR GDSC; 909779
DR GEO; GSM784236
DR GEO; GSM827360
DR GEO; GSM1670566
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Misspelling: 'UNC-11' in PubMed=1563005.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,13
ST D16S539: 11,12
ST D18S51: 14
ST D21S11: 31.2
ST D3S1358: 14
ST D5S818: 11
ST D7S820: 9,11
ST D8S1179: 13,15
ST FGA: 20,24
ST Penta D: 13
ST Penta E: 18,19
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 14,15
DI NCIt; C4038; Lung carcinoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UMC-DgE
AC CVCL_Z423
SY DgE
RX PubMed=10950000;
CC Group: Insect cell line.
OX NCBI_TaxID=61289; ! Diatraea grandiosella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UMC-OnE
AC CVCL_Z424
SY OnE
RX PubMed=10950000;
CC Group: Insect cell line.
OX NCBI_TaxID=29057; ! Ostrinia nubilalis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UMJF-2
AC CVCL_M548
RX PubMed=1649357;
RX PubMed=10936422;
CC Problematic cell line: Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10936422).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UML-49
AC CVCL_D646
DR BTO; BTO:0005284
RX PubMed=20413351;
CC Miscellaneous: Only mentioned as a lymphoblastoid cell line in PubMed=20413351.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID UMMT-ARK-1
AC CVCL_IW26
RX PubMed=22498937;
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UMMT-ARK-2
AC CVCL_IW27
RX PubMed=22498937;
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UMN-MDH-1
AC CVCL_AV47
RX DOI=10.1111/j.1550-7408.1983.tb05338.x;
CC Group: Insect cell line.
OX NCBI_TaxID=40071; ! Malacosoma disstria
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UMN-PIE-1181
AC CVCL_Z394
RX DOI=10.1016/0022-2011(85)90147-8;
RX PubMed=1561320;
CC Group: Insect cell line.
OX NCBI_TaxID=58824; ! Plodia interpunctella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UMNSAH/DF-1
AC CVCL_0570
SY UMNSAH-DF-1; UMNSAH-DF 1; UMNSAH-DF1; UMNSAH/DF#1; DF-1; DF1
DR BTO; BTO:0005956
DR CLO; CLO_0009484
DR MCCL; MCC:0000475
DR ATCC; CRL-12203
DR BCRJ; 0307
DR CCLV; CCLV-RIE 1029
DR CCRID; 3131C0001000400023
DR IZSLER; BS CL 197
DR KCB; KCB 2012111YJ
RX Patent=US5672485;
RX PubMed=9721238;
RX PubMed=16313905;
RX PubMed=18638503;
RX PubMed=19941903;
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/cef/cefcells.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-546.html
CC Group: Bird cell line.
CC Breed/subspecies: East Lansing Line 0 (ELL-0).
OX NCBI_TaxID=9031; ! Gallus gallus
CA Spontaneously immortalized cell line
//
ID UMR-104
AC CVCL_S478
SY UMR 104
RX PubMed=6575864;
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_S479 ! UMR-105
OI CVCL_3617 ! UMR-106
OI CVCL_3618 ! UMR-108
CA Cancer cell line
//
ID UMR-105
AC CVCL_S479
SY UMR 105
RX PubMed=6575864;
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_S478 ! UMR-104
OI CVCL_3617 ! UMR-106
OI CVCL_3618 ! UMR-108
CA Cancer cell line
//
ID UMR-106
AC CVCL_3617
SY UMR 106; UMR106
DR BTO; BTO:0002576
DR CLO; CLO_0009485
DR CLDB; cl4610
DR ATCC; CRL-1661
DR BCRC; 60270
DR BCRJ; 0243
DR CCRID; 3131C0001001200010
DR ECACC; 90111314
DR IZSLER; BS TCL 106
DR NCBI_Iran; C586
RX PubMed=6575864;
RX PubMed=7988420;
CC Characteristics: Responsive to PTH, prostaglandins and bone-resorbing steroids.
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_S478 ! UMR-104
OI CVCL_S479 ! UMR-105
OI CVCL_3618 ! UMR-108
CA Cancer cell line
//
ID UMR-106-01
AC CVCL_D580
SY UMR 106-01; UMR106-01; UMR 106-1
DR BTO; BTO:0005173
DR Lonza; 1311
RX PubMed=3922597;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-316.html
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3617 ! UMR-106
CA Cancer cell line
//
ID UMR-106-06
AC CVCL_S477
SY UMR 106-06; UMR106-06
DR ChEMBL-Cells; CHEMBL3307259
DR ChEMBL-Targets; CHEMBL613502
RX PubMed=1659122;
RX PubMed=3922597;
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3617 ! UMR-106
CA Cancer cell line
//
ID UMR-108
AC CVCL_3618
SY UMR 108; UMR108
DR BTO; BTO:0002577
DR CLO; CLO_0009486
DR CLDB; cl4611
DR ATCC; CRL-1663
DR ECACC; 91060527
DR IZSLER; BS TCL 107
RX PubMed=6575864;
RX PubMed=10457266;
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_S478 ! UMR-104
OI CVCL_S479 ! UMR-105
OI CVCL_3617 ! UMR-106
CA Cancer cell line
//
ID UMR-201
AC CVCL_F683
SY UMR 201; UMR201
RX PubMed=1659122;
RX PubMed=3213604;
CC Doubling time: ~24 hours (PubMed=3213604).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Finite cell line
//
ID UMR-201-10A
AC CVCL_IR40
SY 10A
RX PubMed=1659122;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_F683 ! UMR-201
CA Transformed cell line
//
ID UMR-201-10B
AC CVCL_IR41
SY UMR 201-10B; 10B
RX PubMed=1659122;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_F683 ! UMR-201
CA Transformed cell line
//
ID UMT2
AC CVCL_R739
SY Uveal Melanoma Tubingen 2
DR Cosmic; 1879475
RX PubMed=23456173;
CC Doubling time: 3-4 days (PubMed=23456173).
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UMT26
AC CVCL_R740
SY Uveal Melanoma Tubingen 26
DR Cosmic; 1879477
RX PubMed=23456173;
CC Doubling time: 3-4 months (PubMed=23456173).
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UMT33
AC CVCL_R741
SY Uveal Melanoma Tubingen 33
DR Cosmic; 1879479
RX PubMed=23456173;
CC Doubling time: 33 days (PubMed=23456173).
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UN-KC-6141
AC CVCL_1U11
RX PubMed=24278292;
CC Breed/subspecies: B6.FVB-Tg(Pdx1-cre)6Tuv/J,LSL-Kras(G12D/+).
DI NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID UN-KPC-960
AC CVCL_1U12
RX PubMed=24278292;
CC Breed/subspecies: B6.FVB-Tg(Pdx1-cre)6Tuv/J,LSL-Kras(G12D/+),LSL-Trp53(R175H/+).
DI NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID UN-KPC-961
AC CVCL_1U13
RX PubMed=24278292;
CC Breed/subspecies: B6.FVB-Tg(Pdx1-cre)6Tuv/J,LSL-Kras(G12D/+),LSL-Trp53(R175H/+).
DI NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID UN7RGB
AC CVCL_T332
DR CLO; CLO_0050700
DR BioSample; SAMN03472186
DR RCB; GMC0010
DR RCB; RCB0873
CC Discontinued: RCB; RCB0873; true.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 10,12
ST D5S818: 11
ST D7S820: 12
ST TH01: 6,8
ST TPOX: 8
ST vWA: 14,20
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID UN8RGB
AC CVCL_T333
DR CLO; CLO_0050695
DR BioSample; SAMN03472159
DR RCB; GMC0011
DR RCB; RCB1141
CC Discontinued: RCB; RCB1141; true.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,11
ST D16S539: 10,11
ST D5S818: 12,13
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 16
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID UNC-10
AC CVCL_L890
SY UNC10
DR Cosmic; 1122676
RX PubMed=14732763;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UNC-7
AC CVCL_L891
SY UNC7
DR Cosmic; 1122675
DR Cosmic; 1530766
RX PubMed=14732763;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UNEWi001-A
AC CVCL_9S37
SY UNEW001Ai
DR BioSamples; SAMEA2629641
DR EBiSC; UNEWi001-A
DR ECACC; 66540039
DR hPSCreg; UNEWi001-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C85045; Retinitis pigmentosa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi002-A
AC CVCL_9S38
SY PRPF31 AW; UNEW002Ai
DR BioSamples; SAMEA2629491
DR EBiSC; UNEWi002-A
DR ECACC; 66540040
DR hPSCreg; UNEWi002-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C85045; Retinitis pigmentosa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi003-A
AC CVCL_IU01
SY PRPF31 HD
DR hPSCreg; UNEWi003-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C85045; Retinitis pigmentosa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi004-A
AC CVCL_9S39
SY PRPF31 SH
DR BioSamples; SAMEA3275846
DR EBiSC; UNEWi004-A
DR ECACC; 66540017
DR hPSCreg; UNEWi004-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C85045; Retinitis pigmentosa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi005-A
AC CVCL_9S40
SY PRPF31 RH
DR BioSamples; SAMEA3275904
DR EBiSC; UNEWi005-A
DR ECACC; 66540020
DR hPSCreg; UNEWi005-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C85045; Retinitis pigmentosa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi017-A
AC CVCL_II93
DR BioSamples; SAMEA3142096
DR EBiSC; UNEWi017-A
DR ECACC; 66540057
DR hPSCreg; UNEWi017-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C2870; Aplastic anemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi018-A
AC CVCL_II94
DR BioSamples; SAMEA3142165
DR EBiSC; UNEWi018-A
DR ECACC; 66540012
DR hPSCreg; UNEWi018-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C2870; Aplastic anemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi019-A
AC CVCL_II95
DR BioSamples; SAMEA3275958
DR EBiSC; UNEWi019-A
DR ECACC; 66540021
DR hPSCreg; UNEWi019-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C2869; Anemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi021-A
AC CVCL_IT82
SY F018 13.2
DR BioSamples; SAMEA4092799
DR EBiSC; UNEWi021-A
DR hPSCreg; UNEWi021-A
CC From: University of Newcastle; Newcastle; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT83 ! UNEWi021-B
OI CVCL_IT84 ! UNEWi021-C
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi021-B
AC CVCL_IT83
SY F018 15.8
DR BioSamples; SAMEA4092819
DR EBiSC; UNEWi021-B
DR hPSCreg; UNEWi021-B
CC From: University of Newcastle; Newcastle; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT82 ! UNEWi021-A
OI CVCL_IT84 ! UNEWi021-C
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi021-C
AC CVCL_IT84
SY F018 17/8-1
DR BioSamples; SAMEA4092855
DR EBiSC; UNEWi021-C
DR hPSCreg; UNEWi021-C
CC From: University of Newcastle; Newcastle; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT82 ! UNEWi021-A
OI CVCL_IT83 ! UNEWi021-B
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi022-A
AC CVCL_IT85
SY F181 5.8
DR BioSamples; SAMEA4092883
DR EBiSC; UNEWi022-A
DR hPSCreg; UNEWi022-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT86 ! UNEWi022-B
OI CVCL_IT87 ! UNEWi022-C
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi022-B
AC CVCL_IT86
SY F181 18.2
DR BioSamples; SAMEA4092901
DR EBiSC; UNEWi022-B
DR hPSCreg; UNEWi022-B
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT85 ! UNEWi022-A
OI CVCL_IT87 ! UNEWi022-C
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi022-C
AC CVCL_IT87
SY F181 25.7
DR BioSamples; SAMEA4092914
DR EBiSC; UNEWi022-C
DR hPSCreg; UNEWi022-C
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT85 ! UNEWi022-A
OI CVCL_IT86 ! UNEWi022-B
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi023-A
AC CVCL_IT88
SY F343 clone 2
DR BioSamples; SAMEA4567585
DR hPSCreg; UNEWi023-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT89 ! UNEWi023-B
OI CVCL_IT90 ! UNEWi023-C
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi023-B
AC CVCL_IT89
SY F343 clone 3
DR BioSamples; SAMEA4567587
DR hPSCreg; UNEWi023-B
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT88 ! UNEWi023-A
OI CVCL_IT90 ! UNEWi023-C
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi023-C
AC CVCL_IT90
SY F343 clone 4
DR BioSamples; SAMEA4567588
DR hPSCreg; UNEWi023-C
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT88 ! UNEWi023-A
OI CVCL_IT89 ! UNEWi023-B
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi024-A
AC CVCL_IT91
SY F180-1
DR BioSamples; SAMEA444699
DR EBiSC; UNEWi024-A
DR hPSCreg; UNEWi024-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT92 ! UNEWi024-B
OI CVCL_IT93 ! UNEWi024-C
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi024-B
AC CVCL_IT92
SY F180-2
DR BioSamples; SAMEA4447006
DR EBiSC; UNEWi024-B
DR hPSCreg; UNEWi024-B
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT91 ! UNEWi024-A
OI CVCL_IT93 ! UNEWi024-C
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi024-C
AC CVCL_IT93
SY F180-3
DR BioSamples; SAMEA4447024
DR EBiSC; UNEWi024-C
DR hPSCreg; UNEWi024-C
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT91 ! UNEWi024-A
OI CVCL_IT92 ! UNEWi024-B
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi025-A
AC CVCL_IT94
SY F324 5.8
DR BioSamples; SAMEA4447907
DR EBiSC; UNEWi025-A
DR hPSCreg; UNEWi025-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT95 ! UNEWi025-B
OI CVCL_IT96 ! UNEWi025-C
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi025-B
AC CVCL_IT95
SY F324 12.8
DR BioSamples; SAMEA4447908
DR EBiSC; UNEWi025-B
DR hPSCreg; UNEWi025-B
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT94 ! UNEWi025-A
OI CVCL_IT96 ! UNEWi025-C
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi025-C
AC CVCL_IT96
SY F324 19.7
DR BioSamples; SAMEA4447909
DR EBiSC; UNEWi025-C
DR hPSCreg; UNEWi025-C
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT94 ! UNEWi025-A
OI CVCL_IT95 ! UNEWi025-B
SX Female
CA Induced pluripotent stem cell
//
ID UNEWi026-A
AC CVCL_IT97
SY SF116 clone 1
DR BioSamples; SAMEA4567589
DR hPSCreg; UNEWi026-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT98 ! UNEWi026-B
OI CVCL_IT99 ! UNEWi026-C
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi026-B
AC CVCL_IT98
SY SF116 clone 2
DR BioSamples; SAMEA4567590
DR hPSCreg; UNEWi026-B
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT97 ! UNEWi026-A
OI CVCL_IT99 ! UNEWi026-C
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi026-C
AC CVCL_IT99
SY SF116 clone K
DR BioSamples; SAMEA4567591
DR hPSCreg; UNEWi026-C
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C84391; Macular degeneration
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IT97 ! UNEWi026-A
OI CVCL_IT98 ! UNEWi026-B
SX Male
CA Induced pluripotent stem cell
//
ID UNEWi027-A
AC CVCL_IU00
SY F116
DR BioSamples; SAMEA4458542
DR hPSCreg; UNEWi027-A
CC From: University of Newcastle; Newcastle; UK.
DI NCIt; C85045; Retinitis pigmentosa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UO-31
AC CVCL_1911
AS CVCL_1777
SY UO.31; UO31; U031
DR BTO; BTO:0004234
DR ChEMBL-Cells; CHEMBL3307612
DR ChEMBL-Cells; CHEMBL3308806
DR ChEMBL-Targets; CHEMBL614388
DR ChEMBL-Targets; CHEMBL1075603
DR Cosmic; 687945
DR Cosmic; 875869
DR Cosmic; 897465
DR Cosmic; 905981
DR Cosmic; 974304
DR Cosmic; 1044263
DR Cosmic; 1092643
DR Cosmic; 1175853
DR Cosmic; 1305379
DR Cosmic; 1998486
DR Cosmic-CLP; 905981
DR GDSC; 905981
DR GEO; GSM50232
DR GEO; GSM50296
DR GEO; GSM750841
DR GEO; GSM799378
DR GEO; GSM799441
DR GEO; GSM847169
DR GEO; GSM844724
DR GEO; GSM1153451
DR GEO; GSM1181309
DR GEO; GSM1181327
DR GEO; GSM1670553
DR SKY/M-FISH/CGH; 2808
RX PubMed=2041050;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=35
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 41.7 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=19372543
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 11,13
ST D18S51: 14,16
ST D19S433: 13,16.2
ST D21S11: 32.2
ST D2S1338: 23
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 13
ST FGA: 21,25
ST TH01: 7
ST TPOX: 11
ST vWA: 16,20
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UoC-B1
AC CVCL_A296
SY UOC-B1; UOCB1; UoCB1
DR Cosmic; 1524827
DR GEO; GSM236810
DR GEO; GSM236846
RX PubMed=7849311;
RX PubMed=8231254;
RX PubMed=8704231;
RX PubMed=9108419;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UoC-B10
AC CVCL_A301
SY UOC-B10; UOCB10
RX PubMed=8069867;
RX PubMed=8704231;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UoC-B11
AC CVCL_A299
SY UOC-B11; UOCB11
RX PubMed=8704231;
RX PubMed=9108419;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UoC-B12
AC CVCL_A300
SY UOC-B12; UOCB12; AT-1; AT1
DR Cosmic; 1524790
DR GEO; GSM236778
DR GEO; GSM236814
RX PubMed=8704231;
RX PubMed=12127395;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DI26 ! AT-2
SX Male
CA Cancer cell line
//
ID UoC-B2
AC CVCL_A302
SY UOC-B2; UOCB2
RX PubMed=7687517;
RX PubMed=8704231;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UoC-B3
AC CVCL_A298
SY UOC-B3; UOCB3
RX PubMed=8231254;
RX PubMed=8704231;
RX PubMed=9108419;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A303 ! UoC-B5
SX Female
CA Cancer cell line
//
ID UoC-B4
AC CVCL_A297
SY UOC-B4; UOCB4; UoCB4
RX PubMed=7849311;
RX PubMed=8231254;
RX PubMed=8704231;
RX PubMed=9108419;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A304 ! UoC-B6
SX Female
CA Cancer cell line
//
ID UoC-B5
AC CVCL_A303
SY UOC-B5; UOCB5
RX PubMed=8231254;
RX PubMed=8704231;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A298 ! UoC-B3
SX Female
CA Cancer cell line
//
ID UoC-B6
AC CVCL_A304
SY UOC-B6; UOCB6
RX PubMed=8231254;
RX PubMed=8704231;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A297 ! UoC-B4
SX Female
CA Cancer cell line
//
ID UoC-B7
AC CVCL_A305
SY UOC-B7; UOCB7
RX PubMed=8231254;
RX PubMed=8704231;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UoC-B8
AC CVCL_A306
SY UOC-B8; UOCB8
RX PubMed=8231254;
RX PubMed=8704231;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UoC-B9
AC CVCL_A307
SY UOC-B9; UOCB9
DR Cosmic; 2491079
RX PubMed=8231254;
RX PubMed=8704231;
RX PubMed=9067587;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UoC-M1
AC CVCL_A480
SY UOC-M1; UOCM1
DR Cosmic; 975311
DR DSMZ; ACC-775
DR GEO; GSM1040774
RX PubMed=9665199;
CC Doubling time: ~50-60 hours (DSMZ).
CC Misspelling: 'UCM1' in GEO GSM1040774.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 11
ST TH01: 7
ST TPOX: 9
ST vWA: 15,16
DI NCIt; C7965; Adult acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UOFS-CT-1
AC CVCL_Z828
RX PubMed=2280394;
CC Group: Insect cell line.
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the institution (University of the Orange Free State) and of the species.
OX NCBI_TaxID=561267; ! Culex theileri
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID UOK101
AC CVCL_B076
SY UOK-101; UOK 101
DR CCLE; UOK101_KIDNEY
DR Cosmic; 972889
RX PubMed=1345811;
RX PubMed=7915601;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 28 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK102
AC CVCL_B080
SY UOK-102; UOK 102
DR Cosmic; 972890
RX PubMed=1345811;
RX PubMed=7915601;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK103
AC CVCL_B081
SY UOK-103; UOK 103
RX PubMed=1345811;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK104
AC CVCL_B082
SY UOK-104; UOK 104
RX PubMed=1345811;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK105
AC CVCL_B083
SY UOK-105; UOK 105
RX PubMed=1345811;
RX PubMed=27993170;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK106
AC CVCL_B084
SY UOK-106; UOK 106
RX PubMed=1345811;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK107
AC CVCL_B085
SY UOK-107; UOK 107; UOK 50
RX PubMed=1345811;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK108
AC CVCL_B086
SY UOK-108; UOK 108
RX PubMed=1345811;
RX PubMed=9255309;
RX PubMed=27993170;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK109
AC CVCL_B087
SY UOK-109; UOK 109
DR Cosmic; 1241981
RX PubMed=1345811;
RX PubMed=9255309;
RX PubMed=9393982;
DI NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B088 ! UOK109LN
SX Male
CA Cancer cell line
//
ID UOK109LN
AC CVCL_B088
SY UOK-109LN; UOK 109LN
RX PubMed=1345811;
RX PubMed=9255309;
CC Derived from metastatic site: Lymph node.
DI NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B087 ! UOK109
SX Male
CA Cancer cell line
//
ID UOK110
AC CVCL_B089
SY UOK-110; UOK 110
DR Cosmic; 972891
RX PubMed=1345811;
RX PubMed=7915601;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK111
AC CVCL_B090
SY UOK-111; UOK 111; UOK 39
DR Cosmic; 972892
DR SKY/M-FISH/CGH; 1526
RX PubMed=1345811;
RX PubMed=7915601;
RX PubMed=12759923;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UOK112
AC CVCL_B091
SY UOK-112; UOK 112
RX PubMed=1345811;
RX PubMed=9255309;
RX PubMed=9393982;
RX PubMed=27993170;
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UOK113
AC CVCL_B092
SY UOK-113; UOK 113
RX PubMed=1345811;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK114
AC CVCL_B093
SY UOK-114; UOK 114
RX PubMed=1345811;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK115
AC CVCL_B094
SY UOK-115; UOK 115
DR Cosmic; 845932
DR Cosmic; 972893
DR SKY/M-FISH/CGH; 1484
RX PubMed=1345811;
RX PubMed=7915601;
RX PubMed=9255309;
RX PubMed=10723130;
RX PubMed=12759923;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UOK116
AC CVCL_B095
SY UOK-116; UOK 116
RX PubMed=1345811;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK117
AC CVCL_B096
SY UOK-117; UOK 117
DR Cosmic; 972894
DR SKY/M-FISH/CGH; 1485
RX PubMed=1345811;
RX PubMed=7915601;
RX PubMed=9255309;
RX PubMed=12759923;
RX PubMed=27993170;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UOK117-5
AC CVCL_IS29
DR Cosmic; 845927
RX PubMed=10723130;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B096 ! UOK117
SX Male
CA Cancer cell line
//
ID UOK118
AC CVCL_B097
SY UOK-118; UOK 118
DR Cosmic; 972871
DR Cosmic; 972895
RX PubMed=1345811;
RX PubMed=7915601;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK119
AC CVCL_B098
SY UOK-119; UOK 119
RX PubMed=1345811;
RX PubMed=9255309;
RX PubMed=27993170;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK120
AC CVCL_B099
SY UOK-120; UOK 120
DR Cosmic; 1330966
RX PubMed=1345811;
RX PubMed=7587394;
RX PubMed=8872474;
RX PubMed=9255309;
RX PubMed=27993170;
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UOK121
AC CVCL_B100
SY UOK-121; UOK 121; UoK121
DR SKY/M-FISH/CGH; 1480
RX PubMed=1345811;
RX PubMed=9255309;
RX PubMed=12759923;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B101 ! UOK121LN
SX Male
CA Cancer cell line
//
ID UOK121LN
AC CVCL_B101
SY UOK-121LN; UOK 121LN
RX PubMed=1345811;
RX PubMed=9255309;
CC Derived from metastatic site: Lymph node.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B100 ! UOK121
SX Male
CA Cancer cell line
//
ID UOK122
AC CVCL_B102
SY UOK-122; UOK 122
DR SKY/M-FISH/CGH; 1475
RX PubMed=1345811;
RX PubMed=12759923;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B103 ! UOK122LN
SX Male
CA Cancer cell line
//
ID UOK122LN
AC CVCL_B103
SY UOK-122LN; UOK 122LN
RX PubMed=1345811;
RX PubMed=9255309;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B102 ! UOK122
SX Male
CA Cancer cell line
//
ID UOK123
AC CVCL_B104
SY UOK-123; UOK 123
DR Cosmic; 845926
DR Cosmic; 972896
RX PubMed=1345811;
RX PubMed=7915601;
RX PubMed=9255309;
RX PubMed=10723130;
RX PubMed=27993170;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK124
AC CVCL_B105
SY UOK-124; UOK 124
DR Cosmic; 1330967
RX PubMed=1345811;
RX PubMed=7587394;
RX PubMed=8872474;
RX PubMed=9255309;
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B106 ! UOK124LN
SX Female
CA Cancer cell line
//
ID UOK124LN
AC CVCL_B106
SY UOK-124LN; UOK 124LN
RX PubMed=1345811;
CC Derived from metastatic site: Lymph node.
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B105 ! UOK124
SX Female
CA Cancer cell line
//
ID UOK125
AC CVCL_B107
SY UOK-125; UOK 125
DR Cosmic; 845931
RX PubMed=1345811;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK126
AC CVCL_B108
SY UOK-126; UOK 126
RX PubMed=1345811;
RX PubMed=9255309;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK127
AC CVCL_B109
SY UOK-127; UOK 127
RX PubMed=1345811;
RX PubMed=9255309;
RX PubMed=27993170;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK128
AC CVCL_B110
SY UOK-128; UOK 128
RX PubMed=1345811;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK129
AC CVCL_B111
SY UOK-129; UOK 129
RX PubMed=1345811;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK130
AC CVCL_B112
SY UOK-130; UOK 130
DR Cosmic; 972897
DR Cosmic; 981000
DR SKY/M-FISH/CGH; 1527
RX PubMed=1345811;
RX PubMed=7915601;
RX PubMed=12759923;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UOK131
AC CVCL_B113
SY UOK-131; UOK 131
RX PubMed=1345811;
RX PubMed=9255309;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK132
AC CVCL_B114
SY UOK-132; UOK 132
RX PubMed=9255309;
RX PubMed=9393982;
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UOK133
AC CVCL_B115
SY UOK-133; UOK 133
RX PubMed=9255309;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK134
AC CVCL_B116
SY UOK-134; UOK 134
RX PubMed=9255309;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK135
AC CVCL_B117
SY UOK-135; UOK 135
DR Cosmic; 972898
RX PubMed=7915601;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK136COL
AC CVCL_IS28
SY UOK-136COL; UOK 136COL
RX PubMed=9255309;
CC Derived from metastatic site: Colon.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK139
AC CVCL_B118
SY UOK-139; UOK 139
DR Cosmic; 972899
RX PubMed=7915601;
RX PubMed=9255309;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK140
AC CVCL_B119
SY UOK-140; UOK 140
DR Cosmic; 972900
DR Cosmic; 981002
RX PubMed=7915601;
RX PubMed=9255309;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK141
AC CVCL_B120
SY UOK-141; UOK 141
DR Cosmic; 972901
RX PubMed=7915601;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK142
AC CVCL_B121
SY UOK-142; UOK 142
DR Cosmic; 972902
RX PubMed=7915601;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK143
AC CVCL_B225
SY UOK-143; UOK 143; UoK143
DR SKY/M-FISH/CGH; 1473
RX PubMed=12759923;
RX PubMed=9255309;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UOK145
AC CVCL_B122
SY UOK-145; UOK 145
DR Cosmic; 1241980
RX PubMed=9393982;
RX PubMed=23628822;
DI NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UOK146
AC CVCL_B123
SY UOK-146; UOK 146
DR Cosmic; 1330968
RX PubMed=8872474;
RX PubMed=9255309;
DI NCIt; C6975; Papillary renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UOK147
AC CVCL_B124
SY UOK-147; UOK 147
DR Cosmic; 845924
RX PubMed=9255309;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK150
AC CVCL_B125
SY UOK-150; UOK 150
DR Cosmic; 972903
RX PubMed=7915601;
RX PubMed=9255309;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK151
AC CVCL_B126
SY UOK-151; UOK 151
DR Cosmic; 972875
DR Cosmic; 972904
RX PubMed=7915601;
RX PubMed=9255309;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK152
AC CVCL_B252
SY UOK-152; UOK 152
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK154
AC CVCL_B127
SY UOK-154; UOK 154
DR Cosmic; 972905
DR SKY/M-FISH/CGH; 1524
RX PubMed=7915601;
RX PubMed=9255309;
RX PubMed=12759923;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IS27 ! UOK154LN
SX Female
CA Cancer cell line
//
ID UOK154LN
AC CVCL_IS27
SY UOK-154LN; UOK 154LN
RX PubMed=9255309;
CC Derived from metastatic site: Lymph node.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B127 ! UOK154
SX Female
CA Cancer cell line
//
ID UOK161
AC CVCL_B128
SY UOK-161; UOK 161
DR Cosmic; 972906
RX PubMed=7915601;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK162
AC CVCL_B129
SY UOK-162; UOK 162
DR Cosmic; 972907
DR Cosmic; 981004
RX PubMed=7915601;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK163
AC CVCL_B130
SY UOK-163; UOK 163
DR Cosmic; 972908
RX PubMed=7915601;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK164
AC CVCL_B131
SY UOK-164; UOK 164
DR Cosmic; 972909
RX PubMed=7915601;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOK171
AC CVCL_B223
SY UOK-171; UOK 171
DR SKY/M-FISH/CGH; 1525
RX PubMed=12759923;
WW http://www.ott.nih.gov/technology/e-033-2010
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UOK181
AC CVCL_B224
SY UOK-181; UOK 181
DR SKY/M-FISH/CGH; 1483
RX PubMed=12759923;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UOK257
AC CVCL_S717
SY UOK-257; UOK 257
DR SKY/M-FISH/CGH; 5607
RX PubMed=17028174;
RX PubMed=18206534;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-605.html
WW http://www.bhdsyndrome.org/for-researchers/what-is-bhd/cell-lines-and-model-organisms-for-studying-bhd-syndrome/uok-257-cell-line/
DI NCIt; C28244; Birt-Hogg-Dube syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UOK257-2
AC CVCL_1D69
RX PubMed=17028174;
WW http://www.bhdsyndrome.org/for-researchers/what-is-bhd/cell-lines-and-model-organisms-for-studying-bhd-syndrome/uok-257-cell-line/
CC Transfected with: HGNC; 27310; FLCN.
DI NCIt; C28244; Birt-Hogg-Dube syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S717 ! UOK257
SX Male
CA Cancer cell line
//
ID UOK262
AC CVCL_1D72
SY UOK-262; UOK 262
DR BTO; BTO:0005727
RX PubMed=19963135;
RX PubMed=27993170;
WW http://www.ott.nih.gov/erma/uok-262-hereditary-leiomyomatosis-and-renal-cell-carcinoma-hlrcc-cell-line
CC Derived from metastatic site: Kidney.
DI NCIt; C51302; Hereditary leiomyomatosis and renal cell cancer
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UOK268
AC CVCL_1D73
SY UOK 268
RX PubMed=22867999;
RX PubMed=27993170;
WW http://www.ott.nih.gov/erma/one-1-vial-uok-268-hereditary-leiomyomatosis-and-renal-cell-carcinoma-hlrcc-human-cell-line
DI NCIt; C51302; Hereditary leiomyomatosis and renal cell cancer
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UOKCR
AC CVCL_4Z16
SY UOK(CR)
RX PubMed=17509556;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B112 ! UOK130
SX Male
CA Cancer cell line
//
ID UOXFi001-A
AC CVCL_EE27
SY MK071-1; iPS.MK071.1; GBA-PD 1#1
DR BioSamples; SAMEA4453897
DR EBiSC; UOXFi001-A
DR ECACC; 66540384
DR hPSCreg; UOXFi001-A
RX PubMed=26905200;
CC From: University of Oxford; Oxford; UK.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE28 ! UOXFi001-B
OI CVCL_EE29 ! UOXFi001-C
OI CVCL_EE30 ! UOXFi001-D
SX Female
CA Induced pluripotent stem cell
//
ID UOXFi001-B
AC CVCL_EE28
SY MK071-3; iPS.MK071.3; GBA-PD 1#2
DR BioSamples; SAMEA4453900
DR EBiSC; UOXFi001-B
DR ECACC; 66540385
RX PubMed=26905200;
CC From: University of Oxford; Oxford; UK.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE27 ! UOXFi001-A
OI CVCL_EE29 ! UOXFi001-C
OI CVCL_EE30 ! UOXFi001-D
SX Female
CA Induced pluripotent stem cell
//
ID UOXFi001-C
AC CVCL_EE29
SY MK071-5; iPS.MK071.5
DR BioSamples; SAMEA4453901
DR EBiSC; UOXFi001-C
DR ECACC; 66540386
DR hPSCreg; UOXFi001-C
CC From: University of Oxford; Oxford; UK.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE27 ! UOXFi001-A
OI CVCL_EE28 ! UOXFi001-B
OI CVCL_EE30 ! UOXFi001-D
SX Female
CA Induced pluripotent stem cell
//
ID UOXFi001-D
AC CVCL_EE30
SY MK071-6; iPS.MK071.6
DR BioSamples; SAMEA4454476
DR EBiSC; UOXFi001-D
DR ECACC; 66540387
DR hPSCreg; UOXFi001-D
CC From: University of Oxford; Oxford; UK.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE27 ! UOXFi001-A
OI CVCL_EE28 ! UOXFi001-B
OI CVCL_EE29 ! UOXFi001-C
SX Female
CA Induced pluripotent stem cell
//
ID UOXFi002-A
AC CVCL_IJ04
SY MK082-26
DR BioSamples; SAMEA4458672
DR EBiSC; UOXFi002-A
DR ECACC; 66540388
CC From: University of Oxford; Oxford; UK.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IJ05 ! UOXFi002-B
OI CVCL_IJ06 ! UOXFi002-C
SX Male
CA Induced pluripotent stem cell
//
ID UOXFi002-B
AC CVCL_IJ05
SY MK082-30
DR BioSamples; SAMEA4458549
DR EBiSC; UOXFi002-B
DR ECACC; 66540389
DR hPSCreg; UOXFi002-B
CC From: University of Oxford; Oxford; UK.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IJ04 ! UOXFi002-A
OI CVCL_IJ06 ! UOXFi002-C
SX Male
CA Induced pluripotent stem cell
//
ID UOXFi002-C
AC CVCL_IJ06
SY MK082-31
DR BioSamples; SAMEA7615168
DR EBiSC; UOXFi002-C
DR ECACC; 66540390
CC From: University of Oxford; Oxford; UK.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IJ04 ! UOXFi002-A
OI CVCL_IJ05 ! UOXFi002-B
SX Male
CA Induced pluripotent stem cell
//
ID UOXFi003-A
AC CVCL_EE31
SY MK088-1; GBA-PD 2#1
DR BioSamples; SAMEA4454477
DR EBiSC; UOXFi003-A
DR ECACC; 66540391
DR hPSCreg; UOXFi003-A
RX PubMed=26905200;
CC From: University of Oxford; Oxford; UK.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE32 ! UOXFi003-C
SX Male
CA Induced pluripotent stem cell
//
ID UOXFi003-C
AC CVCL_EE32
SY MK088-7
DR BioSamples; SAMEA4454479
DR EBiSC; UOXFi003-C
DR ECACC; 66540392
DR hPSCreg; UOXFi003-C
CC From: University of Oxford; Oxford; UK.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE31 ! UOXFi003-A
SX Male
CA Induced pluripotent stem cell
//
ID UOXFi004-A
AC CVCL_IJ07
SY OX1-18
DR BioSamples; SAMEA7615918
DR EBiSC; UOXFi004-A
DR ECACC; 66540393
DR hPSCreg; UOXFi004-A
CC From: University of Oxford; Oxford; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IJ08 ! UOXFi004-B
SX Male
CA Induced pluripotent stem cell
//
ID UOXFi004-B
AC CVCL_IJ08
SY OX1-19
DR BioSamples; SAMEA4454111
DR EBiSC; UOXFi004-B
DR ECACC; 66540394
DR hPSCreg; UOXFi004-B
CC From: University of Oxford; Oxford; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IJ07 ! UOXFi004-A
SX Male
CA Induced pluripotent stem cell
//
ID UOXFi005-A
AC CVCL_EE33
SY JR053-1
DR BioSamples; SAMEA4453899
DR EBiSC; UOXFi005-A
DR ECACC; 66540395
DR hPSCreg; UOXFi005-A
CC From: University of Oxford; Oxford; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE34 ! UOXFi005-B
OI CVCL_EE35 ! UOXFi005-C
SX Male
CA Induced pluripotent stem cell
//
ID UOXFi005-B
AC CVCL_EE34
SY JR053-6
DR BioSamples; SAMEA4454480
DR EBiSC; UOXFi005-B
DR ECACC; 66540396
DR hPSCreg; UOXFi005-B
CC From: University of Oxford; Oxford; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE33 ! UOXFi005-A
OI CVCL_EE35 ! UOXFi005-C
SX Male
CA Induced pluripotent stem cell
//
ID UOXFi005-C
AC CVCL_EE35
SY JR053-7
DR BioSamples; SAMEA4454481
DR EBiSC; UOXFi005-C
DR ECACC; 66540397
DR hPSCreg; UOXFi005-C
CC From: University of Oxford; Oxford; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE33 ! UOXFi005-A
OI CVCL_EE34 ! UOXFi005-B
SX Male
CA Induced pluripotent stem cell
//
ID UOXFi006-A
AC CVCL_IJ09
SY OX2-28
DR BioSamples; SAMEA4458551
DR EBiSC; UOXFi006-A
DR ECACC; 66540398
DR hPSCreg; UOXFi006-A
CC From: University of Oxford; Oxford; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID UP-007
AC CVCL_AP56
RX PubMed=25550537;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UP-019
AC CVCL_AP57
RX PubMed=24335698;
RX PubMed=25550537;
ST Source(s): PubMed=24335698
ST Amelogenin: X
ST CSF1PO: 8,11
ST D13S317: 10,12
ST D16S539: 11
ST D21S11: 29
ST D5S818: 12
ST D7S820: 9
ST TH01: 9.3
ST TPOX: 12
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UP-029
AC CVCL_AU95
RX PubMed=24335698;
ST Source(s): PubMed=24335698
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,12
ST D16S539: 10,11
ST D21S11: 28,30
ST D5S818: 12
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UP-032
AC CVCL_AP58
RX PubMed=24335698;
RX PubMed=25550537;
ST Source(s): PubMed=24335698
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12,13
ST D21S11: 30,31
ST D5S818: 12,13
ST D7S820: 10
ST TH01: 8
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPAB
AC CVCL_1R54
SY University of Portsmouth AB
RX CelloPub=CLPUB00261;
RX PubMed=20951163;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPAM
AC CVCL_1T12
SY University of Portsmouth AM
RX PubMed=20951163;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UPCI-SCC-002
AC CVCL_C024
SY UPCI:SCC002; SCC002
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-003
AC CVCL_C025
SY UPCI:SCC003; UPCISCC003; SCC003
RX PubMed=17112776;
RX PubMed=17681875;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-013
AC CVCL_C026
SY UPCI:SCC013; SCC013
RX PubMed=17112776;
DI NCIt; C8181; Oropharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-016
AC CVCL_C027
SY UPCI:SCC016; UPCISCC016; SCC016
RX PubMed=17112776;
RX PubMed=17681875;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2221 ! UPCI-SCC-026
SX Female
CA Cancer cell line
//
ID UPCI-SCC-026
AC CVCL_2221
SY UPCI:SCC026; SCC026
DR BioSample; SAMN03473471
DR DSMZ; ACC-658
RX PubMed=17112776;
RX PubMed=17681875;
CC Doubling time: ~60 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 13
ST D7S820: 10
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C027 ! UPCI-SCC-016
SX Female
CA Cancer cell line
//
ID UPCI-SCC-029A
AC CVCL_1855
SY UPCI-SCC-29A; UPCI:SCC029A; UPCI-SCC-029B; UPCI:SCC029B; UPCI:SCC029; SCC029
DR BioSample; SAMN03473472
DR DSMZ; ACC-659
RX PubMed=17112776;
RX PubMed=17681875;
CC Doubling time: ~60 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8,9
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 14,17
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-030
AC CVCL_C028
SY UPCI:SCC030; SCC030
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-032
AC CVCL_C029
SY UPCI:SCC032; SCC032
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-036
AC CVCL_C030
SY UPCI:SCC036; SCC036
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C050 ! UPCI-SCC-104
OI CVCL_C056 ! UPCI-SCC-142
SX Male
CA Cancer cell line
//
ID UPCI-SCC-040
AC CVCL_2222
SY UPCI:SCC040; SCC040
DR BioSample; SAMN03473474
DR DSMZ; ACC-660
RX PubMed=17112776;
RX PubMed=17681875;
CC Doubling time: ~70-80 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 10,11
ST D7S820: 9,10
ST TH01: 6,8
ST TPOX: 11
ST vWA: 17
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-044
AC CVCL_C031
SY UPCI:SCC044; SCC044
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-045
AC CVCL_C032
SY UPCI:SCC045; SCC045
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-051
AC CVCL_C033
SY UPCI:SCC051; SCC051
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-052
AC CVCL_C034
SY UPCI:SCC052; SCC052
RX PubMed=17112776;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-053
AC CVCL_C035
SY UPCI:SCC053; SCC053
RX PubMed=17112776;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-056
AC CVCL_C036
SY UPCI:SCC056; SCC056
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-062
AC CVCL_C037
SY UPCI:SCC062; SCC062
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-065
AC CVCL_C038
SY UPCI:SCC065; SCC065
RX PubMed=17112776;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-066
AC CVCL_C039
SY UPCI:SCC066; SCC066
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-068
AC CVCL_C040
SY UPCI:SCC068; SCC068
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-070
AC CVCL_C041
SY UPCI:SCC070; SCC070
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-072
AC CVCL_2223
SY UPCI:SCC072; SCC072
DR BioSample; SAMN03473421
DR DSMZ; ACC-667
RX PubMed=17112776;
RX PubMed=17681875;
CC Doubling time: ~120 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 14
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8
ST vWA: 15
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-074
AC CVCL_2224
SY UPCI:SCC074; SCC074
DR BioSample; SAMN03473478
DR DSMZ; ACC-664
RX PubMed=17112776;
RX PubMed=17681875;
CC Doubling time: ~60 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,11
ST D16S539: 9,10
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 7,9.3
ST TPOX: 9,11
ST vWA: 15,17
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-075
AC CVCL_C042
SY UPCI:SCC075; SCC075
RX PubMed=17112776;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-077
AC CVCL_C043
SY UPCI:SCC077; SCC077
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-078
AC CVCL_C044
SY UPCI:SCC078; SCC078
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-080
AC CVCL_C045
SY UPCI:SCC080; SCC080
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-081
AC CVCL_C046
SY UPCI:SCC081; SCC081
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-084
AC CVCL_C047
SY UPCI:SCC084; SCC084
DR Cosmic; 1969497
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-089
AC CVCL_C048
SY UPCI:SCC089; SCC089
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-090
AC CVCL_1899
SY UPCI:SCC090; UPCI:SCC90; UPCI-SCC090; SCC090; SCC90
DR ATCC; CRL-3239
DR BioSample; SAMN03473425
DR Cosmic; 1122679
DR Cosmic; 1530750
DR Cosmic; 2296310
DR Cosmic-CLP; 1299052
DR DSMZ; ACC-670
DR GDSC; 1299052
RX PubMed=17112776;
RX PubMed=17681875;
RX PubMed=25275298;
RX PubMed=27397505;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Characteristics: Contains 100-150 copies of the HPV16 genome.
CC Doubling time: ~120-150 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Omics: Deep exome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25275298
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 14,18
ST D21S11: 29,31
ST D3S1358: 14
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 12
ST FGA: 20
ST Penta D: 11
ST Penta E: 11,12
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C058 ! UPCI-SCC-152
SX Male
CA Cancer cell line
//
ID UPCI-SCC-099
AC CVCL_2225
SY UPCI:SCC099; SCC099
DR BioSample; SAMN03473479
DR DSMZ; ACC-665
RX PubMed=17112776;
RX PubMed=17681875;
CC Doubling time: ~50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 7,9,10
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 14,18,19
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-103
AC CVCL_C049
SY UPCI:SCC103; SCC103
RX PubMed=17112776;
RX PubMed=17681875;
CC Misspelling: Occasionally 'UPMC-SCC103'.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-104
AC CVCL_C050
SY UPCI:SCC104; SCC104
RX PubMed=17112776;
RX PubMed=17681875;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C030 ! UPCI-SCC-036
OI CVCL_C056 ! UPCI-SCC-142
SX Male
CA Cancer cell line
//
ID UPCI-SCC-105
AC CVCL_C051
SY UPCI:SCC105; SCC105
RX PubMed=17112776;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-111
AC CVCL_2226
SY UPCI:SCC111; SCC111; SCC-111
DR BioSample; SAMN03473480
DR Cosmic; 927220
DR Cosmic; 932154
DR DSMZ; ACC-666
RX PubMed=17112776;
RX PubMed=17681875;
CC Doubling time: ~40 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 8,10
ST TH01: 8,10
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-114
AC CVCL_2227
SY UPCI:SCC114; SCC114
DR BioSample; SAMN03473476
DR DSMZ; ACC-662
RX PubMed=17112776;
CC Doubling time: ~60 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8,12
ST TH01: 7,9.3
ST TPOX: 9,11
ST vWA: 16,20
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-116
AC CVCL_2228
SY UPCI:SCC116; SCC116
DR BioSample; SAMN03473477
DR DSMZ; ACC-663
RX PubMed=17112776;
CC Doubling time: ~80 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 9,13
ST D7S820: 8,12
ST TH01: 10
ST TPOX: 8,10
ST vWA: 15,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-121
AC CVCL_C052
SY UPCI:SCC121; SCC121
RX PubMed=17112776;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-122
AC CVCL_C053
SY UPCI:SCC122; SCC122
RX PubMed=17112776;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-125
AC CVCL_C054
SY UPCI:SCC125; UPCISCC125; SCC125
RX PubMed=17112776;
RX PubMed=17681875;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-131
AC CVCL_2229
SY UPCI:SCC131; SCC131
DR BioSample; SAMN03473422
DR DSMZ; ACC-668
RX PubMed=17112776;
CC Doubling time: ~50-60 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 13
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 7,9
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-136
AC CVCL_C055
SY UPCI:SCC136; SCC136
RX PubMed=17112776;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-142
AC CVCL_C056
SY UPCI:SCC142; SCC142
RX PubMed=17112776;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C030 ! UPCI-SCC-036
OI CVCL_C050 ! UPCI-SCC-104
SX Male
CA Cancer cell line
//
ID UPCI-SCC-143
AC CVCL_C057
SY UPCI:SCC143; SCC143
RX PubMed=17112776;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPCI-SCC-152
AC CVCL_C058
SY UPCI:SCC152; SCC152
DR ATCC; CRL-3240
RX PubMed=17112776;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 9,10
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1899 ! UPCI-SCC-090
SX Male
CA Cancer cell line
//
ID UPCI-SCC-153
AC CVCL_C059
SY UPCI:SCC153; UPCISCC153; SCC153
RX PubMed=17112776;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-154
AC CVCL_2230
SY UPCI:SCC154; UPCISCC154; SCC154
DR BioSample; SAMN03473423
DR DSMZ; ACC-669
DR IZSLER; BS TCL 245
RX PubMed=17112776;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~50-60 hours (DSMZ).
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 13
ST D5S818: 11,12
ST D7S820: 9,10
ST TH01: 7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-172
AC CVCL_2231
SY UPCI:SCC172; SCC172
DR BioSample; SAMN03473475
DR DSMZ; ACC-661
RX PubMed=17112776;
CC Doubling time: ~50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 10
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C8181; Oropharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-182
AC CVCL_C060
SY UPCI:SCC182; SCC182
RX PubMed=17112776;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-192
AC CVCL_C061
SY UPCI:SCC192; SCC192
RX PubMed=17112776;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPCI-SCC-200
AC CVCL_2232
SY UPCI:SCC200; SCC200
DR BioSample; SAMN03473427
DR DSMZ; ACC-672
RX PubMed=17112776;
CC Doubling time: ~60-80 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 13,14
ST D16S539: 10,12
ST D5S818: 9,12
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPES/C
AC CVCL_1R55
DR BioSample; SAMN03152029
RX PubMed=20951163;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from mouse (PubMed=20951163).
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Undefined cell line type
//
ID UPHHJA
AC CVCL_1R56
DR BioSample; SAMN03152030
RX PubMed=20951163;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20951163).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Undefined cell line type
//
ID UPJM
AC CVCL_1T13
SY University of Portsmouth JM
RX CelloPub=CLPUB00261;
RX PubMed=20951163;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPMC
AC CVCL_1S99
SY University of Portsmouth MC
RX CelloPub=CLPUB00261;
RX PubMed=20951163;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPMD-1
AC CVCL_C297
SY UPMD1; Uveal Primary Melanoma with Disomy-3 1
DR Cosmic; 1628403
RX PubMed=19212147;
RX PubMed=22236444;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UPMD-2
AC CVCL_C298
SY UPMD2; Uveal Primary Melanoma with Disomy-3 2
DR Cosmic; 1628404
RX PubMed=19212147;
RX PubMed=22236444;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UPMM-1
AC CVCL_C299
SY UPMM1; Uveal Primary Melanoma with Monosomy-3 1
DR Cosmic; 1628399
RX PubMed=16750193;
RX PubMed=19212147;
RX PubMed=22236444;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPMM-2
AC CVCL_C294
SY UPMM2; Uveal Primary Melanoma with Monosomy-3 2
DR Cosmic; 1628400
RX PubMed=16750193;
RX PubMed=19212147;
RX PubMed=22236444;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UPMM-3
AC CVCL_C295
SY UPMM3; Uveal Primary Melanoma with Monosomy-3 3
DR Cosmic; 1628401
DR CLDB; cl7223
DR ICLC; HTL13001
RX PubMed=19212147;
RX PubMed=22236444;
ST Source(s): ICLC
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 12
ST D21S11: 28,31.2
ST D5S818: 10,11
ST D7S820: 8,11
ST TH01: 7,9.3
ST TPOX: 9,10
ST vWA: 16,17
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPMM-4
AC CVCL_C296
SY UPMM4; Uveal Primary Melanoma with Monosomy-3 4
DR Cosmic; 1628407
RX PubMed=19212147;
RX PubMed=22236444;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UPN1
AC CVCL_A795
SY UPN-1
DR Cosmic; 1047109
DR Cosmic; 2296996
DR GEO; GSM119542
RX PubMed=12742154;
RX PubMed=12970738;
RX PubMed=16960149;
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPN2
AC CVCL_A796
SY UPN-2
DR Cosmic; 2296997
DR GEO; GSM119504
RX PubMed=12742154;
RX PubMed=12970738;
RX PubMed=16960149;
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UPN251
AC CVCL_DG78
SY UPN-251
DR GEO; GSM185162
DR GEO; GSM185163
RX PubMed=23415752;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UPS-1
AC CVCL_T762
DR RCB; RCB4451
RX PubMed=7876305;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Urd-A
AC CVCL_1N54
SY CHO Urd-A
RX PubMed=21463;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Urd-B
AC CVCL_1N55
SY A204
RX PubMed=220270;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID Urd-C
AC CVCL_1N56
SY URD-C; CHO Urd-C
RX PubMed=7368045;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID UROtsa
AC CVCL_0571
DR BTO; BTO:0005004
DR MCCL; MCC:0000476
DR Cosmic; 867840
DR ENCODE; ENCBS268AAA
DR ENCODE; ENCBS269AAA
RX PubMed=8788275;
RX PubMed=11564615;
RX PubMed=23691160;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/Urothelia_Crawford_protocol.pdf
CC Problematic cell line: Partially contaminated. Some stocks of UROTsa are contaminated with T24 (PubMed=23691160).
CC Part of: ENCODE project common cell types; tier 3.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UROtsa/F35
AC CVCL_M721
RX PubMed=16102566;
RX PubMed=23691160;
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=23691160).
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID USASK/DSIL-LHRH-A1
AC CVCL_F805
DR CLO; CLO_0009488
DR ATCC; HB-9094
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID USC-DHL-1
AC CVCL_DH84
DR GEO; GSM380152
RX PubMed=19278952;
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: miRNA expression profiling.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID USC-HN1
AC CVCL_D656
SY USC-HNI
DR ATCC; CRL-3026
RX PubMed=20175927;
CC Discontinued: ATCC; CRL-3026; probable.
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USC-HN2
AC CVCL_W327
RX PubMed=21719345;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USH1-hiPSC1
AC CVCL_C368
SY USH-hiPSC1; USH.1.H.iPSC.1
DR RSCB; RSCB0100
CC From: Royan Institute; Theran; Iran.
DI NCIt; C85217; Usher syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C369 ! USH1-hiPSC2
OI CVCL_C370 ! USH1-hiPSC3
OI CVCL_C371 ! USH1-hiPSC4
OI CVCL_C372 ! USH1-hiPSC5
OI CVCL_C373 ! USH1-hiPSC6
OI CVCL_C374 ! USH1-hiPSC7
OI CVCL_C375 ! USH1-hiPSC8
SX Female
CA Induced pluripotent stem cell
//
ID USH1-hiPSC2
AC CVCL_C369
SY USH-hiPSC2; USH.1.H.iPSC.2
DR RSCB; RSCB0101
CC From: Royan Institute; Theran; Iran.
DI NCIt; C85217; Usher syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C368 ! USH1-hiPSC1
OI CVCL_C370 ! USH1-hiPSC3
OI CVCL_C371 ! USH1-hiPSC4
OI CVCL_C372 ! USH1-hiPSC5
OI CVCL_C373 ! USH1-hiPSC6
OI CVCL_C374 ! USH1-hiPSC7
OI CVCL_C375 ! USH1-hiPSC8
SX Female
CA Induced pluripotent stem cell
//
ID USH1-hiPSC3
AC CVCL_C370
SY USH-hiPSC3; USH.1.H.iPSC.3
DR RSCB; RSCB0102
CC From: Royan Institute; Theran; Iran.
DI NCIt; C85217; Usher syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C368 ! USH1-hiPSC1
OI CVCL_C369 ! USH1-hiPSC2
OI CVCL_C371 ! USH1-hiPSC4
OI CVCL_C372 ! USH1-hiPSC5
OI CVCL_C373 ! USH1-hiPSC6
OI CVCL_C374 ! USH1-hiPSC7
OI CVCL_C375 ! USH1-hiPSC8
SX Female
CA Induced pluripotent stem cell
//
ID USH1-hiPSC4
AC CVCL_C371
SY USH-hiPSC4; USH.1.H.iPSC.4
DR RSCB; RSCB0103
CC From: Royan Institute; Theran; Iran.
DI NCIt; C85217; Usher syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C368 ! USH1-hiPSC1
OI CVCL_C369 ! USH1-hiPSC2
OI CVCL_C370 ! USH1-hiPSC3
OI CVCL_C372 ! USH1-hiPSC5
OI CVCL_C373 ! USH1-hiPSC6
OI CVCL_C374 ! USH1-hiPSC7
OI CVCL_C375 ! USH1-hiPSC8
SX Female
CA Induced pluripotent stem cell
//
ID USH1-hiPSC5
AC CVCL_C372
SY USH-hiPSC5; USH.1.H.iPSC.5
DR RSCB; RSCB0104
CC From: Royan Institute; Theran; Iran.
DI NCIt; C85217; Usher syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C368 ! USH1-hiPSC1
OI CVCL_C369 ! USH1-hiPSC2
OI CVCL_C370 ! USH1-hiPSC3
OI CVCL_C371 ! USH1-hiPSC4
OI CVCL_C373 ! USH1-hiPSC6
OI CVCL_C374 ! USH1-hiPSC7
OI CVCL_C375 ! USH1-hiPSC8
SX Female
CA Induced pluripotent stem cell
//
ID USH1-hiPSC6
AC CVCL_C373
SY USH-hiPSC6; USH.1.H.iPSC.6; RIi011-A
DR hPSCreg; RIi011-A
DR RSCB; RSCB0105
CC From: Royan Institute; Theran; Iran.
DI NCIt; C85217; Usher syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C368 ! USH1-hiPSC1
OI CVCL_C369 ! USH1-hiPSC2
OI CVCL_C370 ! USH1-hiPSC3
OI CVCL_C371 ! USH1-hiPSC4
OI CVCL_C372 ! USH1-hiPSC5
OI CVCL_C374 ! USH1-hiPSC7
OI CVCL_C375 ! USH1-hiPSC8
SX Female
CA Induced pluripotent stem cell
//
ID USH1-hiPSC7
AC CVCL_C374
SY USH-hiPSC7; USH.1.H.iPSC.7
DR RSCB; RSCB0106
CC From: Royan Institute; Theran; Iran.
DI NCIt; C85217; Usher syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C368 ! USH1-hiPSC1
OI CVCL_C369 ! USH1-hiPSC2
OI CVCL_C370 ! USH1-hiPSC3
OI CVCL_C371 ! USH1-hiPSC4
OI CVCL_C372 ! USH1-hiPSC5
OI CVCL_C373 ! USH1-hiPSC6
OI CVCL_C375 ! USH1-hiPSC8
SX Female
CA Induced pluripotent stem cell
//
ID USH1-hiPSC8
AC CVCL_C375
SY USH-hiPSC8; USH.1.H.iPSC.8
DR RSCB; RSCB0107
CC From: Royan Institute; Theran; Iran.
DI NCIt; C85217; Usher syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C368 ! USH1-hiPSC1
OI CVCL_C369 ! USH1-hiPSC2
OI CVCL_C370 ! USH1-hiPSC3
OI CVCL_C371 ! USH1-hiPSC4
OI CVCL_C372 ! USH1-hiPSC5
OI CVCL_C373 ! USH1-hiPSC6
OI CVCL_C374 ! USH1-hiPSC7
SX Female
CA Induced pluripotent stem cell
//
ID USP-1
AC CVCL_Z290
SY A32
RX PubMed=12011937;
RX PubMed=25761219;
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID USP-13-Med
AC CVCL_4U90
RX PubMed=26358937;
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID USP-2
AC CVCL_Z291
SY A414
RX PubMed=12011937;
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID USP-3
AC CVCL_Z292
SY B310
RX PubMed=12011937;
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID USP-4
AC CVCL_Z293
SY B410
RX PubMed=12011937;
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID USP-91
AC CVCL_H634
RX PubMed=8400235;
RX PubMed=15356658;
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID USPC-ARK-1
AC CVCL_IV72
SY USPC ARK-1; USPC-ARK1; USC ARK-1; ARK-1
RX PubMed=19920829;
RX PubMed=21246534;
RX PubMed=23891627;
RX PubMed=26325104;
RX PubMed=26625219;
CC Characteristics: Has a PIK3CA p.Glu542Lys mutation.
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-10
AC CVCL_IV81
SY USPC-ARK10
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-11
AC CVCL_IV82
SY USPC-ARK11
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-12
AC CVCL_IV83
SY USPC-ARK12
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-13
AC CVCL_IV84
SY USPC-ARK13
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-14
AC CVCL_IV85
SY USPC-ARK14
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-15
AC CVCL_IV86
SY USPC-ARK15
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-16
AC CVCL_IV87
SY USPC-ARK16
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-17
AC CVCL_IV88
SY USPC-ARK17
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-18
AC CVCL_IV89
SY USPC-ARK18
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-19
AC CVCL_IV90
SY USPC-ARK19
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-2
AC CVCL_IV73
SY USPC ARK-2; USPC-ARK2; USC ARK-2; ARK-2
RX PubMed=19920829;
RX PubMed=21246534;
RX PubMed=23891627;
RX PubMed=26325104;
RX PubMed=26625219;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-20
AC CVCL_IV91
SY USPC-ARK20; USC ARK-20; ARK-20
RX PubMed=23891627;
RX PubMed=26325104;
RX PubMed=26625219;
CC Characteristics: Has a PIK3CA p.His1047Arg mutation.
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-21
AC CVCL_IV92
SY USPC-ARK21; USC ARK-21; ARK-21
RX PubMed=23891627;
RX PubMed=26325104;
RX PubMed=26625219;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-22
AC CVCL_IV93
SY USPC-ARK22
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-3
AC CVCL_IV74
SY USPC ARK-3; USPC-ARK3
RX PubMed=19920829;
RX PubMed=21246534;
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-4
AC CVCL_IV75
SY USPC ARK-4; USPC-ARK4
RX PubMed=19920829;
RX PubMed=21246534;
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-5
AC CVCL_IV76
SY USPC ARK-5; USPC-ARK5
RX PubMed=19920829;
RX PubMed=21246534;
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-6
AC CVCL_IV77
SY USPC ARK-6; USPC-ARK6
RX PubMed=19920829;
RX PubMed=21246534;
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-7
AC CVCL_IV78
SY USPC-ARK7
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-8
AC CVCL_IV79
SY USPC-ARK8
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID USPC-ARK-9
AC CVCL_IV80
SY USPC-ARK9
RX PubMed=23891627;
DI NCIt; C27838; Endometrial serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-1
AC CVCL_4332
SY UT1
DR CLO; CLO_0009489
DR CLDB; cl4612
DR ECACC; 87100701
RX PubMed=6951166;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID UT-2
AC CVCL_DC04
SY UT2
RX PubMed=6643457;
RX PubMed=9305924;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID UT-7
AC CVCL_2233
SY UT7
DR BTO; BTO:0000960
DR CLO; CLO_0009490
DR CLDB; cl5398
DR BioSample; SAMN03472875
DR CCLE; UT7_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3111C0001CCC000120
DR ChEMBL-Cells; CHEMBL3307293
DR ChEMBL-Targets; CHEMBL614057
DR Cosmic; 787487
DR Cosmic; 919130
DR Cosmic; 975312
DR Cosmic; 1012128
DR Cosmic; 1281362
DR Cosmic; 1465951
DR Cosmic; 2089659
DR DSMZ; ACC-137
DR GEO; GSM887730
DR GEO; GSM888825
DR GEO; GSM1374979
DR Lonza; 41
RX PubMed=1824823;
RX PubMed=2217443;
RX PubMed=11021758;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=23955599;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~70 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 10,12
ST D18S51: 14,17
ST D21S11: 31.2
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8
ST D8S1179: 11,15
ST FGA: 23
ST Penta D: 9,11
ST Penta E: 16,17
ST TH01: 6,9
ST TPOX: 10
ST vWA: 14,18
DI NCIt; C7965; Adult acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-7/Epo
AC CVCL_5202
SY UT7-Epo
DR Lonza; 169
RX PubMed=8329702;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7%2fEpo
DI NCIt; C7965; Adult acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2233 ! UT-7
SX Male
CA Cancer cell line
//
ID UT-7/GM
AC CVCL_5203
SY UT7-GM
DR Lonza; 170
RX PubMed=9166841;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7%2fGM
DI NCIt; C7965; Adult acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2233 ! UT-7
SX Male
CA Cancer cell line
//
ID UT-7/TPO
AC CVCL_5204
SY UT7-TPO
DR Lonza; 171
RX PubMed=8639823;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7%2fTPO
DI NCIt; C7965; Adult acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5203 ! UT-7/GM
SX Male
CA Cancer cell line
//
ID UT-EC-1
AC CVCL_X003
RX PubMed=1541432;
DI NCIt; C114656; Endometrial adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-EC-2A
AC CVCL_X004
RX PubMed=7821848;
RX PubMed=8123477;
CC Doubling time: 40 hours, at 17th passage (PubMed=7821848).
DI NCIt; C114656; Endometrial adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X005 ! UT-EC-2B
SX Female
CA Cancer cell line
//
ID UT-EC-2B
AC CVCL_X005
RX PubMed=7821848;
RX PubMed=8123477;
RX PubMed=17178626;
CC Doubling time: 30 hours, at 14th passage (PubMed=7821848).
CC Derived from metastatic site: Supraclavicular fossa lymph node.
DI NCIt; C114656; Endometrial adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X004 ! UT-EC-2A
SX Female
CA Cancer cell line
//
ID UT-EC-3
AC CVCL_X006
RX PubMed=8123477;
RX PubMed=17178626;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-MUC-1
AC CVCL_A438
DR Cosmic; 1520948
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=1571132;
RX PubMed=9187133;
DI NCIt; C6214; Hard palate mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-MUC-2
AC CVCL_A439
DR Cosmic; 1520949
RX PubMed=16444749;
DI NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-SCC-10
AC CVCL_7804
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-11
AC CVCL_7805
SY UTSCC11
RX PubMed=9187133;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-110B
AC CVCL_A091
DR Cosmic; 1140779
DR Cosmic; 1219863
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UT-SCC-118
AC CVCL_7806
SY UT-SCC118
DR BTO; BTO:0004873
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UT-SCC-12A
AC CVCL_7807
DR Cosmic; 1140772
DR Cosmic; 1219856
DR Cosmic; 1351518
RX PubMed=9187133;
DI NCIt; C4819; Skin squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7808 ! UT-SCC-12B
SX Female
CA Cancer cell line
//
ID UT-SCC-12B
AC CVCL_7808
DR Cosmic; 1140773
DR Cosmic; 1219857
DI NCIt; C4819; Skin squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7807 ! UT-SCC-12A
SX Female
CA Cancer cell line
//
ID UT-SCC-13
AC CVCL_7809
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-14
AC CVCL_7810
DR BTO; BTO:0004440
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-15
AC CVCL_7811
DR BTO; BTO:0004441
DR GEO; GSM901099
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-16A
AC CVCL_7812
DR Cosmic; 1140774
DR Cosmic; 1219858
RX PubMed=9187133;
RX PubMed=15287027;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7813 ! UT-SCC-16B
SX Female
CA Cancer cell line
//
ID UT-SCC-16B
AC CVCL_7813
DR Cosmic; 1140775
DR Cosmic; 1219859
RX PubMed=15287027;
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7812 ! UT-SCC-16A
SX Female
CA Cancer cell line
//
ID UT-SCC-17
AC CVCL_7814
DR GEO; GSM901097
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-18
AC CVCL_7815
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-19A
AC CVCL_7816
SY UTSCC19A
RX PubMed=15287027;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7817 ! UT-SCC-19B
SX Male
CA Cancer cell line
//
ID UT-SCC-19B
AC CVCL_7817
SY UTSCC19B
RX PubMed=15287027;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7816 ! UT-SCC-19A
SX Male
CA Cancer cell line
//
ID UT-SCC-1A
AC CVCL_7818
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=9187133;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7819 ! UT-SCC-1B
SX Female
CA Cancer cell line
//
ID UT-SCC-1B
AC CVCL_7819
DR GEO; GSM901092
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7818 ! UT-SCC-1A
SX Female
CA Cancer cell line
//
ID UT-SCC-2
AC CVCL_7820
DR BTO; BTO:0003721
DR GEO; GSM901093
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=9187133;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-20A
AC CVCL_7821
RX PubMed=15287027;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7822 ! UT-SCC-20B
SX Female
CA Cancer cell line
//
ID UT-SCC-20B
AC CVCL_7822
RX PubMed=15287027;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7821 ! UT-SCC-20A
SX Female
CA Cancer cell line
//
ID UT-SCC-21
AC CVCL_7823
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-22
AC CVCL_7824
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-23
AC CVCL_7825
SY UT-SCC23
DR Cosmic; 932292
DR Cosmic; 932293
DR GEO; GSM901098
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-24A
AC CVCL_7826
DR BTO; BTO:0003722
DR Cosmic; 1140778
DR Cosmic; 1219862
DR Cosmic; 1483464
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7827 ! UT-SCC-24B
SX Male
CA Cancer cell line
//
ID UT-SCC-24B
AC CVCL_7827
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7826 ! UT-SCC-24A
SX Male
CA Cancer cell line
//
ID UT-SCC-25
AC CVCL_7828
DR GEO; GSM901095
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-26A
AC CVCL_7829
DR Cosmic; 1483465
RX PubMed=19414362;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7830 ! UT-SCC-26B
SX Male
CA Cancer cell line
//
ID UT-SCC-26B
AC CVCL_7830
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7829 ! UT-SCC-26A
SX Male
CA Cancer cell line
//
ID UT-SCC-27
AC CVCL_7831
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-28
AC CVCL_7832
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-SCC-29
AC CVCL_7833
SY UTSCC29
DR GEO; GSM901096
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-30
AC CVCL_7834
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-SCC-31
AC CVCL_7835
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-32
AC CVCL_7836
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-33
AC CVCL_7837
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-SCC-34
AC CVCL_7838
SY UTSCC34
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-35
AC CVCL_7839
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-36
AC CVCL_7840
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-37
AC CVCL_7841
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-SCC-38
AC CVCL_7842
SY UTSCC38
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-39
AC CVCL_7843
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-4
AC CVCL_7844
RX PubMed=9187133;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-SCC-40
AC CVCL_7845
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-41
AC CVCL_7846
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-42A
AC CVCL_7847
SY UTSCC42A
RX PubMed=15287027;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7848 ! UT-SCC-42B
SX Male
CA Cancer cell line
//
ID UT-SCC-42B
AC CVCL_7848
RX PubMed=15287027;
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7847 ! UT-SCC-42A
SX Male
CA Cancer cell line
//
ID UT-SCC-43A
AC CVCL_7849
RX PubMed=15287027;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7850 ! UT-SCC-43B
SX Female
CA Cancer cell line
//
ID UT-SCC-43B
AC CVCL_7850
RX PubMed=15287027;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7849 ! UT-SCC-43A
SX Female
CA Cancer cell line
//
ID UT-SCC-44
AC CVCL_7851
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-SCC-45
AC CVCL_7852
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-46A
AC CVCL_7853
RX PubMed=15287027;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7854 ! UT-SCC-46B
SX Male
CA Cancer cell line
//
ID UT-SCC-46B
AC CVCL_7854
RX PubMed=15287027;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7853 ! UT-SCC-46A
SX Male
CA Cancer cell line
//
ID UT-SCC-47
AC CVCL_7855
DR GEO; GSM901101
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-48
AC CVCL_7856
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-49
AC CVCL_7857
SY UTSCC49
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-5
AC CVCL_7858
DR BTO; BTO:0004442
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UT-SCC-50
AC CVCL_7859
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-51
AC CVCL_7860
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-52
AC CVCL_7861
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-53
AC CVCL_7862
DI NCIt; C68611; Nasal cavity and paranasal sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-54A
AC CVCL_7863
RX PubMed=15287027;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7864 ! UT-SCC-54B
SX Female
CA Cancer cell line
//
ID UT-SCC-54B
AC CVCL_7864
RX PubMed=15287027;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7863 ! UT-SCC-54A
SX Female
CA Cancer cell line
//
ID UT-SCC-55
AC CVCL_7865
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-60A
AC CVCL_A089
SY UT-SCC 60 A
DR Cosmic; 1140776
DR Cosmic; 1219860
RX PubMed=15287027;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A090 ! UT-SCC-60B
SX Male
CA Cancer cell line
//
ID UT-SCC-60B
AC CVCL_A090
SY UT-SCC 60 B
DR Cosmic; 1140777
DR Cosmic; 1219861
RX PubMed=15287027;
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A089 ! UT-SCC-60A
SX Male
CA Cancer cell line
//
ID UT-SCC-6A
AC CVCL_7866
RX PubMed=15287027;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7867 ! UT-SCC-6B
SX Female
CA Cancer cell line
//
ID UT-SCC-6B
AC CVCL_7867
RX PubMed=15287027;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7866 ! UT-SCC-6A
SX Female
CA Cancer cell line
//
ID UT-SCC-7
AC CVCL_7868
RX PubMed=9187133;
DI NCIt; C4819; Skin squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-75
AC CVCL_A092
SY UTSCC75
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UT-SCC-8
AC CVCL_7869
SY UTSCC8
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCC-9
AC CVCL_7870
DR BTO; BTO:0003720
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UT-SCV-1
AC CVCL_6468
SY University of Turku-Squamous cell Carcinoma of the Vulva-1
RX PubMed=15047230;
CC Doubling time: 38 hours (PubMed=15047230).
CC Derived from metastatic site: Inguinal lymph node.
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-SCV-2
AC CVCL_6469
SY University of Turku-Squamous cell Carcinoma of the Vulva-2
RX PubMed=15047230;
CC Doubling time: 56 hours (PubMed=15047230).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UT-SCV-3
AC CVCL_6470
SY University of Turku-Squamous cell Carcinoma of the Vulva-3
RX PubMed=15047230;
CC Doubling time: 13 hours (PubMed=15047230).
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UTA-SF2-2
AC CVCL_AS03
DR JCRB; NIHS0693
RX PubMed=21124894;
CC Discontinued: JCRB; NIHS0693; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UTA-SF3-2
AC CVCL_AS04
DR JCRB; NIHS0695
RX PubMed=21124894;
CC Discontinued: JCRB; NIHS0695; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID UTA1
AC CVCL_AS02
RX PubMed=21124894;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID UtE-iPS-1
AC CVCL_E031
SY Center; UtE-iPS-A01
DR SKIP; SKIP000350
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D693 ! UtE1104
SX Female
CA Induced pluripotent stem cell
//
ID UtE-iPS-10
AC CVCL_E032
SY Flanker; UtE-iPS-B03
DR SKIP; SKIP000386
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D693 ! UtE1104
SX Female
CA Induced pluripotent stem cell
//
ID UtE-iPS-11
AC CVCL_E033
SY SplitEnd; UtE-iPS-B05
DR SKIP; SKIP000357
RX PubMed=21637780;
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D693 ! UtE1104
SX Female
CA Induced pluripotent stem cell
//
ID UtE-iPS-2
AC CVCL_E034
SY Guard; UtE-iPS-A02
DR SKIP; SKIP000383
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D693 ! UtE1104
SX Female
CA Induced pluripotent stem cell
//
ID UtE-iPS-3
AC CVCL_E035
SY Tackle; UtE-iPS-A03
DR SKIP; SKIP000384
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D693 ! UtE1104
SX Female
CA Induced pluripotent stem cell
//
ID UtE-iPS-4
AC CVCL_E036
SY TightEnd; UtE-iPS-A04
DR SKIP; SKIP000349
RX PubMed=21637780;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D693 ! UtE1104
SX Female
CA Induced pluripotent stem cell
//
ID UtE-iPS-5
AC CVCL_E037
SY FullBack; UtE-iPS-A05
DR SKIP; SKIP000385
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D693 ! UtE1104
SX Female
CA Induced pluripotent stem cell
//
ID UtE-iPS-6
AC CVCL_E038
SY TailBack; UtE-iPS-A06
DR SKIP; SKIP000356
RX PubMed=21637780;
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D693 ! UtE1104
SX Female
CA Induced pluripotent stem cell
//
ID UtE-iPS-7
AC CVCL_E039
SY QuaterBack; UtE-iPS-A07
DR SKIP; SKIP000358
RX PubMed=21637780;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D693 ! UtE1104
SX Female
CA Induced pluripotent stem cell
//
ID UtE1104
AC CVCL_D693
DR JCRB; JCRB1573
RX PubMed=21155951;
RX PubMed=21637780;
RX PubMed=23631808;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,9
ST D16S539: 10,11
ST D5S818: 12,13
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID UTHs
AC CVCL_7871
DR CLO; CLO_0009491
DR CLDB; cl4613
CC Transformant: NCBI_TaxID; 10298; Human herpesvirus 1 (HSV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0579 ! WI-38
SX Female
CA Transformed cell line
//
ID UtLM-hTERT
AC CVCL_9Z19
RX PubMed=12065682;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2T99 ! GM10964
SX Female
CA Telomerase immortalized cell line
//
ID UTMB-460
AC CVCL_8276
DR BioSample; SAMN03151622
RX PubMed=3022081;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID UTMC-2
AC CVCL_4802
SY UTMC2; University of Tennessee Medical Center-2
DR Cosmic; 720762
DR Cosmic; 759911
DR Cosmic; 760393
DR Cosmic; 2081410
DR Cosmic; 2302412
DR Cosmic; 2367294
DR Cosmic; 2391804
RX PubMed=7528862;
RX PubMed=8943038;
RX PubMed=10936422;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=UTMC-2
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UTO-EW1
AC CVCL_W452
RX PubMed=9573488;
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UTOS-1
AC CVCL_H195
RX PubMed=19239720;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UTP-2
AC CVCL_5383
DR BTO; BTO:0004948
DR Cosmic; 996289
DR Cosmic; 998697
DR Cosmic; 1037707
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-5
AC CVCL_W267
DR Cosmic; 721711
RX CelloPub=CLPUB00111;
RX PubMed=10071127;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-6
AC CVCL_W268
DR Cosmic; 721712
RX CelloPub=CLPUB00111;
RX PubMed=10071127;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-DSAL-1
AC CVCL_0C63
DR Cosmic; 2089671
RX PubMed=23955599;
DI NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-ES1
AC CVCL_DH85
DR GEO; GSM393043
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-L10
AC CVCL_5385
DR BTO; BTO:0004947
DR Cosmic; 996288
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-L20
AC CVCL_5386
DR Cosmic; 998693
DR Cosmic; 1037709
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-L3
AC CVCL_5387
DR Cosmic; 998739
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-L5
AC CVCL_5388
DR BTO; BTO:0004946
DR Cosmic; 996286
DR Cosmic; 998691
DR Cosmic; 1037708
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-L51
AC CVCL_5389
DR Cosmic; 998690
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-M1
AC CVCL_5390
DR Cosmic; 998742
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-M2
AC CVCL_5391
DR Cosmic; 998741
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UTP-N-1
AC CVCL_DF75
DR Cosmic; 1153802
DR GEO; GSM333824
DR GEO; GSM333826
RX PubMed=18923524;
CC Omics: SNP array analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID utr-1
AC CVCL_U033
DR ECACC; 10080904
RX PubMed=2158104;
CC Monoclonal antibody target: UniProtKB; P20333; Human TNFRSF1B/CD120b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID utr-4a
AC CVCL_U034
DR ECACC; 10080901
RX PubMed=2158104;
CC Monoclonal antibody target: UniProtKB; P20333; Human TNFRSF1B/CD120b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID UTree-O2
AC CVCL_W195
RX PubMed=16809887;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UtSMC-hTERT
AC CVCL_9Z20
RX PubMed=12065682;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID UTSW-ACC112
AC CVCL_Y492
SY ACC112
DR EFO; EFO_0007070
DR ENCODE; ENCBS726UUU
DR ENCODE; ENCBS827JIC
RX PubMed=10328235;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
DI NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UTSW-ACC52
AC CVCL_Y489
SY ACC52
RX PubMed=10328235;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
DI NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UTSW-CaPA79
AC CVCL_Y490
SY CaPA79
RX PubMed=10328235;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
DI NCIt; C40410; Salivary gland carcinoma ex pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UTSW-EMC52
AC CVCL_Y491
RX PubMed=10328235;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
DI NCIt; C35701; Salivary gland epithelial myoepithelial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UTSW-MEC49
AC CVCL_Y488
SY MEC49
RX PubMed=10328235;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
DI NCIt; C5908; Salivary gland mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UTSW-PA116
AC CVCL_Y485
RX PubMed=10328235;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UTSW-PA125
AC CVCL_Y486
RX PubMed=10328235;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID UTSW-PA37
AC CVCL_Y487
RX PubMed=10328235;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID UV female 1A
AC CVCL_4E30
DR CLO; CLO_0050766
DR RCB; RCB1993
RX PubMed=8205558;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6 x BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID UV female 2
AC CVCL_U951
DR CLO; CLO_0050223
DR RCB; RCB1994
RX PubMed=8205558;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6 x BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID UV male 1d
AC CVCL_4E31
DR CLO; CLO_0050765
DR RCB; RCB1992
RX PubMed=8205558;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6 x BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID UV-2237-IP3
AC CVCL_0J66
SY UV-2237 ip-3; UV2237-IP3
RX PubMed=2529426;
RX PubMed=6935459;
CC Breed/subspecies: C3H/HeN.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_B479 ! UV-2237M
SX Female
CA Cancer cell line
//
ID UV-2237M
AC CVCL_B479
SY UV-2237m; UV2237M; UV2237m; UV2237 M; UV-2237
DR KCLB; 80032
RX PubMed=679204;
CC Breed/subspecies: C3H/HeN.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_0J66 ! UV-2237-IP3
SX Female
CA Cancer cell line
//
ID UV-2237M-ADMR
AC CVCL_D696
SY UV-2237-ADMR
RX PubMed=6616446;
RX PubMed=6831444;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Breed/subspecies: C3H/HeN.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B479 ! UV-2237M
SX Female
CA Cancer cell line
//
ID UV-P3U1-B8
AC CVCL_U860
DR CLO; CLO_0050397
DR RCB; RCB1157
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID UV.B6-1.1
AC CVCL_4E33
DR CLO; CLO_0050754
DR RCB; RCB1997
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.B6-2.1A
AC CVCL_4E34
DR CLO; CLO_0050755
DR RCB; RCB1998
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.B6-4.1
AC CVCL_4E35
DR CLO; CLO_0050756
DR RCB; RCB1999
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.B6-5.1
AC CVCL_4E36
DR CLO; CLO_0050757
DR RCB; RCB2000
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-1.1
AC CVCL_4E37
DR CLO; CLO_0050730
DR RCB; RCB1995
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-12.1
AC CVCL_4E38
DR CLO; CLO_0050735
DR RCB; RCB2030
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-13.1
AC CVCL_4E39
DR CLO; CLO_0050736
DR RCB; RCB2031
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-14.2
AC CVCL_4E40
DR CLO; CLO_0050737
DR RCB; RCB2032
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-15.1
AC CVCL_4E41
DR CLO; CLO_0050738
DR RCB; RCB2033
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-16.1
AC CVCL_4E42
DR CLO; CLO_0050739
DR RCB; RCB2034
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-17.1
AC CVCL_4E43
DR CLO; CLO_0050740
DR RCB; RCB2035
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-18.1
AC CVCL_4E44
DR CLO; CLO_0050741
DR RCB; RCB2036
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-19.1A
AC CVCL_4E45
DR CLO; CLO_0050742
DR RCB; RCB2057
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-2.1D
AC CVCL_4E46
DR CLO; CLO_0050731
DR RCB; RCB1996
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-20.1
AC CVCL_4E47
DR CLO; CLO_0050743
DR RCB; RCB2058
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-21.1
AC CVCL_4E48
DR CLO; CLO_0050744
DR RCB; RCB2059
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-23.1
AC CVCL_4E49
DR CLO; CLO_0050745
DR RCB; RCB2060
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-3.3
AC CVCL_4E50
DR CLO; CLO_0050747
DR RCB; RCB2024
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-5.4G
AC CVCL_4E51
DR CLO; CLO_0050748
DR RCB; RCB2025
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-6.1E
AC CVCL_4E52
DR CLO; CLO_0050732
DR RCB; RCB2026
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-7.1
AC CVCL_4E53
DR CLO; CLO_0050733
DR RCB; RCB2027
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.BAL-8.1
AC CVCL_4E54
DR CLO; CLO_0050734
DR RCB; RCB2028
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.C3B6-1.1
AC CVCL_4E55
DR CLO; CLO_0050728
DR RCB; RCB2061
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6 x C3H/HeN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.C3H-3.3
AC CVCL_4E56
DR CLO; CLO_0050751
DR RCB; RCB2053
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C3H/HeN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.C3H-8.2
AC CVCL_4E57
DR CLO; CLO_0050750
DR RCB; RCB2056
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C3H/HeN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV.CB6-2.1F
AC CVCL_4E58
SY 2.1F
DR CLO; CLO_0050720
DR RCB; RCB2065
RX PubMed=8205558;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6 x BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID UV.CB6-3.4B
AC CVCL_8B28
DR CLO; CLO_0050719
DR RCB; RCB2066
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6 x BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID UV.CB6-4.1D
AC CVCL_8B29
DR RCB; RCB2067
DR CLO; CLO_0050721
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6 x BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID UV.CB6-4.1F
AC CVCL_8B30
DR CLO; CLO_0050722
DR RCB; RCB2068
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6 x BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID UV.CB6-5.2B
AC CVCL_4E59
SY 5.2B
DR CLO; CLO_0050725
DR RCB; RCB2071
RX PubMed=8205558;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6 x BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID UV.CB6-6.1B
AC CVCL_4E60
SY 6.1B
DR CLO; CLO_0050724
DR RCB; RCB2073
RX PubMed=8205558;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: C57BL/6 x BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID UV.CC3-11.1
AC CVCL_4E61
DR CLO; CLO_0050727
DR RCB; RCB2074
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
CC Breed/subspecies: BALB/c x C3H.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID UV135
AC CVCL_4595
SY CHO UV-135; UV-135; GM10908
DR CLO; CLO_0009492
DR CLO; CLO_0023394
DR ATCC; CRL-1867
DR Coriell; GM10908
RX PubMed=2687628;
RX PubMed=3919945;
RX PubMed=8765433;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV152
AC CVCL_1N44
RX PubMed=2687628;
RX PubMed=3919945;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV20
AC CVCL_4596
SY UV-20
DR CLO; CLO_0009493
DR ATCC; CRL-1862
RX PubMed=2687628;
RX PubMed=3919945;
RX PubMed=6943579;
RX PubMed=7404270;
RX PubMed=8765433;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV24
AC CVCL_4597
SY UV-24; UV 24; 60-21
DR CLO; CLO_0009494
DR ATCC; CRL-1866
DR BCRC; 60175
RX PubMed=2687628;
RX PubMed=3919945;
RX PubMed=6943579;
RX PubMed=8765433;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV4
AC CVCL_S480
SY UV-4; AA8 / UV4
DR ChEMBL-Cells; CHEMBL3307475
DR ChEMBL-Cells; CHEMBL3307896
DR ChEMBL-Targets; CHEMBL612800
DR ChEMBL-Targets; CHEMBL614261
RX PubMed=2687628;
RX PubMed=3919945;
RX PubMed=8765433;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV40
AC CVCL_1N50
SY 361-114-33
RX PubMed=8765162;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV41
AC CVCL_4598
SY UV-41; 361-112-10b
DR CLO; CLO_0009495
DR ATCC; CRL-1860
RX PubMed=2687628;
RX PubMed=3919945;
RX PubMed=6943579;
RX PubMed=8765433;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV46
AC CVCL_1N45
RX PubMed=3919945;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV47
AC CVCL_1N46
RX PubMed=3919945;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV5
AC CVCL_4599
SY UV-5; UV 5
DR CLO; CLO_0009496
DR ATCC; CRL-1865
DR BCRC; 60174
RX PubMed=2687628;
RX PubMed=3919945;
RX PubMed=6943579;
RX PubMed=7404270;
RX PubMed=8765433;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV57
AC CVCL_1N47
RX PubMed=3919945;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV61
AC CVCL_1N42
RX PubMed=2687628;
RX PubMed=8765433;
RX PubMed=9806502;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UV78
AC CVCL_1N48
RX PubMed=3919945;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Transformed cell line
//
ID UVE-10
AC CVCL_4600
DR CLO; CLO_0009497
DR ATCC; CRL-6515
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Transformant: NCBI_TaxID; 10533; Adenovirus 1.
CC Discontinued: ATCC; CRL-6515; true.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID UVL-1
AC CVCL_DE20
SY UVL1
RX PubMed=3129654;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Selected for resistance to: ChEBI; CHEBI:77751; 8-azaadenine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_DE19 ! CHO-AT3-2
SX Female
CA Spontaneously immortalized cell line
//
ID UVL-10
AC CVCL_DE21
SY UVL10
RX PubMed=3129654;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Selected for resistance to: ChEBI; CHEBI:77751; 8-azaadenine.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_DE19 ! CHO-AT3-2
SX Female
CA Spontaneously immortalized cell line
//
ID UVU1
AC CVCL_1N43
SY UVU1-CHO
RX PubMed=2687628;
RX PubMed=9258434;
CC Transformant: NCIt; C17231; Ultraviolet radiation.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_S480 ! UV4
SX Female
CA Transformed cell line
//
ID UW-1
AC CVCL_8008
DR GEO; GSM276760
RX PubMed=9154388;
RX PubMed=15714118;
RX PubMed=17487557;
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Spontaneously immortalized cell line
//
ID UW14
AC CVCL_8582
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UW15
AC CVCL_8583
RX PubMed=19706761;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UW19
AC CVCL_8584
RX PubMed=19706761;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UW228
AC CVCL_8585
SY UW 228
DR GEO; GSM919366
RX PubMed=1292757;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UW228-1
AC CVCL_4460
DR BTO; BTO:0004330
RX PubMed=8674085;
RX PubMed=8866661;
RX PubMed=15814657;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8585 ! UW228
SX Female
CA Cancer cell line
//
ID UW228-2
AC CVCL_0572
DR BTO; BTO:0004331
DR MCCL; MCC:0000477
RX PubMed=8674085;
RX PubMed=8866661;
RX PubMed=15814657;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8585 ! UW228
SX Female
CA Cancer cell line
//
ID UW228-3
AC CVCL_0573
DR BTO; BTO:0004332
DR MCCL; MCC:0000478
RX PubMed=8674085;
RX PubMed=8866661;
RX PubMed=15814657;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8585 ! UW228
SX Female
CA Cancer cell line
//
ID UW28
AC CVCL_8586
RX PubMed=18505928;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UW281
AC CVCL_8587
RX PubMed=18505928;
RX PubMed=19706761;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UW35
AC CVCL_8588
RX PubMed=19706761;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UW402
AC CVCL_DH81
SY Uw-402
DR GEO; GSM482331
RX PubMed=23325114;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UW426
AC CVCL_DH82
SY Uw-426
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UW443
AC CVCL_M135
RX PubMed=8674085;
RX PubMed=8866661;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UW467
AC CVCL_DG13
RX PubMed=15814657;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UW473
AC CVCL_DG14
SY Uw-473
RX PubMed=15814657;
RX PubMed=23325114;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID UW479
AC CVCL_DG15
SY UW-479
DR BTO; BTO:0005888
DR GEO; GSM2197892
DR GEO; GSM2197893
DR GEO; GSM2197894
DR GEO; GSM2197895
DR GEO; GSM2197896
DR GEO; GSM2197897
RX PubMed=15814657;
RX PubMed=19365568;
CC Doubling time: 28 hours (PubMed=19365568).
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UW5
AC CVCL_8589
RX PubMed=19706761;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UW77iSMA-e.x
AC CVCL_W563
SY 77iSMA
DR SKIP; SKIP000318
RX PubMed=22723941;
DI NCIt; C98670; Werdnig-Hoffmann disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W562 ! GM09677
SX Male
CA Induced pluripotent stem cell
//
ID UW78
AC CVCL_8590
RX PubMed=19706761;
RX PubMed=18505928;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID UW83iCTR-i.8
AC CVCL_W565
SY 83iCTR
RX PubMed=22723941;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W557 ! GM02183
SX Female
CA Induced pluripotent stem cell
//
ID UWB1.289
AC CVCL_B079
SY UWB1-289
DR ATCC; CRL-2945
DR BioSample; SAMN03471702
DR Cosmic-CLP; 1480374
DR GDSC; 1480374
DR GEO; GSM1670568
RX PubMed=17259345;
RX PubMed=25230021;
RX PubMed=27397505;
CC Part of: OCCP ovarian cancer cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 12
ST D18S51: 19
ST D21S11: 28,31
ST D3S1358: 14,15
ST D5S818: 13
ST D7S820: 7,10
ST D8S1179: 12
ST FGA: 22
ST Penta D: 10
ST Penta E: 8
ST TH01: 9
ST TPOX: 9,11
ST vWA: 16,19
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UWB1.289+BRCA1
AC CVCL_B078
DR ATCC; CRL-2946
RX PubMed=17259345;
RX PubMed=25230021;
CC Part of: OCCP ovarian cancer cell line panel.
CC Transfected with: HGNC; 1100; BRCA1.
ST Source(s): ATCC; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 12
ST D18S51: 19
ST D21S11: 28,31
ST D3S1358: 14,15
ST D5S818: 13
ST D7S820: 7,10
ST D8S1179: 12
ST FGA: 22
ST Penta D: 10
ST Penta E: 8
ST TH01: 9
ST TPOX: 9,11
ST vWA: 16,19
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B079 ! UWB1.289
SX Female
CA Cancer cell line
//
ID UWKOS1
AC CVCL_X350
RX PubMed=23489774;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID UWKOS2
AC CVCL_X351
RX PubMed=23489774;
CC Breed/subspecies: Irish Terrier.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID UWKOS3
AC CVCL_X352
RX PubMed=23489774;
CC Breed/subspecies: Mastiff.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID UWKOS6
AC CVCL_X353
RX PubMed=23489774;
CC Breed/subspecies: Labrador Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID UWKOS7
AC CVCL_X354
RX PubMed=23489774;
CC Breed/subspecies: German Shepherd.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID UWKOS8
AC CVCL_X355
RX PubMed=23489774;
CC Breed/subspecies: Border Collie.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID UWOV1
AC CVCL_9809
RX PubMed=2351639;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UWOV2
AC CVCL_9810
RX PubMed=2351639;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID UWOV2 Sf
AC CVCL_9811
RX PubMed=2351639;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9810 ! UWOV2
SX Female
CA Cancer cell line
//
ID UWWC1-2DS3
AC CVCL_EJ80
SY 2DS3
RX PubMed=23716668;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UWWC1-2DS3.cmsx
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L976 ! GM02504
SX Male
CA Induced pluripotent stem cell
//
ID UWWC1-DS1
AC CVCL_EJ81
SY DS1
RX PubMed=23716668;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UWWC1-DS1.cmsx
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L780 ! AG05397
SX Male
CA Induced pluripotent stem cell
//
ID UWWC1-DS2U
AC CVCL_EJ82
SY DS2U
RX PubMed=23716668;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UWWC1-DS2U.cmsx
CC Characteristics: Lost the third copy of chromosome 21.
ST Source(s): PubMed=23716668
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 10,12
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 8,10
ST vWA: 15,17
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L780 ! AG05397
SX Male
CA Induced pluripotent stem cell
//
ID UWWC1-DS4
AC CVCL_EJ83
SY DS4
RX PubMed=23716668;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UWWC1-DS4.cmsx
ST Source(s): PubMed=23716668
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 10,12
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 8,10
ST vWA: 15,17
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L780 ! AG05397
SX Male
CA Induced pluripotent stem cell
//
ID Uyghur-UCSCCL
AC CVCL_IM36
SY Uyghur Uterine Cervical Squamous Carcinoma Cell Line
RX PubMed=22800521;
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the cell description.
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID V-1181N1
AC CVCL_T435
RX PubMed=4354152;
RX PubMed=4370460;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D317 ! 1181N1
SX Male
CA Cancer cell line
//
ID V-3
AC CVCL_K039
SY CHO-V3; CHO V3; V3
DR CLO; CLO_0050428
DR RCB; RCB2329
RX PubMed=2573661;
RX PubMed=7724535;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4386 ! CHO-AA8
SX Female
CA Spontaneously immortalized cell line
//
ID V-B11
AC CVCL_V246
SY GM16137
DR CLO; CLO_0018899
DR Coriell; GM16137
RX PubMed=3412364;
RX PubMed=3587254;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V-C4
AC CVCL_T044
SY GM16138
DR CLO; CLO_0018897
DR Coriell; GM16138
RX PubMed=2466555;
RX PubMed=3587254;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V-C8
AC CVCL_X405
SY VC8
RX PubMed=3587254;
RX PubMed=7565860;
RX PubMed=11756561;
RX PubMed=16643964;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V-E5
AC CVCL_T045
SY GM16139
DR CLO; CLO_0018896
DR CLO; CLO_0051578
DR Coriell; GM16139
DR RCB; RCB2335
RX PubMed=2466555;
RX PubMed=3587254;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V-G8
AC CVCL_T046
SY GM16140
DR CLO; CLO_0018895
DR CLO; CLO_0051579
DR Coriell; GM16140
DR RCB; RCB2336
RX PubMed=2466555;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V-H1
AC CVCL_V247
SY GM16141
DR CLO; CLO_0018894
DR Coriell; GM16141
RX PubMed=3587254;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V-H4
AC CVCL_V248
SY GM16142
DR CLO; CLO_0018893
DR Coriell; GM16142
RX PubMed=3587254;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V.E.C.
AC CVCL_E860
DR dbMHC; 49050
DR ECACC; 94050309
DR IHW; IHW9314
DR IMGT/HLA; 11521
WW http://bioinformatics.hsanmartino.it/ecbr/cl314.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID V12S-3Y1-2
AC CVCL_K114
DR RCB; RCB0381
RX PubMed=2920374;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12 [E1A 12S isoform].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID V13S-3Y1-4
AC CVCL_K115
DR RCB; RCB0384
RX PubMed=2920374;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12 [E1A 13S isoform].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID v17.2
AC CVCL_6D26
SY V17.2
RX PubMed=9054943;
RX PubMed=9501308;
RX PubMed=11331774;
RX PubMed=11441181;
CC Breed/subspecies: BALB/cTa x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID v18.6
AC CVCL_6D27
SY v 18.6; V18.6
RX PubMed=10655052;
RX PubMed=11331774;
RX PubMed=11441181;
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID V2387
AC CVCL_IP02
RX PubMed=22249266;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID v26.2
AC CVCL_6D28
SY V26.2
RX PubMed=11331774;
RX PubMed=11441181;
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID v30.30
AC CVCL_6D30
SY V30.30
RX PubMed=11331774;
CC Breed/subspecies: C57BL/6J x BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID v39.7
AC CVCL_6D31
SY V39.7
RX PubMed=11331774;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID v6.4
AC CVCL_6D29
SY V6.4
RX PubMed=9501308;
CC Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID v6.5
AC CVCL_C865
SY v 6.5; V6.5
DR EFO; EFO_0006308
DR GEO; GSM344757
DR GEO; GSM344758
DR GEO; GSM1385513
RX PubMed=10655052;
RX PubMed=11331774;
RX PubMed=11441181;
RX PubMed=15464582;
WW http://www.novusbio.com/v65-Mouse-embryonic-stem-cells-_NBP1-41162.html
CC Omics: Transcriptome analysis.
CC Breed/subspecies: C57BL/6 x 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID V79
AC CVCL_2234
SY V-79; V 79; Strain V; GM00215; GM16136; UCW 100
DR BTO; BTO:0001425
DR CLO; CLO_0009500
DR CLO; CLO_0018898
DR CLO; CLO_0025501
DR CLO; CLO_0051573
DR CLDB; cl4625
DR CLDB; cl4626
DR CLDB; cl4627
DR CLDB; cl4628
DR CLDB; cl4952
DR CCRID; 3131C0001000100006
DR CCRID; 3153C0001000000026
DR ChEMBL-Cells; CHEMBL3307528
DR ChEMBL-Targets; CHEMBL614074
DR Coriell; GM00215
DR Coriell; GM16136
DR DSMZ; ACC-335
DR ECACC; 86041102
DR ICLC; AL99002
DR KCB; KCB 93015YJ
DR Lonza; 731
DR RCB; RCB0008
RX PubMed=3558490;
RX PubMed=13576097;
CC Characteristics: Widely used to study DNA damage induced by X-ray, UV radiation and oxidizing agents.
CC Doubling time: ~16 hours (DSMZ).
OX NCBI_TaxID=10029; ! Cricetulus griseus
SX Male
CA Spontaneously immortalized cell line
//
ID V79 A3
AC CVCL_5A61
SY V-79 A3; V-79 A-3; V79, clone A3; A-3; A3
RX PubMed=220255;
RX PubMed=954094;
RX PubMed=1170021;
RX PubMed=4345996;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79 clone S
AC CVCL_7230
DR CLO; CLO_0009501
DR CLDB; cl4629
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79 Dtxr-1
AC CVCL_U412
SY Dtxr-1
RX PubMed=117016;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79 Dtxr-2
AC CVCL_U413
SY Dtxr-2
RX PubMed=117016;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79 Dtxr-3
AC CVCL_U414
SY Dtxr-3
RX PubMed=117016;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79 HPRT~
AC CVCL_8556
SY T2-14
DR JCRB; JCRB0707
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79 HRC
AC CVCL_7231
DR CLO; CLO_0009502
DR CLDB; cl4630
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79-379A
AC CVCL_J371
SY V79 379A; V79.379A; V79-379-A; V-79-379A; V-79-379 A
DR IFO; IFO50082
RX PubMed=475817;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79-4
AC CVCL_2796
SY V-79-4; V 79-4
DR BTO; BTO:0003719
DR CLO; CLO_0009504
DR CLO; CLO_0051576
DR CLDB; cl4632
DR ATCC; CCL-93
DR BCRC; 60183
DR BCRJ; 0244
DR ChEMBL-Cells; CHEMBL3307246
DR ChEMBL-Targets; CHEMBL612801
DR CLS; 603371/p553_V79-4
DR ECACC; 93010723
DR JCRB; JCRB0603
DR RCB; RCB2332
RX PubMed=9023109;
CC Characteristics: Widely used to study DNA damage induced by X-ray, UV radiation and oxidizing agents.
CC Characteristics: Deficient in TP53 due to two mutations, Q-133 and W-135.
CC Doubling time: 12-14 hours (ECACC).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79-6TG
AC CVCL_3241
DR JCRB; JCRB0219
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79-8
AC CVCL_M079
RX PubMed=658159;
RX PubMed=6035652;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79-8HG-
AC CVCL_M080
RX PubMed=658159;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_M079 ! V79-8
SX Male
CA Spontaneously immortalized cell line
//
ID V79-ETO1
AC CVCL_5A65
SY ETO1
RX PubMed=10606818;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2796 ! V79-4
SX Male
CA Spontaneously immortalized cell line
//
ID V79-ETO2
AC CVCL_5A66
SY ETO2
RX PubMed=10606818;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2796 ! V79-4
SX Male
CA Spontaneously immortalized cell line
//
ID V79-ETO3
AC CVCL_5A67
SY ETO3
RX PubMed=10606818;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2796 ! V79-4
SX Male
CA Spontaneously immortalized cell line
//
ID V79-G7
AC CVCL_DQ79
SY G7
RX PubMed=196202;
RX PubMed=1027147;
RX PubMed=6265473;
RX PubMed=9217999;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79-GalK1
AC CVCL_2797
SY GalK1; GalK 1; DR2R1610; DR2R 1610; R1610; R 1610
DR CLO; CLO_0008690
DR ATCC; CRL-1657
DR CCRID; 3131C0001000100005
RX PubMed=1269916;
RX PubMed=6513922;
CC Selected for resistance to: ChEBI; CHEBI:27411; 2-deoxy-D-galactose.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79-hCYP2E1-hSULT1A1
AC CVCL_5A60
RX PubMed=15668106;
CC Transfected with: HGNC; 2631; CYP2E1.
CC Transfected with: HGNC; 11453; SULT1A1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V36 ! V79MZ
SX Male
CA Spontaneously immortalized cell line
//
ID V79-HG04
AC CVCL_4333
DR CLO; CLO_0009505
DR CLDB; cl4633
DR ECACC; 87020406
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79/380
AC CVCL_HM61
SY V79, clone 380
RX PubMed=291939;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79/380-6
AC CVCL_HM62
RX PubMed=6510024;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HM61 ! V79/380
SX Male
CA Spontaneously immortalized cell line
//
ID V79/B7
AC CVCL_7232
SY V79,B7
DR CLO; CLO_0009503
DR CLDB; cl4631
RX PubMed=2896299;
RX PubMed=7679200;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79/E36
AC CVCL_5A58
SY E36; E-36; E36,HGPRT-
DR KCB; KCB 87014YJ
RX PubMed=3049611;
RX PubMed=4345996;
RX PubMed=6752155;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Misspelling: Occasionally 'CHO-E36' or 'CHO E36'. This is incorrect as E36 is not a CHO derivative but rather a V79 derivative.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_5A61 ! V79 A3
SX Male
CA Spontaneously immortalized cell line
//
ID V79/E36-ts20
AC CVCL_0215
SY E36-ts20; E36ts20; TS20; ts20; ts 20
DR MCCL; MCC:0000104
RX PubMed=3049611;
RX PubMed=6752155;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Misspelling: Occasionally 'CHO-TS20', 'CHO-ts20', 'CHO ts20' or 'CHOTS20'. This is incorrect as V79/E36-ts20 is not a CHO derivative but rather a V79 derivative.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_5A58 ! V79/E36
SX Male
CA Spontaneously immortalized cell line
//
ID V79/M12G
AC CVCL_S250
SY M12G
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79/SD1
AC CVCL_GR60
SY SD1; SD-1
DR TOKU-E; 4043
RX PubMed=1441600;
RX PubMed=1800893;
RX PubMed=3137560;
RX PubMed=8596476;
CC Transfected with: RGD; 2466; Cyp2b1.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V36 ! V79MZ
SX Male
CA Spontaneously immortalized cell line
//
ID V79/UC
AC CVCL_S170
RX PubMed=1900371;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_S250 ! V79/M12G
SX Male
CA Spontaneously immortalized cell line
//
ID V79B
AC CVCL_6296
SY V79b; V79 Brighton; GM16143
DR CLO; CLO_0018892
DR CLO; CLO_0051577
DR Coriell; GM16143
DR RCB; RCB2337
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79MZ
AC CVCL_4V36
SY V79-MZ; V79-Mz; V79 Mainz; V79d MZ
RX PubMed=1446722;
RX PubMed=7588408;
RX PubMed=8293790;
RX PubMed=8596476;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID V79MZh11B1
AC CVCL_4709
DR BTO; BTO:0003278
RX PubMed=7588408;
CC Transfected with: HGNC; 2591; CYP11B1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V36 ! V79MZ
SX Male
CA Spontaneously immortalized cell line
//
ID V79MZh11B2
AC CVCL_4710
DR BTO; BTO:0003279
RX PubMed=7588408;
CC Transfected with: HGNC; 2592; CYP11B2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V36 ! V79MZ
SX Male
CA Spontaneously immortalized cell line
//
ID V79MZh1A1
AC CVCL_4V37
RX PubMed=8293790;
CC Transfected with: HGNC; 2595; CYP1A1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V36 ! V79MZ
SX Male
CA Spontaneously immortalized cell line
//
ID V79MZh1A2
AC CVCL_4V39
SY XEMhIA2-MZ#1; XEMhIA2-MZ
RX PubMed=1446722;
RX PubMed=8293790;
CC Transfected with: HGNC; 2596; CYP1A2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V36 ! V79MZ
SX Male
CA Spontaneously immortalized cell line
//
ID V79NH
AC CVCL_4V38
SY V79-NH
RX PubMed=1446722;
RX PubMed=8293790;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_J371 ! V79-379A
SX Male
CA Spontaneously immortalized cell line
//
ID V79NHh1A2
AC CVCL_4V40
SY XEMhIA2-NH#1; XEMhIA2NH
RX PubMed=1446722;
RX PubMed=8293790;
CC Transfected with: HGNC; 2596; CYP1A2.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V38 ! V79NH
SX Male
CA Spontaneously immortalized cell line
//
ID v8.1
AC CVCL_6D32
SY V8.1
RX PubMed=11331774;
RX PubMed=11441181;
CC Breed/subspecies: 129S4/SvJae x FVB.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID V9-7A
AC CVCL_C658
SY NED5; NED 5
DR ISCR; 225
RX PubMed=18371431;
CC From: StemLifeLine, Inc.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID VA-ES-BJ
AC CVCL_1785
SY VAESBJ
DR CLO; CLO_0009509
DR CLDB; cl4635
DR CLDB; cl4636
DR ATCC; CRL-2138
DR BioSample; SAMN03472555
DR ChEMBL-Cells; CHEMBL3308888
DR ChEMBL-Targets; CHEMBL2366259
DR Cosmic; 688121
DR Cosmic-CLP; 688121
DR DSMZ; ACC-328
DR ECACC; 94092303
DR GDSC; 688121
DR GEO; GSM1632462
DR GEO; GSM1632463
DR GEO; GSM1632464
DR GEO; GSM1632465
DR GEO; GSM1670569
DR GEO; GSM1676344
DR GEO; GSM1701675
DR ICLC; HTL97024
RX PubMed=21357725;
RX PubMed=21552805;
RX PubMed=26351324;
RX PubMed=26365879;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 36-39 hours (PubMed=21552805); ~32 hours (PubMed=21357725); ~60-90 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; ICLC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D21S11: 27,28
ST D5S818: 11,13
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C3714; Epithelioid sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VA-N-BR
AC CVCL_9880
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=1580564;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VA13-TS4
AC CVCL_U971
DR BTO; BTO:0003065
RX PubMed=14701864;
CC Transfected with: HGNC; 220; ADAMTS4.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2759 ! WI-38 VA13 subline 2RA
SX Female
CA Transformed cell line
//
ID VAB5
AC CVCL_S600
RX Patent=US6660276;
RX PubMed=7681084;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VACO 1
AC CVCL_5392
SY VACO1
RX PubMed=6498841;
CC Derived from metastatic site: Liver.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VACO 10MS
AC CVCL_5393
SY VACO10MS; V10MS; VACO-10M; VACO10M; V10M; VACO 10; VACO10
DR Cosmic; 948824
DR Cosmic; 986022
DR Cosmic; 1223152
DR Cosmic; 1312319
DR Cosmic; 2302023
DR GEO; GSM784050
DR GEO; GSM1346859
DR GEO; GSM1374980
RX PubMed=6498841;
RX PubMed=7761852;
RX PubMed=8755562;
RX PubMed=20606684;
RX PubMed=24755471;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Visceral (omental).
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5394 ! VACO 10P
SX Female
CA Cancer cell line
//
ID VACO 10P
AC CVCL_5394
SY VACO10P
RX PubMed=6498841;
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5393 ! VACO 10MS
SX Female
CA Cancer cell line
//
ID VACO 143
AC CVCL_9U74
SY VACO143; VaCo143
RX PubMed=9515795;
WW http://www.seltarbase.org/cgi-bin/cell_lines.cgi?extension=latest
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 206
AC CVCL_5395
SY VACO206; Vaco206; V206
RX PubMed=3567899;
RX PubMed=7761852;
RX PubMed=8385345;
RX PubMed=11314036;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VACO 235
AC CVCL_5175
SY VACO235; VACO-235
DR BTO; BTO:0002739
DR Cosmic; 736333
DR Cosmic; 956085
RX PubMed=3567899;
RX PubMed=8132740;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VACO 241
AC CVCL_5396
SY VACO241; Vaco241; V241
RX PubMed=3567899;
RX PubMed=8385345;
RX PubMed=11314036;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VACO 264
AC CVCL_8629
SY Vaco 264; VACO264; V264
RX PubMed=7761852;
RX PubMed=8385345;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 3
AC CVCL_5397
SY VACO3
RX PubMed=6498841;
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VACO 310
AC CVCL_5398
SY VACO310
RX PubMed=3567899;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VACO 330
AC CVCL_5399
SY VACO330; VACO-330
RX PubMed=3567899;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VACO 364
AC CVCL_8630
SY VACO364; Vaco364; V364
RX PubMed=11314036;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 394
AC CVCL_8631
SY Vaco 394; VACO394; Vaco394; V394
DR GEO; GSM784026
RX PubMed=8385345;
RX PubMed=11314036;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 400
AC CVCL_5400
SY Vaco 400; VACO-400; Vaco-400; VACO400; Vaco400; V400
DR BTO; BTO:0004764
DR Cosmic; 1312318
DR GEO; GSM784046
RX PubMed=20606684;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/VACO400.html
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VACO 410
AC CVCL_8632
SY Vaco 410; VACO410; VaCo410; Vaco410; V410
DR GEO; GSM784047
RX PubMed=7824277;
RX PubMed=8385345;
RX PubMed=11314036;
CC Derived from metastatic site: Liver.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VACO 411
AC CVCL_5176
SY Vaco 411; VACO-411; VACO411; V411
DR BTO; BTO:0002739
DR Cosmic; 736334
DR GEO; GSM1448221
RX PubMed=7761852;
RX PubMed=8132740;
RX PubMed=12595761;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5175 ! VACO 235
SX Female
CA Cancer cell line
//
ID VACO 425
AC CVCL_8633
SY VACO425; Vaco 425; Vaco425
RX PubMed=8385345;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 429
AC CVCL_5401
SY Vaco 429; VACO-429; Vaco-429; VACO429; V429
DR Cosmic; 1312320
DR GEO; GSM784051
RX PubMed=7816807;
RX PubMed=8385345;
RX PubMed=20606684;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/VACO429.html
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VACO 432
AC CVCL_5402
SY Vaco 432; VACO432; VaCo432; Vaco432; V432
DR GEO; GSM1448124
RX PubMed=7761852;
RX PubMed=7816807;
RX PubMed=7824277;
RX PubMed=8755562;
RX PubMed=9515795;
RX PubMed=11314036;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VACO 441
AC CVCL_5403
SY VACO441; VaCo441; Vaco441; Vaco 441; V441
RX PubMed=7816807;
RX PubMed=8385345;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 444
AC CVCL_8634
SY Vaco 444; VACO444; V444
DR Cosmic; 1090614
RX PubMed=7761852;
RX PubMed=8385345;
RX PubMed=8755562;
RX PubMed=9515795;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 451
AC CVCL_8635
SY Vaco 451; VACO451; Vaco451; V451
RX PubMed=8385345;
RX PubMed=11314036;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 456
AC CVCL_5404
SY Vaco 456; VACO456; VaCo456; V456
DR GEO; GSM784052
RX PubMed=7816807;
RX PubMed=8385345;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 457
AC CVCL_9T31
SY Vaco 457; Vaco-457; VACO457; Vaco457; V457
DR GEO; GSM1448081
RX PubMed=7761852;
RX PubMed=7824277;
RX PubMed=8755562;
RX PubMed=9515795;
RX PubMed=11314036;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Liver.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VACO 459
AC CVCL_8636
SY Vaco 459; VACO459; V459
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 478
AC CVCL_8637
SY Vaco 478; VACO478; Vaco478
RX PubMed=8385345;
RX PubMed=11314036;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 481
AC CVCL_8638
SY Vaco 481; VACO481; Vaco481; V481
DR Cosmic; 1090615
DR Cosmic; 1131690
DR GEO; GSM1448110
RX PubMed=7761852;
RX PubMed=8385345;
RX PubMed=8755562;
RX PubMed=9515795;
RX PubMed=11314036;
RX PubMed=17363507;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 486
AC CVCL_8639
SY Vaco 486; VACO486
RX PubMed=8385345;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 489
AC CVCL_8640
SY Vaco 489; VACO489
RX PubMed=7824277;
RX PubMed=8385345;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VACO 4A
AC CVCL_5405
SY VACO4A
DR Cosmic; 948843
DR Cosmic; 985654
DR Cosmic; 995404
DR Cosmic; 1043833
DR Cosmic; 1312321
DR GEO; GSM1374981
RX PubMed=6498841;
RX PubMed=10737795;
RX PubMed=11226274;
RX PubMed=20606684;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/VACO4A.html
CC Omics: Transcriptome analysis.
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5406 ! VACO 4S
SX Male
CA Cancer cell line
//
ID VACO 4S
AC CVCL_5406
SY VACO-4S; VACO4S
DR Cosmic; 948849
DR Cosmic; 986023
DR Cosmic; 1043834
DR Cosmic; 2302024
DR GEO; GSM1346860
DR GEO; GSM1374982
RX PubMed=6498841;
RX PubMed=20606684;
RX PubMed=24755471;
CC Omics: Transcriptome analysis.
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5405 ! VACO 4A
SX Male
CA Cancer cell line
//
ID VACO 5
AC CVCL_5407
SY Vaco 5; VACO5; Vaco5; V5
DR Cosmic; 948859
DR Cosmic; 995385
DR Cosmic; 1043835
DR Cosmic; 1090612
DR Cosmic; 1223153
DR Cosmic; 1312322
DR Cosmic; 1479608
DR GEO; GSM1374983
DR GEO; GSM1448121
RX PubMed=6498841;
RX PubMed=7761852;
RX PubMed=8385345;
RX PubMed=8755562;
RX PubMed=9515795;
RX PubMed=10737795;
RX PubMed=11226274;
RX PubMed=11314036;
RX PubMed=20606684;
RX PubMed=25926053;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/VACO5.html
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5409 ! VACO 5A
SX Female
CA Cancer cell line
//
ID VACO 503
AC CVCL_8641
SY Vaco 503; VACO503; V503
DR GEO; GSM784048
RX PubMed=8385345;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 531
AC CVCL_DG24
SY V531
DR GEO; GSM784053
RX PubMed=8755562;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 576
AC CVCL_5408
SY VACO576; Vaco576; V576
DR GEO; GSM784049
RX PubMed=7816807;
RX PubMed=7824277;
CC Derived from metastatic site: Liver.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VACO 5A
AC CVCL_5409
SY VACO5A
RX PubMed=6498841;
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5407 ! VACO 5
SX Female
CA Cancer cell line
//
ID VACO 6
AC CVCL_5410
SY Vaco 6; VACO6; Vaco6; V6
DR Cosmic; 1090613
DR GEO; GSM1448220
RX PubMed=6498841;
RX PubMed=7761852;
RX PubMed=8385345;
RX PubMed=8755562;
RX PubMed=9515795;
RX PubMed=11314036;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VACO 670
AC CVCL_9T32
SY Vaco 670; VACO670; Vaco670; V670
RX PubMed=7761852;
RX PubMed=11314036;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 703
AC CVCL_9T33
SY Vaco 703; VACO703; Vaco703; V703
DR GEO; GSM1448108
RX PubMed=7761852;
RX PubMed=11314036;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 784
AC CVCL_8642
SY VACO784; V784
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 786
AC CVCL_8643
SY VACO786; V786
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 8
AC CVCL_5411
SY Vaco 8; VACO8; V8
RX PubMed=6498841;
RX PubMed=7761852;
RX PubMed=8385345;
RX PubMed=8755562;
RX PubMed=11314036;
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VACO 866
AC CVCL_8644
SY VACO866; V866
DR BTO; BTO:0004763
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VACO 9M
AC CVCL_5412
SY Vaco 9M; VACO9M; Vaco9M; V9M
DR GEO; GSM784025
RX PubMed=6498841;
RX PubMed=7761852;
RX PubMed=8385345;
RX PubMed=8755562;
CC Derived from metastatic site: Liver.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5413 ! VACO 9P
SX Male
CA Cancer cell line
//
ID VACO 9P
AC CVCL_5413
AS CVCL_A437
SY Vaco 9P; VACO9P; V9P
DR Cosmic; 711267
DR Cosmic; 887233
DR Cosmic; 1132562
DR Cosmic; 1479634
RX PubMed=3349466;
RX PubMed=6498841;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=11526487;
RX PubMed=24042735;
CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735).
CC Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained by personal communication of Lind G.E.
ST Source(s): PubMed=24042735
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 12,13
ST D18S51: 13
ST D19S433: 13
ST D21S11: 30
ST D2S1338: 17,20
ST D3S1358: 13,15
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 23,25
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 19
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5412 ! VACO 9M
SX Male
CA Cancer cell line
//
ID VAL
AC CVCL_1819
DR BioSample; SAMN03473489
DR Cosmic; 1086346
DR Cosmic; 1517631
DR Cosmic; 1541908
DR Cosmic; 2276320
DR Cosmic; 2297002
DR Cosmic-CLP; 1331048
DR DSMZ; ACC-586
DR GDSC; 1331048
DR GEO; GSM115973
DR GEO; GSM201349
DR GEO; GSM1670570
DR Lonza; 1237
RX PubMed=8220427;
RX PubMed=16960149;
RX PubMed=19358282;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~50-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,14
ST D16S539: 9,13
ST D5S818: 11
ST D7S820: 10
ST TH01: 6,9
ST TPOX: 8
ST vWA: 14,15
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VAL-1
AC CVCL_9969
RX PubMed=15652923;
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VAL-10B
AC CVCL_9961
SY ESe020-A
DR hPSCreg; ESe020-A
DR ISCR; 2254
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL_10B.pdf
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID VAL-11B
AC CVCL_V174
DR ISCR; 2255
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL_11B.pdf
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VAL-2
AC CVCL_9970
RX PubMed=15652923;
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VAL-3
AC CVCL_9962
SY ESe011-A
DR hPSCreg; ESe011-A
DR ISCR; 1415
RX PubMed=20186513;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/VAL3.pdf
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC Registration: Swiss research registry; BAG-hES-IMP-0021.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID VAL-4
AC CVCL_9963
SY ESe012-A
DR hPSCreg; ESe012-A
DR ISCR; 1416
RX PubMed=20186513;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/VAL4.pdf
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC Registration: Swiss research registry; BAG-hES-IMP-0022.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VAL-5
AC CVCL_9964
SY ESe013-A
DR hPSCreg; ESe013-A
DR ISCR; 1417
RX PubMed=20186513;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/VAL5.pdf
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC Registration: Swiss research registry; BAG-hES-IMP-0023.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VAL-6M
AC CVCL_9965
SY ESe017-A
DR hPSCreg; ESe017-A
DR ISCR; 1418
RX PubMed=20186513;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL_6M_febrero_2008.pdf
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
DI NCIt; C84679; Dystrophia myotonica 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID VAL-7
AC CVCL_9966
SY ESe018-A
DR hPSCreg; ESe018-A
DR ISCR; 1419
RX PubMed=20186513;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL_7_febrero_2008.pdf
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID VAL-8
AC CVCL_9967
SY ESe021-A
DR hPSCreg; ESe021-A
DR ISCR; 1420
RX PubMed=20186513;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL8.pdf
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VAL-9
AC CVCL_9968
SY Val 9; ESe019-A
DR hPSCreg; ESe019-A
DR ISCR; 1421
RX PubMed=20186513;
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL_9.pdf
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC10-45.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID VAL-9-GFP
AC CVCL_V165
DR ISCR; 2256
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_VAL-9-GFP.pdf
CC From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9968 ! VAL-9
SX Male
CA Embryonic stem cell
//
ID ValiScreen human Kv1.3
AC CVCL_5I79
WW http://www.perkinelmer.com/Catalog/Product/ID/AX-010-C
CC Transfected with: HGNC; 6221; KCNA3.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID ValiScreen human TRPC3
AC CVCL_5I80
WW http://www.perkinelmer.com/Catalog/Product/ID/AX-011-C
CC Transfected with: HGNC; 12335; TRPC3.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID ValiScreen human TRPC6
AC CVCL_5I81
WW http://www.perkinelmer.com/Catalog/Product/ID/AX-012-C
CC Transfected with: HGNC; 12338; TRPC6.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID VAMT-1
AC CVCL_A731
SY VAMT 1; VAMT
DR Cosmic; 733834
DR Cosmic; 1522779
DR Cosmic; 1541209
DR GEO; GSM726285
RX CelloPub=CLPUB00125;
RX PubMed=21642991;
CC Omics: SNP array analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VAn2H
AC CVCL_6E14
SY VAN2H; Vertebra Acipenser naccarii 2H
RX DOI=10.1111/j.1439-0426.2010.01408.x;
RX DOI=10.1111/j.1439-0426.2010.01411.x;
CC Group: Fish cell line.
OX NCBI_TaxID=42330; ! Acipenser naccarii
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID VAO1
AC CVCL_S601
RX Patent=US6660276;
RX PubMed=7681084;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VAT-39
AC CVCL_0U25
RX PubMed=24481592;
CC Doubling time: 34 hours, at 50th passage (PubMed=24481592).
CC Derived from metastatic site: Lymph node.
ST Source(s): PubMed=24481592
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9,12
ST D21S11: 30
ST D5S818: 12
ST D7S820: 12,13
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C95966; Ampulla of Vater hepatoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VAVY
AC CVCL_E861
SY Vavy
DR dbMHC; 49051
DR ECACC; 88052023
DR IHW; IHW9023
DR IMGT/HLA; 11522
RX PubMed=7615790;
WW http://bioinformatics.hsanmartino.it/ecbr/cl23.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID VBD234
AC CVCL_E862
SY VBD 234
DR dbMHC; 49052
DR ECACC; 94082260
DR IHW; IHW9160
DR IMGT/HLA; 11703
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl160.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID VBT2
AC CVCL_S587
RX Patent=US6660276;
RX PubMed=7513255;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S588 ! VBT2-EBV
SX Male
CA Cancer cell line
//
ID VBT2-EBV
AC CVCL_S588
RX PubMed=7513255;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S587 ! VBT2
SX Male
CA Transformed cell line
//
ID VC1.Ov
AC CVCL_S371
DR ATCC; CRL-6266
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6266; true.
OX NCBI_TaxID=9627; ! Vulpes vulpes
SX Female
CA Finite cell line
//
ID VC312R
AC CVCL_1R57
DR BioSample; SAMN03152031
RX PubMed=20951163;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20951163).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Undefined cell line type
//
ID VC5
AC CVCL_M545
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VCaP
AC CVCL_2235
SY VCAP; Vcap; Vertebral Cancer of the Prostate
DR BTO; BTO:0003215
DR ATCC; CRL-2876
DR BioSample; SAMN03473238
DR CCLE; VCAP_PROSTATE
DR Cosmic; 1028646
DR Cosmic; 1028698
DR Cosmic; 1043330
DR Cosmic; 1071482
DR Cosmic; 1689710
DR Cosmic; 1995663
DR Cosmic; 2580131
DR Cosmic-CLP; 1299075
DR ECACC; 06020201
DR GDSC; 1299075
DR GEO; GSM525805
DR GEO; GSM648824
DR GEO; GSM887731
DR GEO; GSM888826
DR GEO; GSM1374984
DR GEO; GSM1440913
DR GEO; GSM1440914
DR GEO; GSM1670571
DR IZSLER; BS TCL 234
RX PubMed=11317522;
RX PubMed=14518029;
RX PubMed=22460905;
RX PubMed=23671654;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://capcelllines.ca/details.asp?id=159
WW http://www.addexbio.com/productdetail?pid=73
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 220 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Vertebra.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 13
ST D21S11: 31
ST D3S1358: 14,15
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 12,13
ST FGA: 21,26
ST Penta D: 9
ST Penta E: 10,12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2025 ! DuCaP
SX Male
CA Cancer cell line
//
ID VCP-#1
AC CVCL_T897
DR RCB; HPS0351
DR SKIP; SKIP000225
DI NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T894 ! GM22394
SX Male
CA Induced pluripotent stem cell
//
ID VCP-#2
AC CVCL_T898
DR RCB; HPS0352
DR SKIP; SKIP000226
DI NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T894 ! GM22394
SX Male
CA Induced pluripotent stem cell
//
ID VCP-#4
AC CVCL_T899
DR SKIP; SKIP000227
DI NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T894 ! GM22394
SX Male
CA Induced pluripotent stem cell
//
ID VD-10
AC CVCL_F806
DR CLO; CLO_0009520
DR ATCC; HB-68
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID VE-CL-01
AC CVCL_Z454
SY VE-Clp1; Super Sf9-1; superSf9-1
RX Patent=US7842493;
RX PubMed=19453763;
WW http://www.paratechs.com/ve-bevs-cell-lines/
WW http://www.paratechs.com/ve-bevs-resource-page/
WW http://oetltd.com/product/super-sf9-1-cells/
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Transfected with: UniProtKB; Q56IA8; Campoletis sonorensis ichnovirus P-vankyrin-1.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0549 ! Sf9
SX Female
CA Spontaneously immortalized cell line
//
ID VE-CL-02
AC CVCL_Z455
SY VE-CL2; Super Sf9-2; superSf9-2
RX Patent=US7842493;
RX PubMed=19453763;
WW http://www.paratechs.com/ve-bevs-cell-lines/
WW http://www.paratechs.com/ve-bevs-resource-page/
WW http://oetltd.com/product/super-sf9-2-cells/
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Transfected with: UniProtKB; Q56IA8; Campoletis sonorensis ichnovirus P-vankyrin-1.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0549 ! Sf9
SX Female
CA Spontaneously immortalized cell line
//
ID VE-CL-03
AC CVCL_Z456
SY VE-CL03; Super Sf9-3; superSf9-3
RX Patent=US7842493;
WW http://www.paratechs.com/ve-bevs-cell-lines/
WW http://www.paratechs.com/ve-bevs-resource-page/
WW http://oetltd.com/product/super-sf9-3-cells/
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Transfected with: UniProtKB; Q56IA8; Campoletis sonorensis ichnovirus P-vankyrin-1.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0549 ! Sf9
SX Female
CA Spontaneously immortalized cell line
//
ID VEGF-D 293 clone 11
AC CVCL_W713
DR IZSLER; BS CL 202
RX PubMed=11175849;
CC Transfected with: HGNC; 3708; FIGF.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6974 ! HEK293-EBNA
SX Female
CA Transformed cell line
//
ID VEGF120 fibrosarcoma
AC CVCL_HG18
DR Ximbio; 153239
RX PubMed=18381437;
CC Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF120.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID VEGF120 fibrosarcoma Luc2/mStrawberry
AC CVCL_HG19
DR Ximbio; 152853
CC Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF120.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Transfected with: mStrawberry; a bright red fluorescent protein derived from mRFP1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HG18 ! VEGF120 fibrosarcoma
CA Cancer cell line
//
ID VEGF164 fibrosarcoma
AC CVCL_HG20
DR Ximbio; 153240
RX PubMed=18381437;
CC Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF164.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID VEGF164 fibrosarcoma Luc2/mStrawberry
AC CVCL_HG21
DR Ximbio; 152854
CC Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF164.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Transfected with: mStrawberry; a bright red fluorescent protein derived from mRFP1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HG20 ! VEGF164 fibrosarcoma
CA Cancer cell line
//
ID VEGF188 fibrosarcoma
AC CVCL_HG22
DR Ximbio; 153241
RX PubMed=18381437;
CC Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF188.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID VEGF188 fibrosarcoma Luc2/mStrawberry
AC CVCL_HG23
DR Ximbio; 152855
CC Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF188.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Transfected with: mStrawberry; a bright red fluorescent protein derived from mRFP1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HG22 ! VEGF188 fibrosarcoma
CA Cancer cell line
//
ID VEGFWT fibrosarcoma
AC CVCL_HG24
DR Ximbio; 153238
RX PubMed=18381437;
CC Characteristics: Control cell line for the Vegfa isoform-specific cell lines.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID VEGFWT fibrosarcoma Luc2/mStrawberry
AC CVCL_HG25
DR Ximbio; 152852
RX PubMed=18381437;
CC Characteristics: Control cell line for the Vegfa isoform-specific cell lines.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Transfected with: mStrawberry; a bright red fluorescent protein derived from mRFP1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HG24 ! VEGFWT fibrosarcoma
CA Cancer cell line
//
ID VEN
AC CVCL_E863
DR dbMHC; 49053
DR ECACC; 94022550
DR IHW; IHW9238
DR IMGT/HLA; 11525
WW http://bioinformatics.hsanmartino.it/ecbr/cl238.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID vEPT
AC CVCL_4626
DR CLO; CLO_0009523
DR ATCC; CRL-2087
RX PubMed=1280703;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
SX Male
CA Transformed cell line
//
ID Vero
AC CVCL_0059
SY VERO; Verda reno
DR BTO; BTO:0001444
DR CLO; CLO_0009524
DR CLO; CLO_0050515
DR MCCL; MCC:0000480
DR CLDB; cl4643
DR CLDB; cl4644
DR CLDB; cl4645
DR CLDB; cl4648
DR CLDB; cl4649
DR CLDB; cl4650
DR CLDB; cl4651
DR CLDB; cl5170
DR ATCC; CCL-81
DR ATCC; CCL-81.4
DR ATCC; CRL-6318
DR BCRC; 60013
DR BCRJ; 0245
DR CCLV; CCLV-RIE 0078
DR CCRID; 3111C0001CCC000060
DR CCRID; 3111C0002000000001
DR CCRID; 3131C0001000400010
DR CCRID; 3142C0001000000029
DR CCRID; 3153C0001000000035
DR ChEMBL-Cells; CHEMBL3307520
DR ChEMBL-Targets; CHEMBL391
DR CLS; 605372/p622_VERO
DR ECACC; 08011101
DR ECACC; 84113001
DR ICLC; ATL95005
DR IFO; IFO50471
DR IZSLER; BS CL 86
DR JCRB; JCRB0111
DR JCRB; JCRB9013
DR KCB; KCB 92017YJ
DR KCLB; 10081
DR Lonza; 173
DR MeSH; D014709
DR NCBI_Iran; C101
DR RCB; RCB0001
DR TKG; TKG 0280
DR TOKU-E; 3415
DR Wikidata; Q3066564
RX CelloPub=CLPUB00126;
RX CelloPub=CLPUB00328;
RX DOI=10.12665/J63.Morgan;
RX PubMed=4043530;
RX PubMed=6027511;
RX PubMed=10403033;
RX PubMed=10494966;
RX PubMed=19941903;
RX PubMed=24975811;
RX PubMed=25267831;
RX PubMed=25903999;
WW https://en.wikipedia.org/wiki/Vero_cell
WW http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3616b1a.pdf
WW http://en.vircell.com/products/vero-cell-line/
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/v/cell-lines-detail-60.html
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/vero/verocells.html
CC Group: Vaccine production cell line.
CC Group: Non-human primate cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Biotechnology: Used for the production of the Japanese encephalitis virus (JEV) vaccine Ixiaro.
CC Biotechnology: Used for the production of the inactivated poliovirus vaccine Imovax Polio.
CC Biotechnology: Used for the production of the Purified Vero-cell Rabies Vaccine (PVRV) (Trade name: Verorab).
CC Biotechnology: Used for the production of the Chromatographically Purified Rabies Vaccine (CPRV).
CC Omics: Genome sequenced.
CC Anecdotal: Verda reno means green kidney in Esperanto.
CC Discontinued: ATCC; CCL-81.4; probable.
CC Discontinued: ATCC; CRL-6318; true.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
SX Female
CA Spontaneously immortalized cell line
//
ID Vero 303
AC CVCL_L035
CC Group: Vaccine production cell line.
CC Group: Non-human primate cell line.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Vero 317
AC CVCL_3863
SY Vero-317; Vero317
DR CLO; CLO_0009525
DR CLO; CLO_0050513
DR CLDB; cl4652
DR ECACC; 89070502
DR RCB; RCB0272
CC Group: Vaccine production cell line.
CC Group: Non-human primate cell line.
CC Discontinued: ECACC; 89070502; probable.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_L035 ! Vero 303
SX Female
CA Spontaneously immortalized cell line
//
ID Vero 76
AC CVCL_0603
SY VERO 76; Vero-76; VERO-76; VERO76; Vero76
DR BTO; BTO:0004754
DR CLO; CLO_0009526
DR CLDB; cl4653
DR CLDB; cl4654
DR CLDB; cl4655
DR ATCC; CRL-1587
DR BCRC; 60477
DR CCLV; CCLV-RIE 0228
DR CCRID; 3111C0002000000007
DR ECACC; 85020205
DR IFO; IFO50410
DR IZSLER; BS CL 101
DR JCRB; JCRB9007
DR KCLB; 21587
RX CelloPub=CLPUB00328;
RX PubMed=19941903;
WW https://en.wikipedia.org/wiki/Vero_cell
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/avero_76.htm
CC Group: Vaccine production cell line.
CC Group: Non-human primate cell line.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Vero C1008
AC CVCL_0574
SY VERO C1008; VeroC1008; VEROC1008; VERO C 1008; Vero 76 clone E6; Vero 76 clone E-6; Vero E6; VERO E6; Vero-E6; VeroE6
DR BTO; BTO:0004755
DR CLO; CLO_0009527
DR MCCL; MCC:0000479
DR CLDB; cl4656
DR CLDB; cl4657
DR ATCC; CRL-1586
DR BCRC; 60476
DR CCRID; 3111C0001CCC000388
DR ECACC; 85020206
DR GEO; GSM758827
DR GEO; GSM758828
DR GEO; GSM758829
DR GEO; GSM758830
DR GEO; GSM758831
DR GEO; GSM758832
DR GEO; GSM758833
DR GEO; GSM758834
DR GEO; GSM758835
DR GEO; GSM758836
DR GEO; GSM758837
DR GEO; GSM758838
DR GEO; GSM758839
DR GEO; GSM758840
DR GEO; GSM758841
DR GEO; GSM758842
DR GEO; GSM758843
DR GEO; GSM758844
DR IZSLER; BS CL 87
RX CelloPub=CLPUB00328;
WW https://en.wikipedia.org/wiki/Vero_cell
WW http://en.vircell.com/products/vero-e6-cell-line/
CC Group: Vaccine production cell line.
CC Group: Non-human primate cell line.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0603 ! Vero 76
SX Female
CA Spontaneously immortalized cell line
//
ID Vero F6
AC CVCL_L036
SY F6; F6B2
RX PubMed=1309250;
WW https://en.wikipedia.org/wiki/Vero_cell
CC Group: Non-human primate cell line.
CC Transfected with: UniProtKB; P08356; HHV-1 strain HFEM glycoprotein H (gH).
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Vero M
AC CVCL_EJ70
SY Vero-M; VERO-M; Vero-MARU
CC Group: Non-human primate cell line.
CC From: Middle America Research Unit (MARU); Panama.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Vero-B4
AC CVCL_1912
SY VERO-B4; Vero B4
DR CLO; CLO_0009528
DR CLDB; cl4659
DR CCLV; CCLV-RIE 0929
DR DSMZ; ACC-33
CC Group: Vaccine production cell line.
CC Group: Non-human primate cell line.
CC Doubling time: ~25 hours (DSMZ).
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Vero-Hektor
AC CVCL_4334
SY Vero Hektor
DR ECACC; 03092503
CC Group: Vaccine production cell line.
CC Group: Non-human primate cell line.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Vero-SF-ACF
AC CVCL_1K11
DR ATCC; CCL-81.5
CC Group: Vaccine production cell line.
CC Group: Non-human primate cell line.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Vero-SF-adapted
AC CVCL_AS92
DR CLS; 605372-SF/p17167_VERO,_SF-adapted
CC Group: Vaccine production cell line.
CC Group: Non-human primate cell line.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Vero-SV2neo clone VN5
AC CVCL_GA12
SY Vn5; Vero/G418
RX Patent=US7655406;
RX PubMed=7745744;
CC Group: Non-human primate cell line.
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2659.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Vero/hSLAM
AC CVCL_L037
DR ECACC; 04091501
CC Group: Non-human primate cell line.
CC Transfected with: HGNC; 10903; SLAMF1.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Vero/PPRV H
AC CVCL_GA11
RX PubMed=17050742;
CC Group: Non-human primate cell line.
CC Transfected with: UniProtKB; Q6Q498; PPRV hemagglutinin (H).
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Vero/SF
AC CVCL_1K13
SY VERO/SF
DR ATCC; CCL-81.1
CC Group: Vaccine production cell line.
CC Discontinued: ATCC; CCL-81.1; true.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID Veronica-HSA
AC CVCL_0D02
SY Veronica
RX PubMed=19461996;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID Verots S3
AC CVCL_T368
DR CLO; CLO_0050511
DR RCB; RCB0707
RX PubMed=1368119;
CC Group: Vaccine production cell line.
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_3863 ! Vero 317
SX Female
CA Transformed cell line
//
ID Verots S3(SF)
AC CVCL_T369
DR CLO; CLO_0050512
DR RCB; RCB0706
CC Group: Vaccine production cell line.
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_T368 ! Verots S3
SX Female
CA Transformed cell line
//
ID Vester
AC CVCL_G707
DR BTO; BTO:0003757
RX PubMed=16177958;
CC Miscellaneous: Only mentioned as a mesothelioma cell line in PubMed=16177958.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID vFOP1-1
AC CVCL_W549
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W541 ! GM00513
SX Female
CA Induced pluripotent stem cell
//
ID vFOP1-4
AC CVCL_W550
DR SKIP; SKIP000341
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W541 ! GM00513
SX Female
CA Induced pluripotent stem cell
//
ID vFOP2-1
AC CVCL_W551
DR SKIP; SKIP000336
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W542 ! GM00783
SX Male
CA Induced pluripotent stem cell
//
ID vFOP2-2
AC CVCL_W552
DR SKIP; SKIP000335
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W542 ! GM00783
SX Male
CA Induced pluripotent stem cell
//
ID vFOP4-1
AC CVCL_W553
SY CiRA00041
DR RCB; HPS0376
DR SKIP; SKIP000339
DR SKIP; SKIP000635
RX PubMed=24321451;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Miscellaneous: Assignment of vFOP4-1 to CiRA00041 by personal communication from CiRA.
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W554 ! vFOP4-3
SX Male
CA Induced pluripotent stem cell
//
ID vFOP4-3
AC CVCL_W554
SY CiRA00042
DR RCB; HPS0377
DR SKIP; SKIP000338
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W553 ! vFOP4-1
SX Male
CA Induced pluripotent stem cell
//
ID vFOP5-22
AC CVCL_W555
SY CiRA00043
DR RCB; HPS0378
DR SKIP; SKIP000340
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID VG
AC CVCL_X927
RX PubMed=7535998;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9556; ! Papio cynocephalus
CA Transformed cell line
//
ID VG-1
AC CVCL_0106
SY VG1
DR Cosmic; 1588566
DR GEO; GSM634741
DR GEO; GSM710426
DR GEO; GSM710442
DR Wikidata; Q16258509
RX PubMed=10925292;
RX PubMed=15613351;
RX PubMed=21685375;
WW https://en.wikipedia.org/wiki/VG-1
CC Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M579 ! B301
SX Male
CA Cancer cell line
//
ID VGE
AC CVCL_W084
DR Cosmic; 1522765
DR GEO; GSM726286
RX PubMed=21642991;
CC Omics: SNP array analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VGH-EPY
AC CVCL_Y107
DR BCRC; 60374
ST Source(s): BCRC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 9,12
ST D5S818: 9,10
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3017; Ependymoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VGH-MED
AC CVCL_Y106
SY VGH-Med
DR BCRC; 60375
DR GEO; GSM1938722
CC Discontinued: BCRC; 60375; probable.
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VH-64
AC CVCL_9672
SY VH 64; VH64
DR EFO; EFO_0002870
DR GEO; GSM510015
RX PubMed=1320624;
RX PubMed=8335680;
RX PubMed=15150091;
RX PubMed=19787792;
CC From: Van Valen F.; University of Munster; Germany.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VH-Renal
AC CVCL_X539
DR Cosmic; 849369
RX PubMed=11146448;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VH2
AC CVCL_4369
SY VH 2; VH-2; Viper Heart-2
DR CLO; CLO_0009531
DR CLO; CLO_0009532
DR CLDB; cl4662
DR ATCC; CCL-140
DR ECACC; 90102539
DR IZSLER; BS CL 187
RX PubMed=4358139;
CC Group: Reptilian cell line.
OX NCBI_TaxID=31159; ! Daboia russellii
SX Female
CA Spontaneously immortalized cell line
//
ID VHB-1
AC CVCL_M381
RX PubMed=2824520;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID vHFF1-iPS4
AC CVCL_DQ55
SY vHFF1_iPS_iPS4
RX PubMed=27345787;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3285 ! HFF-1
SX Male
CA Induced pluripotent stem cell
//
ID VI-2A5-A4
AC CVCL_U040
SY B-4; B4
RX PubMed=8734946;
CC Monoclonal antibody target: Leishmania panamensis.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID VI-4D10-D12
AC CVCL_U039
SY B-3; B3
RX PubMed=8734946;
CC Monoclonal antibody target: Leishmania brazilensis and Leishmania panamensis.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Vi-856
AC CVCL_A440
SY Vi856; VI856
DR Cosmic; 1167986
RX PubMed=18165268;
CC From: Majdic O.; Institute for Immunology; Vienna; Austria.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VII-II-5G3-F3
AC CVCL_U041
SY B-11; B11
RX PubMed=8734946;
CC Monoclonal antibody target: Leishmania panamensis.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID VIII-6G10
AC CVCL_F807
DR CLO; CLO_0009533
DR ATCC; HB-10519
RX Patent=US5206345;
CC Monoclonal antibody target: UniProtKB; P19320; Human VCAM1/CD106.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Vin Dor
AC CVCL_U681
DR ATCC; CRL-1097
CC Discontinued: ATCC; CRL-1097; true.
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID VIP-VIIIC8
AC CVCL_2236
DR CLO; CLO_0009534
DR DSMZ; ACC-479
CC Doubling time: ~40-50 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID VIPA
AC CVCL_5177
DR BTO; BTO:0003111
DR SKY/M-FISH/CGH; 2649
RX PubMed=12659655;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VJ-300
AC CVCL_X217
SY KB/VJ300
RX PubMed=2568984;
RX PubMed=2906349;
CC Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0372 ! KB
SX Female
CA Cancer cell line
//
ID VK
AC CVCL_Y578
RX PubMed=1322234;
RX PubMed=23882450;
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VK2/E6E7
AC CVCL_6471
SY Vk2/E6E7; VK-2/E6E7; VK2 (E6/E7)
DR BTO; BTO:0005683
DR CLO; CLO_0009535
DR ATCC; CRL-2616
DR BioSample; SAMN03471675
RX PubMed=9314589;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 9
ST D5S818: 9,10
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID VL-68
AC CVCL_B480
DR Cosmic; 1429647
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VL51
AC CVCL_3169
SY SLVL; VL-51
DR CLO; CLO_0050869
DR BioSample; SAMN03472064
DR Cosmic-CLP; 1331032
DR GDSC; 1331032
DR GEO; GSM827255
DR GEO; GSM866167
DR GEO; GSM1670458
DR JCRB; JCRB0159
DR JCRB; NIHS0247
DR RCB; RCB1702
RX PubMed=8551798;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: JCRB; NIHS0247; true.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8,9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C35425; Splenic lymphoma with circulating villous lymphocytes
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VLM
AC CVCL_2237
SY SV40-VLM
DR CLO; CLO_0009539
DR DSMZ; ACC-429
RX PubMed=4348218;
CC Doubling time: ~25 hours (DSMZ).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID VLN1F9
AC CVCL_Z072
DR ATCC; HB-8635
RX Patent=US4761377;
RX PubMed=3621203;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D039 ! UC 729-6
CA Hybridoma
//
ID VLN3F10
AC CVCL_Z073
DR ATCC; HB-8632
RX Patent=US4761377;
RX PubMed=3621203;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D039 ! UC 729-6
CA Hybridoma
//
ID VLN3G2
AC CVCL_8009
DR CLO; CLO_0009540
DR ATCC; HB-8636
DR BioSample; SAMN03471084
RX Patent=US4761377;
RX PubMed=3621203;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 11,12,13
ST D5S818: 11,12,13
ST D7S820: 9,10,11,14
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16,17,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D039 ! UC 729-6
CA Hybridoma
//
ID VLN5C7
AC CVCL_Z074
DR ATCC; HB-8634
RX Patent=US4761377;
RX PubMed=3621203;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D039 ! UC 729-6
CA Hybridoma
//
ID VLN6H2
AC CVCL_8010
DR CLO; CLO_0009541
DR ATCC; HB-8633
RX Patent=US4761377;
RX PubMed=3621203;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D039 ! UC 729-6
CA Hybridoma
//
ID VM-2
AC CVCL_F808
DR CLO; CLO_0009542
DR ATCC; HB-8530
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID VM-CUB-1
AC CVCL_1786
SY VM-CUB1; VMCUB-1; VMCUB1; VMCub1; VM Cub 1; VM-CUB-I
DR CLO; CLO_0009545
DR BioSample; SAMN03473580
DR CCLE; VMCUB1_URINARY_TRACT
DR ChEMBL-Cells; CHEMBL3308476
DR ChEMBL-Targets; CHEMBL1075607
DR Cosmic; 909780
DR Cosmic; 925825
DR Cosmic; 1016889
DR Cosmic; 1046677
DR Cosmic; 1285133
DR Cosmic; 1285992
DR Cosmic; 2037972
DR Cosmic; 2050470
DR Cosmic; 2057461
DR Cosmic; 2212696
DR Cosmic; 2444228
DR Cosmic-CLP; 909780
DR DSMZ; ACC-400
DR GDSC; 909780
DR GEO; GSM827147
DR GEO; GSM887732
DR GEO; GSM888827
DR GEO; GSM1374985
DR GEO; GSM1574550
DR GEO; GSM1670572
RX PubMed=3708594;
RX PubMed=6244232;
RX PubMed=6582512;
RX PubMed=16885334;
RX PubMed=22460905;
RX PubMed=24018021;
RX PubMed=24367658;
RX PubMed=25997541;
RX PubMed=26621286;
RX PubMed=27397505;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Doubling time: ~30-45 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'VM-CB-1' in Cosmic 1285992.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 11,12 (Cosmic-CLP)
ST CSF1PO: 11 (DSMZ; PubMed=11416159)
ST D13S317: 10,12 (Cosmic-CLP)
ST D13S317: 10 (DSMZ; PubMed=11416159)
ST D16S539: 9,11,12 (Cosmic-CLP)
ST D16S539: 11,12 (DSMZ; PubMed=11416159)
ST D18S51: 16,19,20
ST D21S11: 31
ST D5S818: 10,11 (Cosmic-CLP)
ST D5S818: 11 (DSMZ; PubMed=11416159)
ST D7S820: 8,11
ST D8S1179: 12,13
ST FGA: 22,24
ST TH01: 6,9 (Cosmic-CLP)
ST TH01: 9 (DSMZ)
ST TH01: 9.3 (PubMed=11416159)
ST TPOX: 8
ST vWA: 18,19 (Cosmic-CLP; DSMZ)
ST vWA: 16 (PubMed=11416159)
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VM-CUB-2
AC CVCL_9829
SY VM-CUB2; VMCUB-2; VMCUB2; VMCub2; VM Cub 2; VM-CUB-II; VMCUBII
DR Cosmic; 715728
DR Cosmic; 760477
DR Cosmic; 845569
DR Cosmic; 1046678
DR Cosmic; 1285134
DR Cosmic; 1285993
DR Cosmic; 2050471
DR Cosmic; 2057462
DR Cosmic; 2444233
DR GEO; GSM1574583
RX PubMed=327080;
RX PubMed=6244232;
RX PubMed=6582512;
RX PubMed=24367658;
RX PubMed=25997541;
RX PubMed=26621286;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VM-CUB-3
AC CVCL_9830
SY VM-CUB3; VMCUB-3; VMCUB3; VMCub3; VM Cub 3; VM-CUB-III; VMCUBIII; CUB III; CUBIII
DR BioSample; SAMN03152040
DR Cosmic; 925826
DR Cosmic; 1016888
DR Cosmic; 1046679
DR Cosmic; 1285135
DR Cosmic; 1285994
DR Cosmic; 1938425
DR Cosmic; 2050472
DR Cosmic; 2057463
DR Cosmic; 2444225
DR Cosmic; 2212697
DR GEO; GSM1574580
RX PubMed=3708594;
RX PubMed=6244232;
RX PubMed=7459858;
RX PubMed=16885334;
RX PubMed=20143388;
RX PubMed=24367658;
RX PubMed=25997541;
RX PubMed=26621286;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a VM-CUB-1 derivative (PubMed=3708594, PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1786 ! VM-CUB-1
SX Male
CA Cancer cell line
//
ID VM-M2/Fluc
AC CVCL_0P41
SY VM-M2
RX PubMed=18398829;
WW https://www.kerafast.com/product/1405/highly-systemic-metastatic-cell-lines
CC Doubling time: 2 days (Kerafast).
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: VM/Dk.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID VM-M3/Fluc
AC CVCL_0P42
SY VM-M3
RX PubMed=18398829;
WW https://www.kerafast.com/product/1405/highly-systemic-metastatic-cell-lines
CC Doubling time: 2 days (Kerafast).
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: VM/Dk.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID VM-NM1/Fluc
AC CVCL_0P43
SY VM-NM1
RX PubMed=18398829;
WW https://www.kerafast.com/product/1405/highly-systemic-metastatic-cell-lines
CC Doubling time: 2-5 days (Kerafast).
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: VM/Dk.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID VMM1
AC CVCL_A732
DR ATCC; CRL-3225
DR GEO; GSM1572805
DR GEO; GSM1572806
DR GEO; GSM1572807
DR GEO; GSM1572808
DR GEO; GSM1572809
DR GEO; GSM1572810
RX PubMed=7681084;
RX PubMed=10752474;
RX PubMed=20856146;
RX PubMed=21654344;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Brain.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 9,11
ST D16S539: 10
ST D5S818: 9
ST D7S820: 9,12
ST TH01: 10
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VMM1040
AC CVCL_A733
RX PubMed=20856146;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VMM12
AC CVCL_A734
DR Cosmic; 890887
RX PubMed=10752474;
RX PubMed=15378283;
RX PubMed=20856146;
WW http://dartmouth.eagle-i.net/i/0000013e-d775-02e4-6a92-b95280000000
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F863 ! VMM12-EBV
CA Cancer cell line
//
ID VMM12-EBV
AC CVCL_F863
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A734 ! VMM12
CA Transformed cell line
//
ID VMM14
AC CVCL_A735
RX PubMed=20856146;
RX PubMed=21654344;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VMM15
AC CVCL_A736
DR ATCC; CRL-3227
RX PubMed=10752474;
RX PubMed=20856146;
RX PubMed=21654344;
WW http://dartmouth.eagle-i.net/i/0000013e-7bb5-bd54-8e79-05bd80000000
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 12
ST D5S818: 9,15
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VMM150
AC CVCL_S583
RX PubMed=15378283;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VMM17
AC CVCL_S581
DR ATCC; CRL-3228
RX PubMed=10752474;
RX PubMed=21654344;
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 9,10
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VMM18
AC CVCL_A737
SY VMM-18
DR ATCC; CRL-3229
RX PubMed=10752474;
RX PubMed=15378283;
RX PubMed=20856146;
RX PubMed=21654344;
WW http://dartmouth.eagle-i.net/i/0000013e-7bb5-fe8b-8e79-05bd80000000
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,12
ST D16S539: 11
ST D5S818: 12
ST D7S820: 9
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 15,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F862 ! VMM18-EBV
SX Male
CA Cancer cell line
//
ID VMM18-EBV
AC CVCL_F862
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A737 ! VMM18
SX Male
CA Transformed cell line
//
ID VMM19
AC CVCL_A738
RX PubMed=15378283;
RX PubMed=20856146;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VMM39
AC CVCL_A739
DR BTO; BTO:0005447
DR ATCC; CRL-3230
DR Cosmic; 890888
DR Cosmic; 1054848
DR Cosmic; 1507601
DR Cosmic; 2233683
DR GEO; GSM1572823
DR GEO; GSM1572824
DR GEO; GSM1572825
DR GEO; GSM1572826
DR GEO; GSM1572827
DR GEO; GSM1572828
RX PubMed=17308088;
RX PubMed=20856146;
RX PubMed=21654344;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 7,12
ST TH01: 7
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VMM425
AC CVCL_4D07
DR ATCC; CRL-3231
RX PubMed=21654344;
CC Derived from metastatic site: Pelvic soft tissue.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,13
ST D16S539: 12
ST D5S818: 11
ST D7S820: 9
ST TH01: 8,9.3
ST TPOX: 8,12
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VMM5A
AC CVCL_A740
SY VMM-5A; VMM5
DR ATCC; CRL-3226
DR Cosmic; 890886
RX PubMed=7681084;
RX PubMed=10752474;
RX PubMed=15905528;
RX PubMed=20856146;
RX PubMed=21654344;
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12
ST D5S818: 9
ST D7S820: 9,10
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S584 ! VMM5B
SX Male
CA Cancer cell line
//
ID VMM5B
AC CVCL_S584
SY VMM-5B
RX PubMed=15905528;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A740 ! VMM5A
SX Male
CA Cancer cell line
//
ID VMM609
AC CVCL_4D08
RX PubMed=21654344;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VMM86
AC CVCL_S582
RX PubMed=15378283;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VMM917
AC CVCL_4D09
DR ATCC; CRL-3232
RX PubMed=21654344;
CC Derived from metastatic site: Subcutaneous; right posterior thigh adjacent to buttocks.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 12
ST D5S818: 11
ST D7S820: 8,10
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VMR-0
AC CVCL_F849
SY VMR-O
RX CelloPub=CLPUB00133;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID VMR-100-Liv
AC CVCL_F850
SY VMR-Liv; VMR-liv; VMRLiv
RX CelloPub=CLPUB00133;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F849 ! VMR-0
SX Female
CA Cancer cell line
//
ID VMR-100-Ov
AC CVCL_F851
SY VMR-Ov
RX CelloPub=CLPUB00133;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F849 ! VMR-0
SX Female
CA Cancer cell line
//
ID VMRC-LCD
AC CVCL_1787
SY VMRCLCD; LCD
DR EFO; EFO_0006773
DR BioSample; SAMN03471805
DR CCLE; VMRCLCD_LUNG
DR CGH-DB; 210-1
DR CGH-DB; 9168-4
DR Cosmic; 713869
DR Cosmic; 801581
DR Cosmic; 889100
DR Cosmic; 876140
DR Cosmic; 917975
DR Cosmic; 929163
DR Cosmic; 932928
DR Cosmic; 1066174
DR Cosmic; 1089220
DR Cosmic; 1154600
DR Cosmic; 1239900
DR Cosmic; 1571730
DR Cosmic-CLP; 713869
DR GDSC; 713869
DR GEO; GSM784287
DR GEO; GSM827592
DR GEO; GSM1670573
DR JCRB; JCRB0814
RX PubMed=9290701;
RX PubMed=11005564;
RX PubMed=12569360;
RX PubMed=14581340;
RX PubMed=15185009;
RX PubMed=15746151;
RX PubMed=19472407;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Misspelling: 'RERF-LCD' in PubMed=11005564.
CC Misspelling: 'VMR-LCD' in Cosmic 889100.
CC Misspelling: 'VRMC-LCD' in Cosmic 1571730.
ST Source(s): Cosmic-CLP; JCRB; PubMed=11416159; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 11
ST D18S51: 14
ST D21S11: 30
ST D3S1358: 15
ST D5S818: 10
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 22,24
ST Penta D: 12
ST Penta E: 15,16
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VMRC-LCF
AC CVCL_S848
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VMRC-LCP
AC CVCL_1788
SY VMRCLCP; Patton
DR BioSample; SAMN03470791
DR CCLE; VMRCLCP_LUNG
DR CGH-DB; 193-1
DR CGH-DB; 9177-4
DR ChEMBL-Cells; CHEMBL3308808
DR ChEMBL-Targets; CHEMBL1075608
DR Cosmic; 889101
DR Cosmic; 930300
DR Cosmic; 1066175
DR GEO; GSM827200
DR GEO; GSM1374986
DR JCRB; JCRB0103
RX PubMed=9290701;
RX PubMed=15185009;
RX PubMed=14581340;
RX PubMed=15746151;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Transcriptome analysis.
CC Misspelling: 'VMR-LCP' in Cosmic 889101.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D16S539: 12
ST D5S818: 13
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 8
ST vWA: 18,20
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VMRC-MELG
AC CVCL_1789
SY Leggee
DR BioSample; SAMN03471062
DR ChEMBL-Cells; CHEMBL3308809
DR ChEMBL-Targets; CHEMBL1075609
DR Cosmic; 930301
DR Cosmic-CLP; 930301
DR GDSC; 930301
DR JCRB; JCRB0074
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X (Cosmic-CLP)
ST Amelogenin: X,Y (JCRB)
ST CSF1PO: 10
ST D13S317: 8,11
ST D16S539: 12
ST D5S818: 10,13
ST D7S820: 8,10
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VMRC-PCZ
AC CVCL_X543
DR Cosmic; 849371
RX PubMed=11146448;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VMRC-RCW
AC CVCL_1790
SY Thomas Wirts
DR BTO; BTO:0003714
DR CLO; CLO_0050893
DR BioSample; SAMN03470901
DR BioSample; SAMN03472513
DR CCLE; VMRCRCW_KIDNEY
DR Cosmic; 756014
DR Cosmic; 849370
DR Cosmic-CLP; 1240224
DR GDSC; 1240224
DR GEO; GSM827232
DR GEO; GSM887733
DR GEO; GSM888828
DR JCRB; JCRB0813
DR RCB; RCB1963
DR TKG; TKG 0447
RX PubMed=9290701;
RX PubMed=11146448;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB; TKG
ST Amelogenin: X,Y (JCRB; RCB; TKG)
ST Amelogenin: Y (Cosmic-CLP; PubMed=25877200)
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 11,15
ST D18S51: 15,16
ST D19S433: 13
ST D21S11: 32.2,33.2
ST D2S1338: 21,22
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 12
ST FGA: 21,22
ST Penta D: 9,11
ST Penta E: 11,12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,15
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VMRC-RCZ
AC CVCL_1791
DR BTO; BTO:0003715
DR BioSample; SAMN03472519
DR CCLE; VMRCRCZ_KIDNEY
DR ChEMBL-Cells; CHEMBL3308810
DR ChEMBL-Targets; CHEMBL1075610
DR Cosmic; 909781
DR Cosmic-CLP; 909781
DR GDSC; 909781
DR GEO; GSM827243
DR GEO; GSM887734
DR GEO; GSM888829
DR GEO; GSM1670574
DR JCRB; JCRB0827
RX PubMed=9290701;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Vn19
AC CVCL_8538
SY Vn1919
DR JCRB; JCRB1361
RX PubMed=21073635;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Vn19-15
AC CVCL_8539
RX PubMed=21073635;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_8538 ! Vn19
CA Cancer cell line
//
ID Vn19-21
AC CVCL_8540
RX PubMed=21073635;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_8538 ! Vn19
CA Cancer cell line
//
ID Vn19-4
AC CVCL_8541
SY Vn1919 cl4
DR JCRB; JCRB1365
RX PubMed=21073635;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_8538 ! Vn19
CA Cancer cell line
//
ID Vn19-49
AC CVCL_8542
SY Vn1919 cl49
DR JCRB; JCRB1367
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_8538 ! Vn19
CA Cancer cell line
//
ID Vn19-59
AC CVCL_8543
SY Vn1919 cl59
DR JCRB; JCRB1368
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_8538 ! Vn19
CA Cancer cell line
//
ID vNBS8-iPS-c1
AC CVCL_9U58
RX PubMed=26987925;
DI NCIt; C4692; Nijmegen breakage syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9U59 ! vNBS8-iPS-c2
SX Male
CA Induced pluripotent stem cell
//
ID vNBS8-iPS-c2
AC CVCL_9U59
RX PubMed=26987925;
DI NCIt; C4692; Nijmegen breakage syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9U58 ! vNBS8-iPS-c1
SX Male
CA Induced pluripotent stem cell
//
ID VOA1056_CL
AC CVCL_V536
RX PubMed=24023729;
DI NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VOA1072_CL
AC CVCL_V537
RX PubMed=24023729;
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VOA1312_CL
AC CVCL_V538
RX PubMed=24023729;
DI NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VOA1400_CL
AC CVCL_V539
RX PubMed=24023729;
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VOA1416_CL
AC CVCL_V540
RX PubMed=24023729;
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Vogel
AC CVCL_L422
DR GEO; GSM1974800
RX PubMed=21908323;
RX PubMed=22916246;
RX PubMed=27197945;
CC Part of: FACC canine tumor cell line panel.
CC Doubling time: 35.9 hours (PubMed=22916246).
CC Omics: Transcriptome analysis.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID VOO
AC CVCL_E864
DR dbMHC; 49054
DR ECACC; 94022551
DR IHW; IHW9241
DR IMGT/HLA; 11528
WW http://bioinformatics.hsanmartino.it/ecbr/cl241.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID VP185
AC CVCL_D130
DR GEO; GSM115103
DR GEO; GSM217607
RX PubMed=8877005;
RX PubMed=15677628;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VP207
AC CVCL_W115
RX PubMed=8877005;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VP223
AC CVCL_W116
RX PubMed=8877005;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VP229
AC CVCL_2754
DR BioSample; SAMN03472874
DR Cosmic; 1523834
DR ECACC; 05092804
DR GEO; GSM115113
DR GEO; GSM217608
RX PubMed=8877005;
RX PubMed=11044355;
RX PubMed=12800145;
RX PubMed=15677628;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/VP229.html
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,13
ST D16S539: 11,12
ST D18S51: 16
ST D19S433: 13
ST D21S11: 29
ST D2S1338: 18,25
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 10,13
ST FGA: 18
ST Penta D: 10
ST Penta E: 13,17
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2755 ! VP267
SX Female
CA Cancer cell line
//
ID VP267
AC CVCL_2755
DR BioSample; SAMN03472912
DR ECACC; 05092805
DR GEO; GSM115114
DR GEO; GSM217609
RX PubMed=8877005;
RX PubMed=11044355;
RX PubMed=15677628;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/VP267.html
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,13
ST D16S539: 11,12
ST D18S51: 16
ST D19S433: 13
ST D21S11: 29
ST D2S1338: 25
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 10,13
ST FGA: 18
ST Penta D: 10
ST Penta E: 13,17
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2754 ! VP229
SX Female
CA Cancer cell line
//
ID VP298
AC CVCL_W117
RX PubMed=8877005;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VP303
AC CVCL_2756
DR BioSample; SAMN03472873
DR ECACC; 05092806
DR GEO; GSM217610
RX PubMed=8877005;
RX PubMed=12800145;
RX PubMed=15677628;
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,12
ST D18S51: 12,13
ST D19S433: 13,14
ST D21S11: 28,29
ST D2S1338: 25
ST D3S1358: 17
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 11
ST FGA: 22,23
ST Penta D: 10,13
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VP317
AC CVCL_W118
RX PubMed=8877005;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VP331
AC CVCL_W119
RX PubMed=8877005;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VP342
AC CVCL_W120
RX PubMed=8877005;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VP348
AC CVCL_W180
RX PubMed=8877005;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VPC-6
AC CVCL_IP77
RX CelloPub=CLPUB00252;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VPM 18
AC CVCL_G164
DR ECACC; 93113025
CC Monoclonal antibody target: UniProtKB; W5Q2E5; Sheep PTPRC/CD45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 19
AC CVCL_G165
DR ECACC; 93113026
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 36
AC CVCL_G166
DR ECACC; 93113027
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 37
AC CVCL_G167
DR ECACC; 93113028
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 38
AC CVCL_G168
DR ECACC; 93113029
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 40
AC CVCL_G169
DR ECACC; 93113030
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 41
AC CVCL_G170
DR ECACC; 93113031
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 43
AC CVCL_G171
DR ECACC; 93113032
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 44
AC CVCL_G172
DR ECACC; 93113033
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 45
AC CVCL_G173
DR ECACC; 93113034
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 46
AC CVCL_G174
DR ECACC; 93113035
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 47
AC CVCL_G175
DR ECACC; 93113036
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 48
AC CVCL_G176
DR ECACC; 93113037
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 5
AC CVCL_G177
DR ECACC; 93113022
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 54
AC CVCL_G178
DR ECACC; 93113038
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 6
AC CVCL_G179
DR ECACC; 93113023
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VPM 8
AC CVCL_G180
DR ECACC; 93113024
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID VR09
AC CVCL_N794
DR Cosmic; 1840004
RX PubMed=23285191;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID VSa13
AC CVCL_S952
SY Vertebra Sparus aurata 13
RX DOI=10.1111/j.1439-0426.2010.01411.x;
RX PubMed=14762709;
RX PubMed=15820747;
RX PubMed=17899405;
RX PubMed=19002990;
RX PubMed=21668972;
CC Group: Fish cell line.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=8175; ! Sparus aurata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID VSa16
AC CVCL_S953
SY Vertebra Sparus aurata 16
RX DOI=10.1111/j.1439-0426.2010.01411.x;
RX PubMed=14762709;
RX PubMed=15820747;
RX PubMed=19002990;
RX PubMed=21668972;
CC Group: Fish cell line.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=8175; ! Sparus aurata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID VSW
AC CVCL_4370
DR CLO; CLO_0009549
DR ATCC; CCL-129
RX PubMed=4358139;
RX PubMed=5165585;
CC Group: Reptilian cell line.
OX NCBI_TaxID=31159; ! Daboia russellii
SX Female
CA Spontaneously immortalized cell line
//
ID VT-E
AC CVCL_0C28
RX PubMed=7736387;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID vT{2}
AC CVCL_4010
DR CLO; CLO_0009550
DR ATCC; CRL-2712
CC Transfected with: HGNC; 700; ARNT.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Breed/subspecies: C57L.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9085 ! c4 (B13NBii1)
SX Female
CA Cancer cell line
//
ID VTIS39243
AC CVCL_6G71
DR IMGT/HLA; 12637
RX PubMed=11782282;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID VTIS43878
AC CVCL_6G72
DR IMGT/HLA; 12642
RX PubMed=11782282;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID VTIS45561
AC CVCL_6G73
DR IMGT/HLA; 12638
RX PubMed=11782282;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID VTIS46155
AC CVCL_6G74
DR IMGT/HLA; 12643
RX PubMed=11782282;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID VUB01
AC CVCL_9838
SY VUB-01-WT; VUBe001-A
DR hPSCreg; VUBe001-A
DR ISCR; 208
RX PubMed=16284066;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-24.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID VUB02
AC CVCL_9839
SY VUBe002-A
DR hPSCreg; VUBe002-A
DR ISCR; 209
RX PubMed=16284066;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID VUB03_DM1
AC CVCL_9840
SY VUBe003-A
DR hPSCreg; VUBe003-A
DR ISCR; 249
RX PubMed=16284066;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C84679; Dystrophia myotonica 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB04_CF
AC CVCL_9841
SY VUBe004-A
DR hPSCreg; VUBe004-A
DR ISCR; 248
RX PubMed=16284066;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB05_HD
AC CVCL_9842
SY VUB-05-HD; VUBe005-A
DR hPSCreg; VUBe005-A
DR ISCR; 247
RX PubMed=16284066;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-24.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID VUB06
AC CVCL_9843
SY VUBe006-A
DR hPSCreg; VUBe006-A
DR ISCR; 246
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB07
AC CVCL_9844
SY VUBe007-A
DR hPSCreg; VUBe007-A
DR ISCR; 245
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB08_MFS
AC CVCL_9845
SY VUBe008-A
DR hPSCreg; VUBe008-A
DR ISCR; 244
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB09_FSHD
AC CVCL_9846
SY VUBe009-A
DR hPSCreg; VUBe009-A
DR ISCR; 243
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C84704; Facioscapulohumeral muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB10_SCA7
AC CVCL_9847
SY VUBe010-A
DR hPSCreg; VUBe010-A
DR ISCR; 242
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C82341; Spinocerebellar ataxia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB11_FXS
AC CVCL_9848
SY VUBe011-A
DR hPSCreg; VUBe011-A
DR ISCR; 241
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB13_FXS
AC CVCL_9849
SY VUBe012-A
DR hPSCreg; VUBe012-A
DR ISCR; 240
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB14
AC CVCL_9850
SY VUBe021-A
DR hPSCreg; VUBe021-A
DR ISCR; 1422
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB15
AC CVCL_9851
DR ISCR; 1285
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID VUB16
AC CVCL_9852
DR ISCR; 1286
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID VUB17
AC CVCL_9853
DR ISCR; 1423
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB19_DM1
AC CVCL_9854
SY VUBe013-A
DR hPSCreg; VUBe013-A
DR ISCR; 239
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C84679; Dystrophia myotonica 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB20_CMT1A
AC CVCL_9855
SY VUBe014-A
DR hPSCreg; VUBe014-A
DR ISCR; 238
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C75468; Charcot-Marie-Tooth disease type 1A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB21_HEMA
AC CVCL_9856
DR ISCR; 1289
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID VUB22_CF
AC CVCL_9857
SY VUBe015-A
DR hPSCreg; VUBe015-A
DR ISCR; 237
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB23_OI
AC CVCL_9858
SY VUBe016-A
DR hPSCreg; VUBe016-A
DR ISCR; 236
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C99003; Osteogenesis imperfecta type I
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID VUB24_DM1
AC CVCL_9859
SY VUBe017-A
DR hPSCreg; VUBe017-A
DR ISCR; 235
RX PubMed=20224973;
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB26
AC CVCL_9860
SY VUB26_QUATRO; VUBe019-A
DR hPSCreg; VUBe019-A
DR ISCR; 234
RX PubMed=19633307;
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUB27
AC CVCL_9861
SY VUB27_PATRU; VUBe020-A
DR hPSCreg; VUBe020-A
DR ISCR; 1281
RX PubMed=19633307;
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID VUB28_HD_MFS
AC CVCL_9862
SY VUBe018-A
DR hPSCreg; VUBe018-A
DR ISCR; 233
RX PubMed=20224973;
WW http://emgerege.vub.ac.be/HESC_2.php
CC From: Vrije Universiteit Brussel; Brussels; Belgium.
DI NCIt; C82342; Huntington's disease
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID VUMC-DIPG-A
AC CVCL_IT43
SY VU-DIPG-A; VU-DIPG.A; DIPG-A
RX PubMed=23637844;
RX PubMed=25939062;
CC Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VUMC-DIPG-B
AC CVCL_IT44
SY VU-DIPG-B; VU-DIPG.B; DIPG-B
RX PubMed=23637844;
RX PubMed=25939062;
CC Characteristics: Has a HIST1H3B p.Lys28Met mutation (H3.1K27M).
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID VUP
AC CVCL_J307
SY VUP-1
RX CelloPub=CLPUB00127;
RX PubMed=6819484;
RX PubMed=12098005;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID VUP15
AC CVCL_J305
RX Patent=WO2006091868A2;
RX PubMed=10205165;
CC Transfected with: HGNC; 6156; ITGB3.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_J307 ! VUP
CA Cancer cell line
//
ID VUP20
AC CVCL_J306
RX Patent=WO2006091868A2;
CC Selected for resistance to: ChEBI; CHEBI:17939; Puromycin.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_J307 ! VUP
CA Cancer cell line
//
ID VV-1H831
AC CVCL_EG63
DR JCRB; JCRB1632
RX PubMed=3008418;
CC Monoclonal antibody target: UniProtKB; P08714; Vaccinia virus HA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID vWTa
AC CVCL_0G81
DR SKIP; SKIP000533
RX PubMed=24321451;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID vWTb
AC CVCL_0G82
DR SKIP; SKIP000534
RX PubMed=24321451;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID Vx2
AC CVCL_3864
SY VX2; Vx-2; VX-2
DR CLO; CLO_0009553
DR CLDB; cl4673
DR ATCC; CRL-6503
DR BCRJ; 0297
DR CCRID; 3111C0001CCC000320
DR CLS; 609374/NA
DR ECACC; 90030912
DR TKG; TKG 0332
RX PubMed=6126038;
RX PubMed=6500159;
RX PubMed=14955572;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6503; true.
CC Discontinued: CLS; 609374; true.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
SX Male
CA Cancer cell line
//
ID Vx7
AC CVCL_3470
SY VX7; Vx-7; VX-7
DR CLO; CLO_0009554
DR ATCC; CRL-6504
DR BCRJ; 0246
RX PubMed=6286852;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6504; true.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Cancer cell line
//
ID VXG3
AC CVCL_J128
DR ATCC; CRL-11865
RX Patent=US5976860;
CC Discontinued: ATCC; CRL-11865; probable.
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID W-20-17
AC CVCL_6529
SY W-20 clone 17
DR CLO; CLO_0009556
DR ATCC; CRL-2623
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID W-2K-11
AC CVCL_6E69
RX PubMed=195084;
RX PubMed=6262522;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [777].
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6E66 ! C3H2K-C4
CA Transformed cell line
//
ID W-3Y-23
AC CVCL_6E71
RX PubMed=195084;
RX PubMed=6262522;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [777].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID W-98
AC CVCL_DG19
DR GEO; GSM114602
RX PubMed=16966431;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID W-ES
AC CVCL_W528
DR Cosmic; 1381110
RX PubMed=2486606;
RX PubMed=2731119;
RX PubMed=8221663;
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID W-V
AC CVCL_E079
DR CLO; CLO_0050644
DR BioSample; SAMN03472349
DR RCB; RCB0252
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 9,10
ST TH01: 9
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID W1
AC CVCL_0C64
DR Cosmic; 2089679
RX PubMed=7769852;
RX PubMed=8182949;
RX PubMed=23955599;
DI NCIt; C7463; Acute myelomonocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID W10-1A
AC CVCL_C706
DR ISCR; 1602
RX PubMed=19222349;
CC From: StemLifeLine, Inc.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID W12 [Human keratinocytes]
AC CVCL_T290
RX PubMed=2467886;
RX PubMed=16505361;
CC Characteristics: Derived from a low-grade squamous intraepithelial lesion (LG-SIL).
CC Characteristics: At early passages contains about 100 HPV16 episomes per cell.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID W12 [Mouse ESC]
AC CVCL_Y631
RX PubMed=11084865;
CC Breed/subspecies: 129S9/SvEvH.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID W13-1C
AC CVCL_C707
DR ISCR; 1603
RX PubMed=19222349;
CC From: StemLifeLine, Inc.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID W14-1A
AC CVCL_C708
DR ISCR; 1604
RX PubMed=19222349;
CC From: StemLifeLine, Inc.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID W162
AC CVCL_3807
DR CLO; CLO_0009555
DR ATCC; CRL-2783
DR ATCC; JHU-66
RX PubMed=6310575;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5 [E4].
CC Discontinued: ATCC; CRL-2783; true.
CC Discontinued: ATCC; JHU-66; true.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Transformed cell line
//
ID W2
AC CVCL_Y632
RX PubMed=11084865;
CC Breed/subspecies: 129S9/SvEvH.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID W20C6
AC CVCL_Z823
DR DGRC; 159
RX PubMed=1905427;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID W3
AC CVCL_Y633
RX PubMed=11084865;
CC Breed/subspecies: 129S9/SvEvH.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID W3/13
AC CVCL_G185
DR ECACC; 84112001
RX PubMed=88272;
CC Monoclonal antibody target: UniProtKB; P13838; Rat Spn.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID W3/15
AC CVCL_G186
SY W3/15 HLK
DR ECACC; 88051305
RX PubMed=88272;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID W3/25
AC CVCL_G187
SY W3/25 HL
DR ECACC; 84112002
RX PubMed=88272;
CC Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID W3C4E11
AC CVCL_IQ37
RX Patent=US20080038272;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2668.
CC Monoclonal antibody target: UniProtKB; O60353; Human FZD6.
CC Monoclonal antibody target: UniProtKB; O00144; Human FZD9.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID W3D2B10
AC CVCL_IQ38
RX Patent=US20080038272;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2669.
CC Monoclonal antibody target: UniProtKB; O75084; Human FZD7.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID W3UF
AC CVCL_X940
DR CGH-DB; 333-2
DR CGH-DB; 9355-4
RX PubMed=10457904;
RX PubMed=11330945;
RX PubMed=12417041;
RX PubMed=17671176;
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A620 ! HUOCA-II
SX Female
CA Cancer cell line
//
ID W4 [Mouse ESC]
AC CVCL_Y634
RX PubMed=11084865;
CC Breed/subspecies: 129S6/SvEvTac.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID W4 [Mouse lymphoma]
AC CVCL_H588
DR ChEMBL-Cells; CHEMBL3308050
DR ChEMBL-Targets; CHEMBL613708
RX PubMed=7689176;
CC Transfected with: MGI; MGI:95484; Fas.
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4338 ! WR19L
SX Female
CA Cancer cell line
//
ID W4F.5B
AC CVCL_F809
DR CLO; CLO_0009557
DR ATCC; HB-9282
RX Patent=US4845026;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID W5
AC CVCL_Y635
RX PubMed=11084865;
CC Breed/subspecies: 129S9/SvEvH.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID W5-6
AC CVCL_0U29
DR ATCC; CRL-9267
DR BioSample; SAMN03471214
RX Patent=US6004761;
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 9,10
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0608 ! Calu-1
SX Male
CA Cancer cell line
//
ID W6/1
AC CVCL_U056
SY W6/1 HLK
DR ECACC; 13082201
RX PubMed=88272;
RX PubMed=667938;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID W6/32
AC CVCL_7872
SY HB95
DR CLO; CLO_0009558
DR ATCC; HB-95
DR CCRID; 3111C0001CCC000389
DR CCRID; 3142C0001000000123
DR ECACC; 84112003
DR IZSLER; BS Hy 32
DR PRIDE; PXD000394
RX PubMed=88272;
RX PubMed=667938;
RX PubMed=25576301;
CC Omics: HLA class I peptidome analysis by proteomics.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID W6/32HK
AC CVCL_G134
DR ECACC; 86012801
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7872 ! W6/32
CA Hybridoma
//
ID W6/32HL
AC CVCL_G135
DR ECACC; 85102222
DR NCBI_Iran; H127
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7872 ! W6/32
CA Hybridoma
//
ID W8-8A
AC CVCL_C705
DR ISCR; 1605
RX PubMed=19222349;
CC From: StemLifeLine, Inc.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID Wa Fen
AC CVCL_3279
DR CLO; CLO_0009559
DR ATCC; CRL-1271
CC Discontinued: ATCC; CRL-1271; true.
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Wa-2
AC CVCL_M847
SY Wa2
DR Cosmic; 802253
RX PubMed=2180563;
DI NCIt; C6586; Extrarenal rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WA-C3CD5+
AC CVCL_Y438
SY WaC3 CD5+; WaC3CD5+; WaC3CD5; WAC3CD5+; WAC3-CD5; WAC-CD5+; Wa C3,CD5+; Waco3-CD5
DR DSMZ; ACC-769
DR NCBI_Iran; C547
RX PubMed=8127151;
RX PubMed=19358282;
RX PubMed=23297799;
CC Doubling time: ~40-50 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ; NCBI_Iran
ST Amelogenin: X,Y
ST CSF1PO: 9,10
ST D13S317: 9
ST D16S539: 8,11 (NCBI_Iran)
ST D16S539: 9,12 (DSMZ)
ST D18S51: 11,18
ST D21S11: 29,30
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 10,13
ST FGA: 19,20
ST TH01: 8,9 (NCBI_Iran)
ST TH01: 8,9.3 (DSMZ)
ST TPOX: 7,11 (NCBI_Iran)
ST TPOX: 8,11 (DSMZ)
ST vWA: 18
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y549 ! WA-OSEL
SX Male
CA Transformed cell line
//
ID WA-hT
AC CVCL_8766
DR CLO; CLO_0050041
DR BioSample; SAMN03471949
DR RCB; RCB2279
RX PubMed=16142338;
RX PubMed=22576795;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 9,10
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WA-mFib
AC CVCL_U894
DR CLO; CLO_0050749
DR RCB; RCB1925
RX PubMed=16142338;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID WA-OSEL
AC CVCL_Y549
SY WA-osel; Wa osel
DR DSMZ; ACC-767
RX PubMed=8127151;
RX PubMed=23297799;
CC Doubling time: ~40 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 9,10
ST D13S317: 9
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 8,10
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y438 ! WA-C3CD5+
SX Male
CA Transformed cell line
//
ID WA01
AC CVCL_9771
SY WA 01; WA1; H1; H1-hESC; ESC H1; GE01; WAe001-A; WICELLe001-A
DR EFO; EFO_0003042
DR BioSample; SAMN03471895
DR BioSamples; SAMEA7768168
DR ENCODE; ENCBS001VRA
DR ENCODE; ENCBS011NFB
DR ENCODE; ENCBS019EUF
DR ENCODE; ENCBS040WGM
DR ENCODE; ENCBS051SJH
DR ENCODE; ENCBS055BDT
DR ENCODE; ENCBS055DBZ
DR ENCODE; ENCBS060CKC
DR ENCODE; ENCBS081AUS
DR ENCODE; ENCBS083WOY
DR ENCODE; ENCBS086PQW
DR ENCODE; ENCBS103ZIA
DR ENCODE; ENCBS111ENC
DR ENCODE; ENCBS131GSD
DR ENCODE; ENCBS153GON
DR ENCODE; ENCBS215WGD
DR ENCODE; ENCBS244HDB
DR ENCODE; ENCBS262EHC
DR ENCODE; ENCBS270AGK
DR ENCODE; ENCBS282MUP
DR ENCODE; ENCBS285QSX
DR ENCODE; ENCBS299BNQ
DR ENCODE; ENCBS299NOL
DR ENCODE; ENCBS309DZE
DR ENCODE; ENCBS345JIP
DR ENCODE; ENCBS368BPP
DR ENCODE; ENCBS380OBH
DR ENCODE; ENCBS409PYK
DR ENCODE; ENCBS440MTS
DR ENCODE; ENCBS479XUT
DR ENCODE; ENCBS428NIG
DR ENCODE; ENCBS484NGW
DR ENCODE; ENCBS497CZZ
DR ENCODE; ENCBS513BIK
DR ENCODE; ENCBS534NMZ
DR ENCODE; ENCBS559QNR
DR ENCODE; ENCBS568FYY
DR ENCODE; ENCBS570AYT
DR ENCODE; ENCBS582QGL
DR ENCODE; ENCBS614LXI
DR ENCODE; ENCBS626BQK
DR ENCODE; ENCBS649THQ
DR ENCODE; ENCBS661AAA
DR ENCODE; ENCBS665AAA
DR ENCODE; ENCBS668AAA
DR ENCODE; ENCBS670AAA
DR ENCODE; ENCBS704NOS
DR ENCODE; ENCBS706WYC
DR ENCODE; ENCBS708BLT
DR ENCODE; ENCBS711AAA
DR ENCODE; ENCBS716AAA
DR ENCODE; ENCBS716FMR
DR ENCODE; ENCBS717WTB
DR ENCODE; ENCBS718AAA
DR ENCODE; ENCBS720AAA
DR ENCODE; ENCBS731AAA
DR ENCODE; ENCBS732AAA
DR ENCODE; ENCBS733AAA
DR ENCODE; ENCBS734AAA
DR ENCODE; ENCBS739PSV
DR ENCODE; ENCBS740OND
DR ENCODE; ENCBS780AAA
DR ENCODE; ENCBS780WAB
DR ENCODE; ENCBS797AAA
DR ENCODE; ENCBS802AAA
DR ENCODE; ENCBS803AAA
DR ENCODE; ENCBS819TBN
DR ENCODE; ENCBS820AAA
DR ENCODE; ENCBS847AAA
DR ENCODE; ENCBS854AAA
DR ENCODE; ENCBS855AAA
DR ENCODE; ENCBS874KZJ
DR ENCODE; ENCBS887ZGJ
DR ENCODE; ENCBS899KQD
DR ENCODE; ENCBS899NYB
DR ENCODE; ENCBS929BKG
DR ENCODE; ENCBS945MCY
DR ENCODE; ENCBS977TKX
DR ENCODE; ENCBS982HXP
DR ENCODE; ENCBS984IPH
DR GEO; GSM347921
DR GEO; GSM409307
DR GEO; GSM409308
DR GEO; GSM409312
DR GEO; GSM410807
DR GEO; GSM410808
DR GEO; GSM428286
DR GEO; GSM428289
DR GEO; GSM428291
DR GEO; GSM428295
DR GEO; GSM428296
DR GEO; GSM429321
DR GEO; GSM429322
DR GEO; GSM429323
DR GEO; GSM432392
DR GEO; GSM432685
DR GEO; GSM432686
DR GEO; GSM433167
DR GEO; GSM433170
DR GEO; GSM433171
DR GEO; GSM433174
DR GEO; GSM433176
DR GEO; GSM433177
DR GEO; GSM433179
DR GEO; GSM434762
DR GEO; GSM434776
DR GEO; GSM434785
DR GEO; GSM438361
DR GEO; GSM438362
DR GEO; GSM450236
DR GEO; GSM450239
DR GEO; GSM450266
DR GEO; GSM450268
DR GEO; GSM450270
DR GEO; GSM466732
DR GEO; GSM466734
DR GEO; GSM466737
DR GEO; GSM466739
DR GEO; GSM469971
DR GEO; GSM484408
DR GEO; GSM537679
DR GEO; GSM537680
DR GEO; GSM537681
DR GEO; GSM537682
DR GEO; GSM537683
DR GEO; GSM537684
DR GEO; GSM537685
DR GEO; GSM543005
DR GEO; GSM579898
DR GEO; GSM579899
DR GEO; GSM602251
DR GEO; GSM602252
DR GEO; GSM602253
DR GEO; GSM816632
DR GEO; GSM856729
DR GEO; GSM1040242
DR GEO; GSM1040312
DR GEO; GSM1153529
DR GEO; GSM1489248
DR GEO; GSM1489459
DR hPSCreg; WAe001-A
DR IGRhCellID; H1%20p61
DR ISCR; 87
DR PRIDE; PXD003903
RX PubMed=9804556;
RX PubMed=14745950;
RX PubMed=16388305;
RX PubMed=16919167;
RX PubMed=17572666;
RX PubMed=21714037;
RX PubMed=21983960;
RX PubMed=22514597;
RX PubMed=22802639;
RX PubMed=23117585;
RX PubMed=23325432;
RX PubMed=24259714;
RX PubMed=24374290;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=29
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa01.cmsx
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa01-matched-research-bank.cmsx
WW https://stemcelldb.nih.gov/cellLineDetails.do?id=12
WW http://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/
CC Part of: ENCODE project common cell types; tier 1.
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0043.
CC Registration: Swiss research registry; BAG-hES-IMP-0001.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-06.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K27ac ChIP-seq epigenome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me1 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
CC Omics: Transcriptome analysis.
CC Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.
ST Source(s): PubMed=16919167; PubMed=24374290; WiCell
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 9,13
ST D18S51: 17,18
ST D21S11: 28,32.2
ST D3S1358: 15
ST D5S818: 9,11
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 20,24
ST Penta D: 10,13
ST Penta E: 10,12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WA07
AC CVCL_9772
SY WA 07; WA7; H7; H7 GE07; hESC; H7-hESC; ES-WA7; WAe002-A; WICELLe002-A; WAe007-A
DR EFO; EFO_0005904
DR BioSample; SAMN03471896
DR ENCODE; ENCBS017AOD
DR ENCODE; ENCBS052WSJ
DR ENCODE; ENCBS058YII
DR ENCODE; ENCBS068KXI
DR ENCODE; ENCBS291AAA
DR ENCODE; ENCBS292AAA
DR ENCODE; ENCBS293AAA
DR ENCODE; ENCBS297CQV
DR ENCODE; ENCBS311AAZ
DR ENCODE; ENCBS465FZV
DR ENCODE; ENCBS559YVY
DR ENCODE; ENCBS611ORI
DR ENCODE; ENCBS624XJG
DR ENCODE; ENCBS721YNV
DR ENCODE; ENCBS851RDN
DR ENCODE; ENCBS884CKU
DR ENCODE; ENCBS920PVU
DR ENCODE; ENCBS962QAF
DR GEO; GSM347922
DR GEO; GSM510581
DR GEO; GSM537623
DR GEO; GSM537639
DR GEO; GSM537640
DR GEO; GSM537641
DR GEO; GSM537657
DR GEO; GSM580005
DR GEO; GSM621347
DR GEO; GSM621353
DR GEO; GSM669896
DR GEO; GSM669926
DR GEO; GSM856730
DR GEO; GSM945183
DR GEO; GSM945184
DR GEO; GSM945185
DR GEO; GSM945186
DR GEO; GSM981283
DR GEO; GSM1008596
DR GEO; GSM1215275
DR GEO; GSM1215276
DR hPSCreg; WAe007-A
DR IGRhCellID; H7%20p91
DR ISCR; 88
RX PubMed=9804556;
RX PubMed=14745950;
RX PubMed=15345125;
RX PubMed=16388305;
RX PubMed=16919167;
RX PubMed=17572666;
RX PubMed=21983960;
RX PubMed=23117585;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=413
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/H7-hESC_StamAndCrawford_protocol.pdf
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa07.cmsx
WW https://stemcelldb.nih.gov/cellLineDetails.do?id=3
WW http://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/
CC Part of: ENCODE project common cell types; tier 3.
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0061.
CC Registration: Swiss research registry; BAG-hES-IMP-0034.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-18.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me1 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: Transcriptome analysis.
CC Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.
ST Source(s): PubMed=16919167; WiCell
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,15
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WA09
AC CVCL_9773
SY WA 09; WA9; H9; H9.hESCs; H9 ESC; H9 hES; H9ES; GE09; WAe003-A; WICELLe003-A; WAe009-A
DR BioSample; SAMN03471903
DR BioSamples; SAMEA7769668
DR ENCODE; ENCBS013BRF
DR ENCODE; ENCBS061KRP
DR ENCODE; ENCBS140HIH
DR ENCODE; ENCBS277KDR
DR ENCODE; ENCBS298AAA
DR ENCODE; ENCBS299AAA
DR ENCODE; ENCBS300AAA
DR ENCODE; ENCBS315DEY
DR ENCODE; ENCBS375GFI
DR ENCODE; ENCBS377MXB
DR ENCODE; ENCBS399JWQ
DR ENCODE; ENCBS417MAQ
DR ENCODE; ENCBS477SFO
DR ENCODE; ENCBS532LWE
DR ENCODE; ENCBS616QKE
DR ENCODE; ENCBS656LSW
DR ENCODE; ENCBS692FVF
DR ENCODE; ENCBS703ZDS
DR ENCODE; ENCBS741LLD
DR ENCODE; ENCBS769EPD
DR ENCODE; ENCBS808UWK
DR ENCODE; ENCBS853WXF
DR GEO; GSM347923
DR GEO; GSM579901
DR GEO; GSM579902
DR GEO; GSM603054
DR GEO; GSM603055
DR GEO; GSM605307
DR GEO; GSM605310
DR GEO; GSM605314
DR GEO; GSM605316
DR GEO; GSM605324
DR GEO; GSM616127
DR GEO; GSM616128
DR GEO; GSM616129
DR GEO; GSM665037
DR GEO; GSM667608
DR GEO; GSM667609
DR GEO; GSM667610
DR GEO; GSM667611
DR GEO; GSM667612
DR GEO; GSM667613
DR GEO; GSM667616
DR GEO; GSM667619
DR GEO; GSM667620
DR GEO; GSM667621
DR GEO; GSM667622
DR GEO; GSM667623
DR GEO; GSM667625
DR GEO; GSM667626
DR GEO; GSM667628
DR GEO; GSM667629
DR GEO; GSM667630
DR GEO; GSM667631
DR GEO; GSM667632
DR GEO; GSM667633
DR GEO; GSM667634
DR GEO; GSM667635
DR GEO; GSM667636
DR GEO; GSM667637
DR GEO; GSM667638
DR GEO; GSM667639
DR GEO; GSM667640
DR GEO; GSM667643
DR GEO; GSM669899
DR GEO; GSM669901
DR GEO; GSM670053
DR GEO; GSM674603
DR GEO; GSM706044
DR GEO; GSM706059
DR GEO; GSM706060
DR GEO; GSM706061
DR GEO; GSM706062
DR GEO; GSM706063
DR GEO; GSM706064
DR GEO; GSM706066
DR GEO; GSM706071
DR GEO; GSM706076
DR GEO; GSM816629
DR GEO; GSM856731
DR GEO; GSM1040243
DR GEO; GSM1040313
DR GEO; GSM1215278
DR GEO; GSM1215279
DR GEO; GSM1227088
DR GEO; GSM1489249
DR GEO; GSM1489460
DR hPSCreg; WAe009-A
DR IGRhCellID; H9%20p25-2
DR IGRhCellID; H9%20p34
DR ISCR; 89
DR PRIDE; PXD003903
DR TOKU-E; 4223
DR Wikidata; Q27555433
RX PubMed=9804556;
RX PubMed=14745950;
RX PubMed=16388305;
RX PubMed=16919167;
RX PubMed=17572666;
RX PubMed=21983960;
RX PubMed=22514597;
RX PubMed=22802639;
RX PubMed=23117585;
RX PubMed=24259714;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=414
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/BG02ES_and_H9ES_Myers_protocols.pdf
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=88
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa09.cmsx
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa09-cgmp-material.cmsx
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa09-matched-research.cmsx
WW https://stemcelldb.nih.gov/cellLineDetails.do?id=13
WW http://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/
CC Group: Clinical grade hESC cell line.
CC Part of: ENCODE project common cell types; tier 3.
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0062.
CC Registration: Swiss research registry; BAG-hES-IMP-0016.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-06.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: H2AK5ac ChIP-seq epigenome analysis.
CC Omics: H2BK12ac ChIP-seq epigenome analysis.
CC Omics: H2BK15ac ChIP-seq epigenome analysis.
CC Omics: H2BK5ac ChIP-seq epigenome analysis.
CC Omics: H3K18ac ChIP-seq epigenome analysis.
CC Omics: H3K23ac ChIP-seq epigenome analysis.
CC Omics: H3K23me2 ChIP-seq epigenome analysis.
CC Omics: H3K27ac ChIP-seq epigenome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4ac ChIP-seq epigenome analysis.
CC Omics: H3K4me1 ChIP-seq epigenome analysis.
CC Omics: H3K4me2 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K56ac ChIP-seq epigenome analysis.
CC Omics: H3K79me1 ChIP-seq epigenome analysis.
CC Omics: H3K79me2 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
CC Omics: H4K20me1 ChIP-seq epigenome analysis.
CC Omics: H4K5ac ChIP-seq epigenome analysis.
CC Omics: H4K8ac ChIP-seq epigenome analysis.
CC Omics: H4K91ac ChIP-seq epigenome analysis.
CC Omics: Transcriptome analysis.
CC Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.
ST Source(s): PubMed=16919167; WiCell
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 12,13
ST D18S51: 13
ST D21S11: 30
ST D3S1358: 13,16
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 8,14
ST FGA: 26,28
ST Penta D: 11,13
ST Penta E: 11,14
ST TH01: 9.3
ST TPOX: 10,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WA09 MIXL1-2A-eGFP
AC CVCL_GQ06
SY MIXL1-2A-eGFP
RX PubMed=27558609;
CC Characteristics: TALEN-engineered line where the stop codon of MIXL1 was replaced with a 2A-eGFP cassette, thus, creating a MIXL1-2A-eGFP allele.
ST Source(s): PubMed=27558609
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 12,13
ST D18S51: 13
ST D21S11: 30
ST D3S1358: 13,16
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 8,14
ST FGA: 26,28
ST Penta D: 9,13
ST Penta E: 11,14
ST TH01: 9.3
ST TPOX: 10,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9773 ! WA09
SX Female
CA Induced pluripotent stem cell
//
ID WA13
AC CVCL_9774
SY WA 13; H13; GE13; WAe004-A; WICELLe004-A; WAe013-A
DR BioSample; SAMN03471898
DR GEO; GSM347924
DR GEO; GSM856732
DR hPSCreg; WAe013-A
DR ISCR; 92
RX PubMed=9804556;
RX PubMed=17572666;
RX PubMed=23117585;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=415
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa13.cmsx
WW https://stemcelldb.nih.gov/cellLineDetails.do?id=4
WW http://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0063.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18.
CC Omics: Transcriptome analysis.
CC Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,15
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WA14
AC CVCL_9775
SY WA 14; H14; GE14; WAe005-A; WICELLe005-A; WAe014-A
DR BioSample; SAMN03471899
DR GEO; GSM347925
DR GEO; GSM856733
DR hPSCreg; WAe014-A
DR ISCR; 93
RX PubMed=9804556;
RX PubMed=14745950;
RX PubMed=16388305;
RX PubMed=17572666;
RX PubMed=21983960;
RX PubMed=23117585;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=416
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa14.cmsx
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa14-cgmp-material.cmsx
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa14-matched-research.cmsx
WW https://stemcelldb.nih.gov/cellLineDetails.do?id=29
WW http://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/
CC Group: Clinical grade hESC cell line.
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0064.
CC Registration: Swiss research registry; BAG-hES-IMP-0033.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-18.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Transcriptome analysis.
CC Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,13
ST D18S51: 12,14
ST D21S11: 30,31
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 21
ST Penta D: 12,13
ST Penta E: 13,20
ST TH01: 6,7
ST TPOX: 8
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WA15
AC CVCL_9776
SY WISCe001-A
DR hPSCreg; WISCe001-A
DR ISCR; 1668
RX PubMed=16388305;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=473
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa15.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0096.
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 11,12
ST D5S818: 9,13
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WA16
AC CVCL_9777
SY WISCe002-A
DR hPSCreg; WISCe002-A
DR ISCR; 1669
RX PubMed=16388305;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=474
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa16.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0097.
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C34752; Klinefelter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WA17
AC CVCL_9778
DR ISCR; 1831
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=475
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa17.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0098.
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 8
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 8,12
ST TH01: 6,7
ST TPOX: 11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WA18
AC CVCL_9779
DR ISCR; 1832
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=476
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa18.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0099.
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 12,13
ST D7S820: 8,11
ST TH01: 6,8
ST TPOX: 8
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WA19
AC CVCL_9780
DR ISCR; 1833
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=477
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa19.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0100.
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 13
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WA20
AC CVCL_9781
DR ISCR; 1834
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=478
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa20.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0101.
ST Source(s): WiCell
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 13,14
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WA21
AC CVCL_9782
DR ISCR; 1835
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=479
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa21.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0102.
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 11
ST D7S820: 9
ST TH01: 8,9
ST TPOX: 8,12
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WA22
AC CVCL_9783
SY WAe022-A
DR hPSCreg; WAe022-A
DR ISCR; 1836
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=480
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa22.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0103.
ST Source(s): WiCell
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11,14
ST D5S818: 13
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WA23
AC CVCL_9784
DR ISCR; 1837
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=481
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa23.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0104.
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WA24
AC CVCL_9785
DR ISCR; 1838
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=482
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa24.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0105.
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WA25
AC CVCL_E080
DR ISCR; 2001
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=582
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa25.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0196.
ST Source(s): WiCell
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,12
ST D16S539: 8,14
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WA26
AC CVCL_E081
DR ISCR; 2021
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=583
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa26.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0197.
ST Source(s): WiCell
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 12,14
ST D5S818: 12
ST D7S820: 10
ST TH01: 7,10
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WA27
AC CVCL_E082
DR ISCR; 2022
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=584
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/wa27.cmsx
CC From: University of Wisconsin; Madison; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0198.
ST Source(s): WiCell
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6,8
ST TPOX: 8,10
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WAC2
AC CVCL_0575
SY WAC-2; WAC 2
DR MCCL; MCC:0000481
RX PubMed=2364393;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0522 ! SH-EP007
SX Female
CA Cancer cell line
//
ID WAF
AC CVCL_1H00
SY Wallago Attu Fin
RX PubMed=24381102;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=5
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC005.
OX NCBI_TaxID=36718; ! Wallago attu
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WAG
AC CVCL_1H01
SY Wallago Attu Gill
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=48
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC048.
OX NCBI_TaxID=36718; ! Wallago attu
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WaGa
AC CVCL_E998
SY WAGA
DR Cosmic; 1699819
DR Cosmic; 2273918
RX PubMed=20444890;
CC Characteristics: Contains a Merkel cell polyomavirus (MCPyV) genome.
CC Derived from metastatic site: Ascites.
DI NCIt; C9231; Merkel cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WAI,DL
AC CVCL_E865
SY WAI, DL
DR dbMHC; 49055
DR IHW; IHW9204
DR IMGT/HLA; 11745
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl204.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Waji
AC CVCL_W202
SY WAJI
RX PubMed=3164747;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WAL,FD
AC CVCL_E866
SY WAL, FD
DR dbMHC; 49056
DR ECACC; 94082228
DR IHW; IHW9129
DR IMGT/HLA; 11672
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl129.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Walker-256-TC
AC CVCL_4984
SY Walker256-TC
DR CLO; CLO_0051604
DR RCB; RCB2909
DR TKG; TKG 0565
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3537 ! LLC-WRC 256
SX Female
CA Cancer cell line
//
ID Walvax-2
AC CVCL_5J50
SY WALVAX-2; WALVAX 2; WALVAX2
RX Patent=CN103525770A;
RX PubMed=25803132;
CC Group: Vaccine production cell line.
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201055.
CC Characteristics: Maintains excellent capabilities for growth and proliferation until PDL 50 (max PDL is 58).
CC Anecdotal: Is causing an outrage in some pro-lifer circles because it is a cell line originating from an aborted (for medical reasons) 3-month old female fetus.
ST Source(s): PubMed=25803132
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 15,18
ST D21S11: 29,30
ST D3S1358: 15,16
ST D5S818: 10,11
ST D7S820: 8,12
ST D8S1179: 13,15
ST FGA: 21,24
ST Penta D: 10,11
ST Penta E: 5,18
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WAM
AC CVCL_1H02
SY Wallago Attu Muscle
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=47
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC047.
OX NCBI_TaxID=36718; ! Wallago attu
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Wan-BL
AC CVCL_M654
SY WAN-BL; WAN BL; Wan.BL; WAN; Wan
RX PubMed=1356511;
RX PubMed=2824665;
RX PubMed=2898508;
RX PubMed=2943927;
RX PubMed=2985508;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WAPS 12.2
AC CVCL_F810
SY WAPS12.2
DR CLO; CLO_0009560
DR ATCC; HB-299
CC Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID WART
AC CVCL_8011
SY Wart
RX PubMed=9551745;
RX PubMed=9615717;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WASMC
AC CVCL_9500
DR CLO; CLO_0009561
DR CLDB; cl4677
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
SX Male
CA Finite cell line
//
ID WATANABE
AC CVCL_E867
SY WATANABI
DR dbMHC; 49057
DR ECACC; 94082225
DR IHW; IHW9126
DR IMGT/HLA; 11669
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl126.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Watanabe
AC CVCL_W437
RX PubMed=8721091;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WAZ-2T
AC CVCL_5G88
SY WAZ-2t; WAZ2T
RX PubMed=7306960;
RX PubMed=7371012;
CC Breed/subspecies: BALB/c.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID WB-F344
AC CVCL_9806
SY WB F344; WBF344
DR BTO; BTO:0004318
DR EFO; EFO_0002871
DR JCRB; JCRB0193
RX PubMed=6468534;
RX PubMed=9846981;
RX PubMed=20140209;
CC Omics: Transcriptome analysis.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID WB2054
AC CVCL_4335
SY WB-2054
CC Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).
CC Breed/subspecies: Wistar Furth x Brown Norway.
DI NCIt; C63866; Adenocarcinoma of the rat colon
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID WB2054M
AC CVCL_4336
DR CLO; CLO_0009562
DR CLDB; cl4678
DR ECACC; 91011802
RX PubMed=2910247;
CC Transformant: ChEBI; CHEBI:73755; 1,2-dimethylhydrazine (DMH).
CC Breed/subspecies: Wistar Furth x Brown Norway.
DI NCIt; C63866; Adenocarcinoma of the rat colon
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4335 ! WB2054
CA Cancer cell line
//
ID WB311
AC CVCL_X199
SY WB-311
DR BTO; BTO:0004319
RX PubMed=2774059;
RX PubMed=20140209;
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Omics: Transcriptome analysis.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_9806 ! WB-F344
SX Male
CA Transformed cell line
//
ID WB-5-11
AC CVCL_DN33
RX PubMed=2862991;
RX PubMed=2862992;
RX PubMed=3970142;
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_9806 ! WB-F344
SX Male
CA Transformed cell line
//
ID WB6a
AC CVCL_Y636
RX PubMed=11084865;
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID WB6b
AC CVCL_Y637
RX PubMed=11084865;
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID WB6d
AC CVCL_Y638
RX PubMed=11084865;
RX PubMed=17828574;
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID WBC264-9C
AC CVCL_8981
SY WBC264-9
DR CLO; CLO_0009563
DR ATCC; HB-8902
RX Patent=US4970162;
RX PubMed=3741419;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1P00 ! RAW264-TG3
CA Hybrid cell line
//
ID WBD001088
AC CVCL_E868
DR dbMHC; 49058
DR ECACC; 94082253
DR IHW; IHW9153
DR IMGT/HLA; 11696
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl153.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID WBD001816
AC CVCL_E869
DR dbMHC; 49059
DR ECACC; 94082254
DR IHW; IHW9154
DR IMGT/HLA; 11697
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl154.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID WBE
AC CVCL_5604
SY White Bass Embryo
DR CLO; CLO_0009564
DR ATCC; CRL-2773
RX PubMed=12892524;
CC Group: Fish cell line.
OX NCBI_TaxID=46259; ! Morone chrysops
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WBS-A
AC CVCL_0G88
DR SKIP; SKIP000557
RX PubMed=23283491;
DI NCIt; C85232; Williams syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0G89 ! WBS-B
OI CVCL_0G90 ! WBS-C
OI CVCL_0G91 ! WBS-I
SX Male
CA Induced pluripotent stem cell
//
ID WBS-B
AC CVCL_0G89
DR SKIP; SKIP000558
RX PubMed=23283491;
DI NCIt; C85232; Williams syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0G88 ! WBS-A
OI CVCL_0G90 ! WBS-C
OI CVCL_0G91 ! WBS-I
SX Male
CA Induced pluripotent stem cell
//
ID WBS-C
AC CVCL_0G90
DR SKIP; SKIP000559
RX PubMed=23283491;
DI NCIt; C85232; Williams syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0G88 ! WBS-A
OI CVCL_0G89 ! WBS-B
OI CVCL_0G91 ! WBS-I
SX Male
CA Induced pluripotent stem cell
//
ID WBS-I
AC CVCL_0G91
DR SKIP; SKIP000560
RX PubMed=23283491;
DI NCIt; C85232; Williams syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0G88 ! WBS-A
OI CVCL_0G89 ! WBS-B
OI CVCL_0G90 ! WBS-C
SX Male
CA Induced pluripotent stem cell
//
ID WC-1
AC CVCL_4555
SY WC 1
DR CLO; CLO_0009565
DR CLDB; cl4679
DR IZSLER; BS TCL 65
RX DOI=10.1139/f80-139;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Cancer cell line
//
ID WC005i-FX11-7
AC CVCL_EJ76
SY FX11-7
RX PubMed=24654675;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WC005i-FX11-7.cmsx
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ77 ! WC006i-FX11-9U
SX Male
CA Induced pluripotent stem cell
//
ID WC006i-FX11-9U
AC CVCL_EJ77
SY FX11-9U
RX PubMed=24654675;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WC006i-FX11-9U.cmsx
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EJ76 ! WC005i-FX11-7
SX Male
CA Induced pluripotent stem cell
//
ID WC007i-FX13-2
AC CVCL_EJ78
SY FX13-2
RX PubMed=24654675;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WC007i-FX13-2.cmsx
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID WC009i-FX08-01
AC CVCL_EJ79
SY FX08-1
RX PubMed=24654675;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WC009i-FX08-01.cmsx
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID WCH-17
AC CVCL_3471
SY WCH17
DR CLO; CLO_0009566
DR ATCC; CRL-2082
DR NCBI_Iran; C573
RX PubMed=2839596;
CC From: Fernie B.; Georgetown University; Rockville; USA.
DI NCIt; C124251; Woodchuck hepatocellular carcinoma
OX NCBI_TaxID=9995; ! Marmota monax
CA Cancer cell line
//
ID WCL2
AC CVCL_DC12
SY WCL-2
RX PubMed=2019585;
RX PubMed=2243084;
CC Transfected with: MGI; MGI:95824; Nr3c1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Spontaneously immortalized cell line
//
ID WCMC-1
AC CVCL_V488
SY WMC 1; WMC1
RX CelloPub=CLPUB00245;
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WCMC-10
AC CVCL_V493
SY WCMC 10; WMC 10
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=849
CC From: Weill Cornell Medical College; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0367.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-11
AC CVCL_V494
SY WCMC 11; WMC 11
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=848
CC From: Weill Cornell Medical College; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0366.
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-12
AC CVCL_V495
SY WMC 12
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-13
AC CVCL_V496
SY WCMC 13; WMC 13
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=847
CC From: Weill Cornell Medical College; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0365.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-14
AC CVCL_V497
SY WMC 14
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C34375; Thalassemia major
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-15
AC CVCL_V498
SY WMC 15
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C82342; Huntington's disease
DI NCIt; C36529; Trisomy 13
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-16
AC CVCL_V499
SY WMC 16
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-17
AC CVCL_V500
SY WMC 17
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-18
AC CVCL_V501
SY WMC 18
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-19
AC CVCL_V502
SY WMC 19
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-2
AC CVCL_B922
SY WMC 2; WMC-2; WMC2
RX CelloPub=CLPUB00245;
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-14.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WCMC-20
AC CVCL_V503
SY WMC 20
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-21
AC CVCL_V504
SY WMC 21
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-22
AC CVCL_V505
SY WMC 22
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-23
AC CVCL_V506
SY WCMC 23; WMC 23
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=846
CC From: Weill Cornell Medical College; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0364.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-24
AC CVCL_V507
SY WMC 24
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-25
AC CVCL_V508
SY WMC 25
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-26
AC CVCL_V509
SY WMC 26
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-27
AC CVCL_V510
SY WMC 27
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C27146; Hemophilia A
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-28
AC CVCL_V511
SY WMC 28
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C34345; Achondroplasia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-29
AC CVCL_V512
SY WMC 29
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-3
AC CVCL_V489
SY WMC 3; WMC3
RX CelloPub=CLPUB00245;
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WCMC-30
AC CVCL_V513
SY WMC 30
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C118780; Autosomal dominant torsion dystonia 1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-31
AC CVCL_V514
SY WMC 31
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-32
AC CVCL_V515
SY WMC 32
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C34345; Achondroplasia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-33
AC CVCL_V516
SY WMC 33
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C34345; Achondroplasia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-34
AC CVCL_V517
SY WMC 34
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C36529; Trisomy 13
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-35
AC CVCL_V518
SY WMC 35
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-36
AC CVCL_V519
SY WMC 36
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C37865; Trisomy 17
DI NCIt; C36626; Trisomy 18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-37
AC CVCL_B919
SY WCMC 37; WCMC37; WMC 37
DR ISCR; 2257
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=573
CC From: Weill Cornell Medical College; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0211.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WCMC-38
AC CVCL_V520
SY WMC 38
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C114765; Trisomy 22
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-39
AC CVCL_V521
SY WCMC 39; WMC 39
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=845
CC From: Weill Cornell Medical College; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0363.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-4
AC CVCL_V490
SY WMC 4; WMC4
RX CelloPub=CLPUB00245;
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V491 ! WCMC-5
SX Male
CA Embryonic stem cell
//
ID WCMC-40
AC CVCL_V522
SY WMC 40
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C34345; Achondroplasia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-41
AC CVCL_V523
SY WMC 41
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-42
AC CVCL_V524
SY WMC 42
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
DI NCIt; C36529; Trisomy 13
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-43
AC CVCL_V525
SY WMC 43
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-5
AC CVCL_V491
SY WMC 5; WMC5
RX CelloPub=CLPUB00245;
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V490 ! WCMC-4
SX Male
CA Embryonic stem cell
//
ID WCMC-6
AC CVCL_V492
SY WCMC 6; WMC 6; WMC6
RX CelloPub=CLPUB00245;
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V419 ! WCMC-7
SX Male
CA Embryonic stem cell
//
ID WCMC-7
AC CVCL_V419
SY WCMC 7; WMC 7; WMC7
RX CelloPub=CLPUB00245;
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
CC From: Weill Cornell Medical College; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V492 ! WCMC-6
SX Male
CA Embryonic stem cell
//
ID WCMC-8
AC CVCL_B920
SY WCMC 8; WMC 8; WMC8
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=851
CC From: Weill Cornell Medical College; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0369.
DI NCIt; C36101; BRCA2 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCMC-9
AC CVCL_B921
SY WCMC 9; WMC 9; WMC9
WW http://corefacilities.weill.cornell.edu/pdf/WCM_esc_lines.pdf
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=850
CC From: Weill Cornell Medical College; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0368.
DI NCIt; C36101; BRCA2 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WCQH-9801
AC CVCL_X186
RX PubMed=21310132;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WD PaCa
AC CVCL_8435
SY WDPaCa; Well-Differentiated Pancreatic adenoCarcinoma; WD
RX PubMed=3971476;
RX PubMed=6435863;
RX PubMed=6805945;
RX PubMed=8863680;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Cancer cell line
//
ID WD39
AC CVCL_Y528
DR SKIP; SKIP000514
RX PubMed=23039195;
RX PubMed=24936452;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID WDC-1
AC CVCL_R803
RX PubMed=10721940;
DI NCIt; C7889; Duodenal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WDS3
AC CVCL_A741
DR Cosmic; 1006171
RX PubMed=10201537;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WDV
AC CVCL_E870
AS CVCL_F296
SY WVB; GM06816; GM17002
DR CLO; CLO_0018043
DR CLO; CLO_0036533
DR Coriell; GM06816
DR Coriell; GM17002
DR dbMHC; 49060
DR ECACC; 88052062
DR IHW; IHW9062
DR IMGT/HLA; 11555
RX PubMed=6417008;
WW http://bioinformatics.hsanmartino.it/ecbr/cl62.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Part of: Human variation panel.
CC Population: Northern European.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Misspelling: 'WVD' in Coriell GM06816.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WE
AC CVCL_5M23
RX PubMed=4735239;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_5M20 ! KF
OI CVCL_5M21 ! MB
OI CVCL_5M22 ! TD
CA Cancer cell line
//
ID WE-68
AC CVCL_9717
SY WE 68; WE68
DR EFO; EFO_0002872
DR GEO; GSM510016
RX PubMed=1320624;
RX PubMed=8335680;
RX PubMed=15150091;
RX PubMed=19787792;
CC From: Van Valen F.; University of Munster; Germany.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9718 ! WE-M1-68
OI CVCL_9719 ! WE-M2-68
SX Female
CA Cancer cell line
//
ID WE-afin8e
AC CVCL_AZ93
SY Wall Eye-anal fin 8e
RX CelloPub=CLPUB00324;
RX PubMed=25424833;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WE-brain3
AC CVCL_AZ94
SY Wall Eye-brain 3
RX CelloPub=CLPUB00324;
RX PubMed=25424833;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WE-brain5
AC CVCL_AZ95
SY Wall Eye-brain 5
RX CelloPub=CLPUB00324;
RX PubMed=25424833;
RX PubMed=26251287;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WE-cfin11e
AC CVCL_AZ96
SY Wall Eye-caudal fin 11e; WECF11e; Wall Eye Caudal Fine 11e
RX CelloPub=CLPUB00324;
RX PubMed=23891577;
RX PubMed=25424833;
RX PubMed=25643858;
RX PubMed=26251287;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WE-cfin11f
AC CVCL_AZ97
SY Wall Eye-caudal fin 11f
RX CelloPub=CLPUB00324;
RX PubMed=25424833;
RX PubMed=25589167;
RX PubMed=25643858;
RX PubMed=26251287;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WE-heart1
AC CVCL_AZ98
SY Wall Eye-heart 1
RX CelloPub=CLPUB00324;
RX PubMed=25424833;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WE-heart6
AC CVCL_AZ99
SY Wall Eye-heart 6
RX CelloPub=CLPUB00324;
RX PubMed=25424833;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WE-liver3
AC CVCL_BA00
SY Wall Eye-liver 3
RX CelloPub=CLPUB00324;
RX PubMed=26251287;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WE-M1-68
AC CVCL_9718
RX PubMed=1320624;
CC From: Van Valen F.; University of Munster; Germany.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9717 ! WE-68
OI CVCL_9719 ! WE-M2-68
SX Female
CA Cancer cell line
//
ID WE-M2-68
AC CVCL_9719
RX PubMed=1320624;
CC From: Van Valen F.; University of Munster; Germany.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9717 ! WE-68
OI CVCL_9718 ! WE-M1-68
SX Female
CA Cancer cell line
//
ID WE-skin11f
AC CVCL_BA01
SY Wall Eye-skin 11f
RX CelloPub=CLPUB00324;
RX PubMed=25424833;
RX PubMed=26251287;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WE-spleen6
AC CVCL_BA02
SY Wall Eye-spleen 6; WE-spleen
RX CelloPub=CLPUB00324;
RX PubMed=25424833;
RX PubMed=25701636;
RX PubMed=26251287;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WE17/10
AC CVCL_X625
SY We17/10
DR NIH-ARP; 462-168
RX CelloPub=CLPUB00150;
RX PubMed=2144349;
CC Characteristics: IL2 dependent.
DI NCIt; C3466; T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Factor-dependent cell line
//
ID WEBA
AC CVCL_BA03
SY Wall Eye Bulbus Arteriosus
RX CelloPub=CLPUB00324;
RX PubMed=25424833;
RX PubMed=25461487;
RX PubMed=26251287;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WEG-1
AC CVCL_8012
RX PubMed=8536610;
WW http://www2.kumc.edu/soalab/LabLinks/cell%20lines/weg1.htm
WW https://www.researchgate.net/post/Does_anyone_know_of_an_established_mouse_uterine_epithelial_cell_line_in_existence
CC Breed/subspecies: CF-1.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID WEGLI-11
AC CVCL_7873
SY WEGLI 11; WEGLI11; Wegli 11
RX PubMed=7684623;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID WEGLI-13
AC CVCL_7874
SY WEGLI 13; WEGLI13
RX PubMed=7684623;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID WEGLI-16
AC CVCL_7875
SY WEGLI 16; WEGLI16
RX PubMed=7684623;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID WEGLI-18
AC CVCL_7876
SY WEGLI 18; WEGLI18
DR BTO; BTO:0001927
RX PubMed=7684623;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID WEGLI-20
AC CVCL_7877
SY WEGLI 20; WEGLI20
RX PubMed=7684623;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID WEGLI-22
AC CVCL_7878
SY WEGLI 22; WEGLI22
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID WEGLI-3
AC CVCL_7879
SY WEGLI 3; WEGLI3
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID WEGLI-9
AC CVCL_7880
SY WEGLI 9; WEGLI9
RX PubMed=7684623;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID WEHI-105.7
AC CVCL_F528
SY WEHI 105.7
RX PubMed=4630643;
CC Breed/subspecies: NZB.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID WEHI-13VAR
AC CVCL_3619
SY WEHI-13var
DR CLO; CLO_0009572
DR ATCC; CRL-2148
DR CCRID; 3111C0002000000029
RX PubMed=7590904;
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0J47 ! WEHI-164 clone 13
CA Cancer cell line
//
ID WEHI-164
AC CVCL_2251
SY WEHI 164; WEHI164
DR CLO; CLO_0009567
DR CLO; CLO_0009573
DR CLDB; cl4680
DR CLDB; cl4681
DR CLDB; cl4683
DR ATCC; CRL-1751
DR BCRJ; 0247
DR CCRID; 3142C0001000000111
DR ChEMBL-Cells; CHEMBL3308344
DR ChEMBL-Targets; CHEMBL614227
DR CLS; 400438/p944_WEHI-164
DR ECACC; 87022501
DR ICLC; ATL96004
DR IZSLER; BS TCL 195
DR KCLB; 21751
DR NCBI_Iran; C200
RX PubMed=9753870;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=WEHI-164
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID WEHI-164 clone 13
AC CVCL_0J47
SY WEHI 164 clone 13; WEHI 164(13)
RX PubMed=3782828;
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2251 ! WEHI-164
CA Cancer cell line
//
ID WEHI-164R
AC CVCL_4561
SY WEHI 164R; WEHI164R
DR CLO; CLO_0050182
DR RCB; RCB2904
DR TKG; TKG 0281
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2251 ! WEHI-164
CA Cancer cell line
//
ID WEHI-164S
AC CVCL_2238
SY WEHI 164S; WEHI164S
DR CLO; CLO_0009574
DR CLO; CLO_0050183
DR CLDB; cl4682
DR DSMZ; ACC-25
DR RCB; RCB2905
DR TKG; TKG 0282
CC Doubling time: ~30-50 hours (DSMZ).
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2251 ! WEHI-164
CA Cancer cell line
//
ID WEHI-22.1
AC CVCL_2248
SY WEHI 22.1
DR CLO; CLO_0009568
DR ATCC; TIB-54
RX PubMed=4630643;
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID WEHI-231
AC CVCL_0577
SY WEHI 231; WEHI231
DR BTO; BTO:0001093
DR CLO; CLO_0009575
DR MCCL; MCC:0000483
DR CLDB; cl4687
DR ATCC; CRL-1702
DR CCRID; 3131C0001000300013
DR ECACC; 85022107
DR Lonza; 756
DR PRIDE; PRD000029
DR TOKU-E; 3440
RX PubMed=3495708;
RX PubMed=6170720;
RX PubMed=6969756;
CC Breed/subspecies: BALB/c x NZB.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID WEHI-265.1
AC CVCL_3620
SY WEHI 265.1; WEHI265.1; WEHI:265
DR CLO; CLO_0009576
DR ATCC; TIB-204
DR ChEMBL-Cells; CHEMBL3307249
DR ChEMBL-Targets; CHEMBL612805
RX PubMed=6170720;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID WEHI-274.1
AC CVCL_3621
SY Wehi-274.1; WEHI 274.1; WEHI:274
DR CLO; CLO_0009577
DR CLDB; cl4688
DR ATCC; CRL-1679
DR ECACC; 91061231
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID WEHI-279
AC CVCL_3278
DR CLO; CLO_0009578
DR CLDB; cl4689
DR ATCC; CRL-1704
DR ECACC; 94110901
DR Lonza; 1131
CC Breed/subspecies: NZC.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID WEHI-3
AC CVCL_3622
SY WEHI 3; WEHI3; Wehi-3
DR BTO; BTO:0000295
DR CLO; CLO_0009579
DR CLO; CLO_0051420
DR CLDB; cl4691
DR ATCC; TIB-68
DR BCRC; 60176
DR CCRID; 3111C0001CCC000029
DR CLS; 400381/p827_WEHI-3
DR JCRB; JCRB9093
DR KCB; KCB 2012094YJ
DR RCB; RCB0035
RX PubMed=3792703;
RX PubMed=6170720;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Misspelling: Occasionally 'WEIHI3'.
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID WEHI-3B
AC CVCL_2239
SY WEHI-3b; WEHI 3B; WEHI3B
DR BTO; BTO:0005282
DR CLO; CLO_0009569
DR CLO; CLO_0009580
DR CLO; CLO_0050196
DR CLDB; cl4684
DR CLDB; cl4685
DR CLDB; cl4686
DR CLDB; cl4937
DR BCRJ; 0248
DR ChEMBL-Cells; CHEMBL3307352
DR ChEMBL-Targets; CHEMBL614249
DR CLS; 400376/p545_WEHI-3b
DR DSMZ; ACC-26
DR ECACC; 86013003
DR ICLC; ATL99003
DR IFO; IFO50296
DR RCB; RCB2853
DR TKG; TKG 0584
RX PubMed=3792703;
RX PubMed=17635523;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=WEHI-3B
CC Doubling time: ~20-30 hours (DSMZ).
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3622 ! WEHI-3
CA Cancer cell line
//
ID WEHI-3B D+
AC CVCL_4357
SY WEHI-3B(D+); WEHI-3BD; WEHI 3BD
DR CLO; CLO_0009570
DR CLO; CLO_0009581
DR CLDB; cl4693
DR CLDB; cl4694
DR ECACC; 92110401
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2239 ! WEHI-3B
CA Cancer cell line
//
ID WEHI-3B/CPX
AC CVCL_3430
SY WEHI-3B/CPXRES
DR CLO; CLO_0009582
DR CLDB; cl4938
DR ICLC; ATL99004
RX CelloPub=CLPUB00272;
RX PubMed=17635523;
CC Selected for resistance to: ChEBI; CHEBI:100241; Ciprofloxacin.
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4357 ! WEHI-3B D+
CA Cancer cell line
//
ID WEHI-3B/CTRES
AC CVCL_4Y52
SY WEHI-3B/CT/REV
RX PubMed=12083375;
RX PubMed=16541129;
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4357 ! WEHI-3B D+
CA Cancer cell line
//
ID WEHI-3B/NOVO
AC CVCL_9260
RX PubMed=1316227;
CC Selected for resistance to: ChEBI; CHEBI:28368; Novobiocin.
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4357 ! WEHI-3B D+
CA Cancer cell line
//
ID WEHI-3B/S
AC CVCL_9261
RX PubMed=1316227;
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4357 ! WEHI-3B D+
CA Cancer cell line
//
ID WEHI-5
AC CVCL_0J46
SY WEHI 5
RX PubMed=3495708;
RX PubMed=6170720;
CC Breed/subspecies: BALB/c x NZB.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID WEHI-7
AC CVCL_F526
SY WEHI 7; WEHI7
RX PubMed=2019585;
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID WEHI-7.1
AC CVCL_0576
SY W7; WEHI 7.1; WEHI7.1; Wehi 7.1
DR CLO; CLO_0009571
DR MCCL; MCC:0000482
DR ATCC; TIB-53
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F526 ! WEHI-7
CA Cancer cell line
//
ID WEHI-7.2
AC CVCL_3950
SY WEHI 7.2; WEHI7.2
DR BTO; BTO:0003181
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F526 ! WEHI-7
CA Cancer cell line
//
ID WEHI-7TG
AC CVCL_F527
SY WEHI7TG
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F526 ! WEHI-7
CA Cancer cell line
//
ID WERC
AC CVCL_7881
RX PubMed=4107530;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID WERI
AC CVCL_2757
DR ECACC; 06070602
CC From: Gallie B.; Toronto Hospital for Sick Children; Toronto; Canada.
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WERI-Rb-1
AC CVCL_1792
SY WERI-RB-1; WERI-Rb1; WERI-RB1; WERI Rb-1
DR CLO; CLO_0009583
DR CLO; CLO_0009584
DR CLO; CLO_0051563
DR EFO; EFO_0005715
DR CLDB; cl4695
DR ATCC; HTB-169
DR BioSample; SAMN03472730
DR CCRID; 3131C0001001200012
DR Cosmic; 688119
DR Cosmic; 909782
DR DSMZ; ACC-90
DR ENCODE; ENCBS087YAE
DR ENCODE; ENCBS270AAA
DR ENCODE; ENCBS282DQM
DR ENCODE; ENCBS283KOW
DR ENCODE; ENCBS283WND
DR ENCODE; ENCBS679NMZ
DR GEO; GSM824870
DR GEO; GSM945263
DR GEO; GSM945318
DR IGRhCellID; WERIRb1
DR IZSLER; BS TCL 231
DR Lonza; 1147
DR RCB; RCB2146
DR TKG; TKG 0601
RX DOI=10.5795/jjscc.24.451;
RX PubMed=844036;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/WERI-Rb-1_Stam_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Doubling time: ~49 hours (DSMZ).
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
ST Source(s): ATCC; DSMZ; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,12,13 (ATCC; DSMZ; RCB)
ST CSF1PO: 10 (TKG)
ST D13S317: 14
ST D16S539: 13
ST D5S818: 11,12
ST D7S820: 10,13
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WERI-Rb24
AC CVCL_S609
SY W-24
RX PubMed=2391623;
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WERI-Rb27
AC CVCL_S610
SY WERI-RB27; W-27
RX PubMed=1679230;
RX PubMed=2391623;
CC Problematic cell line: Contaminated. Shown to be a Y-79 derivative (PubMed=1679230).
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1893 ! Y-79
SX Female
CA Cancer cell line
//
ID WErpe
AC CVCL_BA04
SY Wall Eye retinal pigment epithelium
RX PubMed=26251287;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WES
AC CVCL_4337
SY Ad12-SV40 WES
DR CLO; CLO_0009585
DR CLDB; cl4696
DR ATCC; CRL-1609
DR ECACC; 91011612
DR KCB; KCB 93006YJ
RX PubMed=1335029;
RX PubMed=6264437;
CC Group: Non-human primate cell line.
CC Transformant: Ad12-SV40.
CC Discontinued: ATCC; CRL-1609; true.
OX NCBI_TaxID=9598; ! Pan troglodytes
CA Transformed cell line
//
ID WEWAK1
AC CVCL_E871
DR dbMHC; 49061
DR ECACC; 94022553
DR IHW; IHW9219
DR IMGT/HLA; 11558
WW http://bioinformatics.hsanmartino.it/ecbr/cl219.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID WF-1
AC CVCL_R857
SY Wakasaki Fin-1
RX DOI=10.1577/1548-8667(1993)005<0137:eacosc>2.3.CO;2;
RX DOI=10.3147/jsfp.28.27;
CC Group: Fish cell line.
OX NCBI_TaxID=240830; ! Hypomesus olidus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WF2
AC CVCL_4556
SY WF 2; WF-2; Walleye Fry-2
DR CLO; CLO_0009586
DR CLDB; cl4697
DR IZSLER; BS CL 88
RX DOI=10.1111/j.1749-7345.2005.tb00402.x;
CC Group: Fish cell line.
OX NCBI_TaxID=283036; ! Sander vitreus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WF215-200
AC CVCL_V387
DR IMGT/HLA; 14463
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID WFL3C6.1
AC CVCL_9240
SY 3C6
DR CLO; CLO_0009587
DR ATCC; HB-8157
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID WFL4F12.3
AC CVCL_9241
SY 4F12
DR CLO; CLO_0009588
DR ATCC; HB-8156
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Wg-1A
AC CVCL_0F72
SY WG-1A; Wg1A; Wg1a; CH-WG-1A
RX PubMed=762193;
RX PubMed=4359531;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_3472 ! Don
SX Male
CA Spontaneously immortalized cell line
//
ID WG-59
AC CVCL_FA28
RX PubMed=27110824;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): PubMed=27110824
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 12,13
ST D5S818: 10,12
ST D7S820: 9,10
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 14,15
DI NCIt; C128803; Bicuspid aortic valve
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WG0915
AC CVCL_0E55
SY WG915
RX PubMed=3478720;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C121563; Lysinuric protein intolerance
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID WG0919
AC CVCL_0E56
SY WG919
RX PubMed=3478720;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C121563; Lysinuric protein intolerance
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID WG1077
AC CVCL_0E57
SY WG 1077
RX PubMed=1437403;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C85029; Prolidase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID WG1130
AC CVCL_0F56
SY WG 1130
RX PubMed=7909321;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C98986; Methylmalonic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WG1264
AC CVCL_0E58
RX PubMed=3478720;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WG1265
AC CVCL_0E59
RX PubMed=3478720;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C121563; Lysinuric protein intolerance
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WG1269
AC CVCL_0E60
RX PubMed=3478720;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C121563; Lysinuric protein intolerance
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID WG1270
AC CVCL_0E61
RX PubMed=3478720;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WG1271
AC CVCL_0E62
RX PubMed=3478720;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C121563; Lysinuric protein intolerance
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WG1273
AC CVCL_0E63
RX PubMed=3478720;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C121563; Lysinuric protein intolerance
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID WG1288
AC CVCL_0E65
RX PubMed=3478720;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C84664; Cystinuria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WG1534
AC CVCL_5I47
SY PWSdel1; PWS-1
RX PubMed=20876107;
RX PubMed=24816254;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C75463; Prader-Willi syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WG1625
AC CVCL_0E64
SY WG 1625
RX PubMed=1437403;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C85029; Prolidase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WG1631
AC CVCL_5I46
SY ASdel2
RX PubMed=20876107;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C75462; Angelman syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID WG1681
AC CVCL_0D81
SY WG 1681
RX PubMed=7909321;
CC From: Montreal Children's Hospital cell repository; Montreal; Canada.
DI NCIt; C98986; Methylmalonic acidemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID WGA
AC CVCL_0578
DR MCCL; MCC:0000484
RX PubMed=15572372;
DI NCIt; C3728; Hepatoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0027 ! Hep-G2
SX Male
CA Cancer cell line
//
ID Wgd5
AC CVCL_3808
DR CLO; CLO_0009589
DR CLDB; cl4698
DR ATCC; CRL-1817
DR ECACC; 95082908
CC Discontinued: ECACC; 95082908; probable.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3433 ! WOP
CA Transformed cell line
//
ID WH
AC CVCL_0C39
DR Cosmic; 2057464
DR Cosmic; 2444235
RX PubMed=2296606;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Wh-Ir
AC CVCL_S392
DR ATCC; CRL-6562
CC Group: Cetacean cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6562; true.
OX NCBI_TaxID=9770; ! Balaenoptera physalus
SX Sex undetermined
CA Finite cell line
//
ID WH19-4
AC CVCL_H783
RX PubMed=1316607;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [U19tsa].
CC Breed/subspecies: Wistar Kyoto.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID WH257GE10
AC CVCL_4Z95
RX PubMed=3905560;
DI NCIt; C124251; Woodchuck hepatocellular carcinoma
OX NCBI_TaxID=9995; ! Marmota monax
CA Cancer cell line
//
ID WH44KA
AC CVCL_4Z96
RX DOI=10.2957/kanzo.29.272;
RX PubMed=2453497;
DI NCIt; C124251; Woodchuck hepatocellular carcinoma
OX NCBI_TaxID=9995; ! Marmota monax
CA Cancer cell line
//
ID WHN2
AC CVCL_0G08
SY WHN-2
RX PubMed=8390425;
RX PubMed=9738977;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WHO NP192
AC CVCL_E872
SY WHONP192
DR dbMHC; 49062
DR ECACC; 94082240
DR IHW; IHW9140
DR IMGT/HLA; 11683
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl140.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WHO NP199
AC CVCL_E873
SY WHONP199
DR dbMHC; 49063
DR ECACC; 94082233
DR IHW; IHW9134
DR IMGT/HLA; 11677
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl134.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WHO NP439
AC CVCL_E874
SY WHONP439
DR dbMHC; 49064
DR ECACC; 94082239
DR IHW; IHW9139
DR IMGT/HLA; 11682
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl139.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WI-1003
AC CVCL_4557
SY WI 1003
DR CLO; CLO_0009590
DR CLO; CLO_0009592
DR CLDB; cl4699
DR CLDB; cl4700
DR ATCC; CCL-154
DR IZSLER; BS CL 108
RX PubMed=7065527;
RX PubMed=14315085;
CC Discontinued: ATCC; CCL-154; true.
CC Discontinued: IZSLER; BS CL 108; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WI-25
AC CVCL_V827
SY WI 25
RX PubMed=13905658;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WI-26
AC CVCL_V826
SY WI 26
DR ATCC; CCL-95
DR BioSample; SAMN03471292
RX PubMed=7065527;
RX PubMed=14315085;
CC Discontinued: ATCC; CCL-95; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,13
ST TH01: 6,7
ST TPOX: 10,11
ST vWA: 17,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID WI-26 VA4
AC CVCL_2758
SY WI 26 VA4; WI 26 VA 4; WI-26; WI26 VA4; VA-4
DR BTO; BTO:0003482
DR CLO; CLO_0009593
DR CLDB; cl4701
DR CLDB; cl4702
DR ATCC; CCL-95.1
DR ECACC; 89101301
DR GEO; GSM827466
DR IZSLER; BS CL 89
DR JCRB; JCRB9042
DR KCLB; 10095.1
RX DOI=10.1002/jcp.1030650110;
RX PubMed=7065527;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC; JCRB; KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 9,11
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 10,13
ST FGA: 25
ST TH01: 6,7
ST TPOX: 10,11
ST vWA: 17,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V826 ! WI-26
SX Male
CA Transformed cell line
//
ID WI-38
AC CVCL_0579
SY WI 38; WI38; Wistar Institute-38; AG06814-J; AG06814-M; AG06814-N
DR BTO; BTO:0000458
DR CLO; CLO_0009591
DR CLO; CLO_0009594
DR CLO; CLO_0035526
DR CLO; CLO_0035534
DR EFO; EFO_0001260
DR MCCL; MCC:0000485
DR CLDB; cl4703
DR CLDB; cl4704
DR CLDB; cl4705
DR ATCC; CCL-75
DR ATCC; CRL-7728
DR BioSample; SAMN01821606
DR BioSample; SAMN01821721
DR BioSample; SAMN03471285
DR CCRID; 3111C0001CCC000210
DR CCRID; 3111C0002000000067
DR CCRID; 3131C0001000200008
DR CCRID; 3142C0001000000016
DR ChEMBL-Cells; CHEMBL3307614
DR ChEMBL-Targets; CHEMBL614391
DR Coriell; AG06814-J
DR Coriell; AG06814-M
DR Coriell; AG06814-N
DR ECACC; 90020107
DR GEO; GSM827323
DR IFO; IFO50075
DR IGRhCellID; WI38
DR IZSLER; BS CL 90
DR JCRB; JCRB9017
DR KCB; KCB 200556YJ
DR KCLB; 10075
DR Lonza; 495
DR RCB; RCB0702
DR RCB; RCB0704
DR TKG; TKG 0360
DR Wikidata; Q7950532
RX DOI=10.1038/498407a;
RX DOI=10.1038/498422a;
RX PubMed=4203458;
RX PubMed=5834207;
RX PubMed=7065527;
RX PubMed=14315085;
RX PubMed=22984048;
RX PubMed=25903999;
WW https://en.wikipedia.org/wiki/WI-38
WW http://ascb.org/the-story-of-wi-38-the-other-famous-cell-line/
WW http://www.bioedge.org/index.php/bioethics/bioethics_article/10637
CC Group: Vaccine production cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Biotechnology: Used for the production of RA27/3 - the first rubella virus vaccine.
CC Biotechnology: Used for the production of live oral adenovirus type 4 and type 7 vaccine.
CC Characteristics: Life expectancy of 50 +- 10 population doublings.
CC Doubling time: ~24 hours (ECACC).
CC Discontinued: ATCC; CRL-7728; true.
CC Discontinued: JCRB; JCRB9017; true.
CC Discontinued: KCLB; 10075; probable.
ST Source(s): ATCC; ECACC; JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 10
ST D7S820: 9,11
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 19,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WI-38 CT-1
AC CVCL_L281
SY CT-1
RX PubMed=7418975;
CC Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0579 ! WI-38
SX Female
CA Transformed cell line
//
ID WI-38 KTr
AC CVCL_5605
DR CLO; CLO_0009596
DR CLDB; cl4710
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0579 ! WI-38
SX Female
CA Finite cell line
//
ID WI-38 VA13 subline 2RA
AC CVCL_2759
SY WI 38 VA13 subline 2RA; WI 38 VA-13 subline 2RA; WI 38VA13 subline 2RA; WI-38 VA13 sub 2 RA; WI38-VA13 subline 2RA; WI38 VA13/2RA; WI-38 VA13; WI 38 VA 13; WI38/VA13; WI38VA13; VA-13; VA13; AG07217; AG7217
DR BTO; BTO:0003066
DR CLO; CLO_0009597
DR CLO; CLO_0009598
DR CLO; CLO_0009599
DR CLO; CLO_0035575
DR CLO; CLO_0050044
DR CLDB; cl4711
DR CLDB; cl4712
DR CLDB; cl4713
DR CLDB; cl4714
DR ATCC; CCL-75.1
DR BCRC; 60504
DR BioSample; SAMN03471286
DR CCRID; 3111C0001CCC000390
DR CCRID; 3142C0001000000095
DR ChEMBL-Cells; CHEMBL3308010
DR ChEMBL-Targets; CHEMBL612807
DR CLS; 300421/p574_Wi-38_VA-13_2RA
DR Coriell; AG07217
DR ECACC; 85062512
DR GEO; GSM784286
DR IZSLER; BS CL 91
DR JCRB; JCRB9057
DR KCLB; 10075.1
DR RCB; RCB0251
DR TOKU-E; 3451
RX PubMed=3413074;
RX PubMed=4290661;
RX PubMed=7065527;
RX PubMed=9175740;
RX PubMed=24116068;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC; CLS; JCRB; KCLB; PubMed=24116068; RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 16,18
ST D19S433: 13,16.2
ST D21S11: 30,30.2
ST D2S1338: 19,25
ST D3S1358: 16,17
ST D5S818: 10
ST D7S820: 9,11
ST D8S1179: 14
ST FGA: 22,24
ST Penta D: 13
ST Penta E: 13,14
ST TH01: 9.3
ST TPOX: 8
ST vWA: 19,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0579 ! WI-38
SX Female
CA Transformed cell line
//
ID WI-38-30
AC CVCL_2812
SY WI 38-30; WI-38 PDL 30
DR JCRB; JCRB0517
CC Discontinued: JCRB; JCRB0517; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0579 ! WI-38
SX Female
CA Finite cell line
//
ID WI-38-40
AC CVCL_2813
SY WI 38-40; WI-38 PDL 40
DR JCRB; JCRB0518
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0579 ! WI-38
SX Female
CA Finite cell line
//
ID WI-38/hTERT/GFP-RAF-ER
AC CVCL_N806
DR ENCODE; ENCBS070MZP
DR ENCODE; ENCBS157XHV
DR ENCODE; ENCBS601ENJ
DR ENCODE; ENCBS606ENC
DR ENCODE; ENCBS607ENC
DR ENCODE; ENCBS608ENC
DR ENCODE; ENCBS715PYA
DR ENCODE; ENCBS787LHJ
DR GEO; GSM651580
DR GEO; GSM651581
DR GEO; GSM651582
DR GEO; GSM651583
DR GEO; GSM945215
DR GEO; GSM945223
DR GEO; GSM945245
DR GEO; GSM945265
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/WI38_Stam_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Characteristics: Transfected with a construct that is composed of EGFP at the N-terminus, the catalytic domain of RAF1 (with 340-DD-341) in the middle and the hormone-binding domain of ESR1 at the C-terminus. Protein kinase activity is activated by estrogen or analogs such as 4-hydroxy-tamoxifen.
CC Characteristics: Cells can be senesced after exposure for 72 hours with 4-hydroxy-tamoxifen.
CC Transfected with: HGNC; 9829; RAF1 (catalytic domain with D-340 and D-341).
CC Transfected with: HGNC; 3467; ESR1 (hormone-binding domain).
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0579 ! WI-38
SX Female
CA Telomerase immortalized cell line
//
ID WI-L2-729HF2
AC CVCL_6741
SY WI-L2-729-HF2; WI-L2-729 HF2
DR CLO; CLO_0009603
DR ATCC; CRL-8062
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-8062; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 9,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 17,20
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6544 ! WIL2
SX Male
CA Transformed cell line
//
ID WI-MN-1
AC CVCL_F811
DR CLO; CLO_0009607
DR ATCC; HB-8672
RX Patent=US5654408;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID WIBR1
AC CVCL_9765
SY WIBR 1; WIBRe003-A
DR BioSamples; SAMEA185109
DR GEO; GSM523596
DR GEO; GSM523597
DR GEO; GSM529408
DR GEO; GSM529411
DR GEO; GSM529414
DR GEO; GSM529417
DR hPSCreg; WIBRe003-A
DR ISCR; 1424
RX PubMed=20471072;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=417
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0074.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WIBR2
AC CVCL_9766
SY WIBR 2; WIBRe002-A
DR BioSamples; SAMEA2660497
DR GEO; GSM523598
DR GEO; GSM523599
DR GEO; GSM529409
DR GEO; GSM529412
DR GEO; GSM529415
DR GEO; GSM529418
DR hPSCreg; WIBRe002-A
DR ISCR; 1425
RX PubMed=20471072;
RX PubMed=25090446;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=418
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0075.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-58.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WIBR3
AC CVCL_9767
SY WIBR 3; WIBR38; WIBRe001-A
DR BioSample; SAMN00010935
DR GEO; GSM523600
DR GEO; GSM523601
DR GEO; GSM529410
DR GEO; GSM529413
DR GEO; GSM529416
DR GEO; GSM529419
DR hPSCreg; WIBRe001-A
DR ISCR; 1426
RX PubMed=20471072;
RX PubMed=25090446;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=419
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0079.
CC Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-58.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WIBR3 Oct4-2A-GFP
AC CVCL_IU05
SY WIBRe001-A-2
DR BioSamples; SAMEA103887531
DR hPSCreg; WIBRe001-A-2
RX PubMed=25090446;
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9767 ! WIBR3
SX Female
CA Embryonic stem cell
//
ID WIBR3 Oct4-deltaPE-GFP
AC CVCL_IU04
SY WIBRe001-A-1
DR BioSamples; SAMEA103887532
DR hPSCreg; WIBRe001-A-1
RX PubMed=25090446;
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9767 ! WIBR3
SX Female
CA Embryonic stem cell
//
ID WIBR4
AC CVCL_9768
SY WIBR 4
DR ISCR; 1427
RX PubMed=20471072;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=432
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0080.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WIBR5
AC CVCL_9769
SY WIBR 5
DR ISCR; 1428
RX PubMed=20471072;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=433
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0081.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID WIBR6
AC CVCL_9770
SY WIBR 6
DR ISCR; 1429
RX PubMed=20471072;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=434
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0082.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WIC04i-127-33
AC CVCL_EJ72
SY iPS-R306C-WT
RX PubMed=21074045;
RX PubMed=21966470;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WIC04i-127-33.cmsx
DI NCIt; C75488; Rett syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F181 ! GM11270
SX Female
CA Induced pluripotent stem cell
//
ID WIC05i-127-325
AC CVCL_EJ73
SY iPS-R306C-MT
RX PubMed=21074045;
RX PubMed=21966470;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WIC05i-127-325.cmsx
DI NCIt; C75488; Rett syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F181 ! GM11270
SX Female
CA Induced pluripotent stem cell
//
ID WIC06i-07982-2
AC CVCL_EJ74
SY iPS-V247X-WT
RX PubMed=21966470;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WIC06i-07982-2.cmsx
DI NCIt; C75488; Rett syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V341 ! GM07982
SX Female
CA Induced pluripotent stem cell
//
ID WIC07i-07982-4
AC CVCL_EJ75
SY iPS-V247X-MT
RX PubMed=21966470;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/WIC07i-07982-4.cmsx
DI NCIt; C75488; Rett syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V341 ! GM07982
SX Female
CA Induced pluripotent stem cell
//
ID WiDr
AC CVCL_2760
SY WiDR; WIDR; WiDr-TC; WiDrTC; LED-WiDr; Led-WiDr
DR BTO; BTO:0001483
DR CLO; CLO_0009600
DR EFO; EFO_0002389
DR CLDB; cl4715
DR CLDB; cl4988
DR ATCC; CCL-218
DR BCRC; 60157
DR BioSample; SAMN03151797
DR ChEMBL-Cells; CHEMBL3307674
DR ChEMBL-Targets; CHEMBL614647
DR CLS; 300377/p484_WiDr
DR Cosmic; 738928
DR Cosmic; 887216
DR Cosmic; 897740
DR Cosmic; 905002
DR Cosmic; 1066213
DR Cosmic; 1122336
DR Cosmic; 1132695
DR Cosmic; 1184091
DR Cosmic; 1187326
DR Cosmic; 1218881
DR Cosmic; 1466826
DR Cosmic; 1479615
DR Cosmic; 1609498
DR Cosmic; 1676736
DR ECACC; 85111501
DR GEO; GSM784020
DR GEO; GSM827327
DR GEO; GSM1374987
DR GEO; GSM1374988
DR GEO; GSM1448091
DR ICLC; HTL00003
DR IFO; IFO50043
DR IGRhCellID; WIDR
DR JCRB; JCRB0224
DR KCLB; 10218
DR LINCS; 50049
DR RCB; RCB1908
DR TKG; TKG 0513
DR TKG; TKG 0516
RX PubMed=90012;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1389533;
RX PubMed=3472642;
RX PubMed=4203458;
RX PubMed=9290701;
RX PubMed=10674020;
RX PubMed=11414198;
RX PubMed=20143388;
RX PubMed=24042735;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=26537799;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=3472642, PubMed=20143388).
CC Doubling time: 15 hours (PubMed=90012).
CC Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=24042735; PubMed=25926053).
CC Omics: Deep glycome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: RCB; RCB1908; true.
ST Source(s): ATCC; CLS; ECACC; JCRB; KCLB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12 (ATCC; ECACC; KCLB)
ST D13S317: 11 (CLS; JCRB)
ST D16S539: 11,12
ST D18S51: 13
ST D21S11: 29,30
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 10
ST FGA: 20,22
ST Penta D: 11,13
ST Penta E: 14,16
ST TH01: 6,9 (ATCC; ECACC; JCRB; KCLB)
ST TH01: 6 (CLS)
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID WiDr/R
AC CVCL_2N03
RX CelloPub=CLPUB00271;
RX PubMed=2894893;
CC Problematic cell line: Contaminated. The parent cell line (WiDr) had been shown to be a HT-29 derivative.
CC Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2760 ! WiDr
SX Female
CA Cancer cell line
//
ID Wien 133
AC CVCL_6958
SY WIEN 133; Wien-133; Wien133; WIEN133; W133
DR CCRID; 3111C0002000000061
DR Cosmic; 2297026
DR GEO; GSM115810
RX PubMed=3496952;
RX PubMed=7849311;
RX PubMed=16960149;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WIF-B
AC CVCL_A050
DR BTO; BTO:0005889
RX PubMed=7506266;
RX PubMed=8056838;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_A051 ! WIF12-1
CA Hybrid cell line
//
ID WIF12-1
AC CVCL_A051
RX PubMed=1955480;
RX PubMed=8056838;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0269 ! Fao
HI CVCL_0579 ! WI-38
CA Hybrid cell line
//
ID WIL,M
AC CVCL_E875
SY WIL, M
DR dbMHC; 49065
DR ECACC; 94082213
DR IHW; IHW9114
DR IMGT/HLA; 11659
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl114.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WIL1
AC CVCL_6747
SY WIL-1; WI-L1
RX PubMed=4323138;
RX PubMed=5673231;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WIL2
AC CVCL_6544
SY WIL-2; WI-L2
DR BTO; BTO:0001523
DR ChEMBL-Cells; CHEMBL3307818
DR ChEMBL-Cells; CHEMBL3308011
DR ChEMBL-Cells; CHEMBL3308575
DR ChEMBL-Targets; CHEMBL612809
DR ChEMBL-Targets; CHEMBL613549
DR ChEMBL-Targets; CHEMBL614862
RX PubMed=4323138;
RX PubMed=5673231;
RX PubMed=6600440;
RX PubMed=8316623;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Misspelling: 'W1-L2' in ChEMBL CHEMBL613549 and CHEMBL3307818.
CC Misspelling: 'WI-L' in ChEMBL CHEMBL614862 and CHEMBL3308575.
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WIL2 NS
AC CVCL_2761
SY WIL2-NS; WIL-2NS; WIL-2-NS; WI-L2 NS
DR BTO; BTO:0001524
DR CLO; CLO_0009601
DR CLO; CLO_0009604
DR CLDB; cl4717
DR ATCC; CRL-8155
DR BioSample; SAMN03471196
DR BioSample; SAMN03472416
DR ChEMBL-Cells; CHEMBL3308012
DR ChEMBL-Targets; CHEMBL612810
DR Cosmic-CLP; 1331049
DR ECACC; 90112121
DR GDSC; 1331049
DR GEO; GSM827461
DR GEO; GSM1670575
DR IMGT/HLA; 11561
DR JCRB; JCRB9063
DR RCB; RCB2285
RX Patent=US4806476;
RX PubMed=27397505;
CC Group: Hybridoma fusion partner cell line.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: RCB; RCB2285; true.
ST Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 9,12
ST TH01: 8,9.3 (ATCC; Cosmic-CLP; ECACC; RCB)
ST TH01: 8,10 (JCRB)
ST TPOX: 8,11
ST vWA: 17,20
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6544 ! WIL2
SX Male
CA Transformed cell line
//
ID WIL2 S
AC CVCL_3809
SY WIL2-S; WIL2S
DR BTO; BTO:0001525
DR CLO; CLO_0009605
DR ATCC; CRL-8885
DR CCRID; 3111C0002000000032
DR Lonza; 966
RX Patent=US4806476;
WW http://www.addexbio.com/productdetail?pid=4890
CC Group: Hybridoma fusion partner cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 9,11
ST F13A01: 6,7
ST F13B: 10
ST FESFPS: 11,12
ST LPL: 9,10
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 17,20
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6544 ! WIL2
SX Male
CA Transformed cell line
//
ID WIL2.NS.6TG
AC CVCL_2762
SY Wil2.NS.6TG
DR CLO; CLO_0009602
DR CLDB; cl4718
DR ECACC; 93031001
DR NCBI_Iran; C148
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2761 ! WIL2 NS
SX Male
CA Transformed cell line
//
ID WIL2:RD1694
AC CVCL_Y425
RX PubMed=7537518;
CC Selected for resistance to: ChEBI; CHEBI:5847; ICI D1694 (Tomudex; ZD1694).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6544 ! WIL2
SX Male
CA Transformed cell line
//
ID WILCL
AC CVCL_2763
DR CLO; CLO_0009606
DR CLDB; cl4719
DR ECACC; 89120565
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E340 ! LUDLU-23
CA Transformed cell line
//
ID WILF 7C11
AC CVCL_9Q57
SY WILF-7C11; WILF7C11
RX PubMed=2542153;
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0F71 ! MB63
CA Hybrid cell line
//
ID WILF 7C9
AC CVCL_9Q58
SY WILF7C9
DR ATCC; CRL-2790
RX PubMed=2542153;
CC Discontinued: ATCC; CRL-2790; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0F71 ! MB63
CA Hybrid cell line
//
ID WILL-1
AC CVCL_1900
SY WILL1
DR BioSample; SAMN03473464
DR DSMZ; ACC-651
DR GEO; GSM1374989
RX PubMed=18972186;
CC Doubling time: ~30-50 hours, but 50-70 hours after recovery from liquid nitrogen freezing (DSMZ).
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 9,11
ST D16S539: 9,11
ST D5S818: 10
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WILL-2
AC CVCL_1901
SY WILL2
DR BioSample; SAMN03473465
DR DSMZ; ACC-652
DR GEO; GSM1374990
RX PubMed=19330555;
CC Doubling time: ~36-48 hours (DSMZ).
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,9
ST D16S539: 9,13
ST D5S818: 9,12
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WILTU-1
AC CVCL_B481
SY Wiltu-1; WIL-TU-1; WILTU1
DR ATCC; HTB-50
RX PubMed=833871;
RX PubMed=6244232;
CC Discontinued: ATCC; HTB-50; probable.
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WIN
AC CVCL_E876
DR dbMHC; 49066
DR ECACC; 94092814
DR IHW; IHW9095
DR IMGT/HLA; 11565
WW http://bioinformatics.hsanmartino.it/ecbr/cl95.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Win Mec
AC CVCL_3277
DR CLO; CLO_0009608
DR ATCC; CRL-1172
RX PubMed=225015;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WIN-1
AC CVCL_Y311
SY WIN1; Whitehead Institute Naive-1
RX PubMed=25090446;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=713
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0299.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID WIN-2
AC CVCL_Y312
SY WIN2; Whitehead Institute Naive-2
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=768
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0300.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WIN-3
AC CVCL_Y313
SY WIN3; Whitehead Institute Naive-3
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=769
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0301.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WIN-4
AC CVCL_Y314
SY WIN4; Whitehead Institute Naive-4
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=770
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0302.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WIN-5
AC CVCL_Y315
SY WIN5; Whitehead Institute Naive-5
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=771
CC From: Whitehead Institute for Biomedical Research; Boston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0303.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID WISH
AC CVCL_1909
SY Wistar Institute, Susan Hayflick
DR BTO; BTO:0000069
DR CLO; CLO_0009609
DR CLDB; cl4720
DR CLDB; cl4721
DR CLDB; cl4723
DR CLDB; cl4724
DR ATCC; CCL-25
DR ATCC; CRL-7727
DR BioSample; SAMN03151764
DR CCRID; 3111C0001CCC000088
DR CCRID; 3131C0001000200011
DR CCRID; 3142C0001000000040
DR ChEMBL-Cells; CHEMBL3308013
DR ChEMBL-Targets; CHEMBL612811
DR ECACC; 88102403
DR IFO; IFO50004
DR IZSLER; BS CL 92
DR KCLB; 10025
DR Lonza; 1163
RX CelloPub=CLPUB00262;
RX DOI=10.1007/978-1-4757-1647-4_13;
RX PubMed=566722;
RX PubMed=1246601;
RX PubMed=6451928;
RX PubMed=13712490;
RX PubMed=20143388;
RX PubMed=23925245;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=WISH
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722, PubMed=1246601, PubMed=6451928, PubMed=20143388). Originally thought to originate from cells of the amniotic sac of Susan Hayflick, the daughter of Leonard Hayflick.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: Genome sequenced (low read coverage).
CC Discontinued: ATCC; CRL-7727; true.
ST Source(s): ATCC; JCRB; KCLB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 13.3 (ATCC; JCRB; KCLB)
ST D13S317: 14 (ECACC)
ST D16S539: 9,10
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 8,12 (ATCC; JCRB; KCLB)
ST D7S820: 12 (ECACC)
ST FGA: 21
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID WISH-PC2
AC CVCL_4907
SY Weizmann Institute Sheba Hospital - Prostate Cancer 2
RX PubMed=11118033;
WW http://capcelllines.ca/details.asp?id=109
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WISi005-A
AC CVCL_IU02
DR BioSamples; SAMEA103992707
DR hPSCreg; WISi005-A
CC From: Weizmann Institute of Science; Rehovot; Israel.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID WISi006-A
AC CVCL_IU03
SY FX1 iPSC
DR BioSamples; SAMEA103992705
DR hPSCreg; WISi006-A
CC From: Weizmann Institute of Science; Rehovot; Israel.
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID WiT49
AC CVCL_0583
SY WiT 49
DR MCCL; MCC:0000489
DR Cosmic; 1196557
RX PubMed=14506735;
RX PubMed=19824073;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/w/cell-lines-detail-622.html
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Wittier
AC CVCL_M734
RX PubMed=7680730;
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WIV-BS-02
AC CVCL_Z703
RX DOI=10.13242/j.cnki.bingduxuebao.000368;
CC Group: Insect cell line.
OX NCBI_TaxID=1049282; ! Biston suppressaria
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WIV-BS-481
AC CVCL_Z701
CC Group: Insect cell line.
OX NCBI_TaxID=1049282; ! Biston suppressaria
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WIV-BS-484
AC CVCL_Z702
SY BS-484; Bs-484
RX CelloPub=CLPUB00201;
CC Group: Insect cell line.
OX NCBI_TaxID=1049282; ! Biston suppressaria
SX Female
CA Spontaneously immortalized cell line
//
ID WJ1
AC CVCL_W352
RX PubMed=17703357;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WJR076
AC CVCL_E877
DR dbMHC; 49067
DR ECACC; 88052012
DR IHW; IHW9012
DR IMGT/HLA; 11567
WW http://bioinformatics.hsanmartino.it/ecbr/cl12.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WK
AC CVCL_W800
DR Cosmic; 706111
RX PubMed=9692547;
RX PubMed=10766161;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WK-1
AC CVCL_GR57
WW http://license.umn.edu/technologies/z04191_avian-cell-lines-a-rapidly-growing-immortal-chicken-embryo-fibroblast-cell-line-wk-1
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Sex undetermined
CA Undefined cell line type
//
ID WK2
AC CVCL_HF83
RX PubMed=24627082;
CC Doubling time: 32 hours (PubMed=24627082).
DI NCIt; C8171; Lower gingival squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_HF84 ! WK3F
SX Male
CA Cancer cell line
//
ID WK3F
AC CVCL_HF84
RX PubMed=24627082;
CC Doubling time: 24 hours (PubMed=24627082).
CC Derived from metastatic site: Cervical lymph node.
DI NCIt; C8171; Lower gingival squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_HF83 ! WK2
SX Male
CA Cancer cell line
//
ID WKD
AC CVCL_2764
SY Wong-Kilbourne Derivative; Wong-Kilbourne
DR CLO; CLO_0009610
DR CLDB; cl4725
DR BioSample; SAMN03151765
DR BioSample; SAMN03151766
DR ECACC; 93120839
RX PubMed=1246601;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID WKPT-0293 Cl.2
AC CVCL_R947
RX PubMed=8807581;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Wistar Kyoto.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R948 ! WKPT-0293 Cl.3
SX Male
CA Transformed cell line
//
ID WKPT-0293 Cl.3
AC CVCL_R948
RX PubMed=8807581;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Wistar Kyoto.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R947 ! WKPT-0293 Cl.2
SX Male
CA Transformed cell line
//
ID WKPT-1292 Cl.10
AC CVCL_R949
RX PubMed=8807581;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Wistar Kyoto.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R951 ! WKPT-1292 Cl.3
OI CVCL_R952 ! WKPT-1292 Cl.4
OI CVCL_R953 ! WKPT-1292 Cl.8
OI CVCL_R950 ! WKPT-1292 Cl.16
SX Male
CA Transformed cell line
//
ID WKPT-1292 Cl.16
AC CVCL_R950
RX PubMed=8807581;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Wistar Kyoto.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R951 ! WKPT-1292 Cl.3
OI CVCL_R952 ! WKPT-1292 Cl.4
OI CVCL_R953 ! WKPT-1292 Cl.8
OI CVCL_R949 ! WKPT-1292 Cl.10
SX Male
CA Transformed cell line
//
ID WKPT-1292 Cl.3
AC CVCL_R951
RX PubMed=8807581;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Wistar Kyoto.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R952 ! WKPT-1292 Cl.4
OI CVCL_R953 ! WKPT-1292 Cl.8
OI CVCL_R949 ! WKPT-1292 Cl.10
OI CVCL_R950 ! WKPT-1292 Cl.16
SX Male
CA Transformed cell line
//
ID WKPT-1292 Cl.4
AC CVCL_R952
RX PubMed=8807581;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Wistar Kyoto.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R951 ! WKPT-1292 Cl.3
OI CVCL_R953 ! WKPT-1292 Cl.8
OI CVCL_R949 ! WKPT-1292 Cl.10
OI CVCL_R950 ! WKPT-1292 Cl.16
SX Male
CA Transformed cell line
//
ID WKPT-1292 Cl.8
AC CVCL_R953
RX PubMed=8807581;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Wistar Kyoto.
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_R951 ! WKPT-1292 Cl.3
OI CVCL_R952 ! WKPT-1292 Cl.4
OI CVCL_R949 ! WKPT-1292 Cl.10
OI CVCL_R950 ! WKPT-1292 Cl.16
SX Male
CA Transformed cell line
//
ID WL-E
AC CVCL_0C29
DR Cosmic; 2239084
RX PubMed=1311980;
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=9815546;
RX PubMed=10037197;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WLC-3
AC CVCL_5A04
RX PubMed=2888713;
CC Transformant: ChEBI; CHEBI:34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
OX NCBI_TaxID=9995; ! Marmota monax
SX Male
CA Transformed cell line
//
ID WLNA6
AC CVCL_H618
RX PubMed=6604917;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D039 ! UC 729-6
CA Hybridoma
//
ID WM 1043
AC CVCL_4602
DR CLO; CLO_0009611
DR ATCC; CRL-6466
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6466; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID WM1 [Human Waldenstrom macroglobulinemia]
AC CVCL_M088
RX PubMed=6288575;
RX PubMed=22950966;
DI NCIt; C80307; Waldenstrom macroglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WM1 [Mouse hybridoma]
AC CVCL_J776
DR ECACC; 92021211
DR NCBI_Iran; H126
CC Monoclonal antibody target: UniProtKB; P01024; Human C3.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID WM1-LCL-PI 13
AC CVCL_9V71
DR NCBI_Iran; C215
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C80307; Waldenstrom macroglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WM1026
AC CVCL_AP84
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51626
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 8,11
ST D13S317: 9,11
ST D16S539: 9,13
ST D18S51: 13,16
ST D19S433: 14
ST D21S11: 28,31
ST D2S1338: 18,25
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 12,14
ST FGA: 21,22
ST TH01: 9.3
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM115
AC CVCL_0040
SY WM-115; WM 115; WM115F; WM115-mel; WM115mel; WC00079
DR BTO; BTO:0003075
DR CLO; CLO_0009613
DR EFO; EFO_0002390
DR CLDB; cl4727
DR CLDB; cl4728
DR ATCC; CRL-1675
DR CCLE; WM115_SKIN
DR CGH-DB; 9323-4
DR ChEMBL-Cells; CHEMBL3308813
DR ChEMBL-Targets; CHEMBL1075611
DR Coriell; WC00079
DR Cosmic; 886835
DR Cosmic; 888868
DR Cosmic; 897480
DR Cosmic; 905236
DR Cosmic; 909784
DR Cosmic; 932717
DR Cosmic; 972277
DR Cosmic; 1155268
DR Cosmic; 1155547
DR Cosmic; 1238102
DR Cosmic; 1238104
DR Cosmic-CLP; 909784
DR ECACC; 91061232
DR ESTDAB; ESTDAB-066
DR GDSC; 909784
DR GEO; GSM827472
DR GEO; GSM887735
DR GEO; GSM888830
DR GEO; GSM1670576
DR IGRhCellID; WM115
DR IZSLER; BS TCL 74
DR LINCS; 50567
RX PubMed=3020539;
RX PubMed=3856042;
RX PubMed=15009714;
RX PubMed=15467732;
RX PubMed=18632627;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.proteinatlas.org/learn/cellines
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
WW http://www.rockland-inc.com/Product.aspx?id=51634
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Wistar Institute melanoma cell line collection.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'WH115mel' in CGH-DB 9323-4.
CC Discontinued: Coriell; WC00079; probable.
CC Discontinued: ECACC; 91061232; probable.
ST Source(s): ATCC; Cosmic-CLP; ESTDAB; Wistar
ST Amelogenin: X
ST CSF1PO: 12 (ATCC; Cosmic-CLP; ESTDAB)
ST CSF1PO: 11,12 (Wistar)
ST D13S317: 12,13
ST D16S539: 11,12
ST D18S51: 17
ST D19S433: 13
ST D21S11: 29
ST D3S1358: 15,18
ST D5S818: 13
ST D7S820: 8
ST D8S1179: 8,13
ST FGA: 21,23
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L033 ! WM165-1
OI CVCL_6795 ! WM239A
OI CVCL_2765 ! WM266-4
SX Female
CA Cancer cell line
//
ID WM1158
AC CVCL_6785
SY WM-1158; WM 1158; WC00046
DR Coriell; WC00046
DR Cosmic; 686407
DR Cosmic; 888849
DR Cosmic; 897486
DR Cosmic; 928686
DR Cosmic; 1155287
DR Cosmic; 1507610
DR Cosmic; 2233684
DR GDSC; 1299077
DR GEO; GSM185164
DR GEO; GSM185165
RX PubMed=15009714;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
WW http://www.rockland-inc.com/Product.aspx?id=51651
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00046; probable.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9,12
ST D16S539: 12,14
ST D18S51: 12,13
ST D19S433: 13,15
ST D21S11: 31.2,33
ST D2S1338: 22,25
ST D3S1358: 17,18
ST D5S818: 12
ST D7S820: 9,13
ST D8S1179: 10,15
ST FGA: 21
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM1193C
AC CVCL_C265
SY WM-1193C; WM 1193C
DR GEO; GSM185166
DR GEO; GSM185167
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM122
AC CVCL_DG74
SY WM 122
DR GEO; GSM186467
DR GEO; GSM186468
DR GEO; GSM188230
DR GEO; GSM188260
DR GEO; GSM188319
RX PubMed=2068080;
CC Part of: Wistar Institute melanoma cell line collection.
CC Misspelling: 'MW122' in PubMed=2068080, material and method.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WM1232
AC CVCL_6786
SY WM-1232; WM 1232; WC00084
DR Coriell; WC00084
DR Cosmic; 2233685
DR GEO; GSM185168
DR GEO; GSM185169
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51660
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00084; probable.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 14
ST D19S433: 13,14
ST D21S11: 28,29
ST D2S1338: 20,25
ST D3S1358: 18
ST D5S818: 10,12
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 23
ST TH01: 7,9.3
ST TPOX: 11,12
ST vWA: 16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM1321
AC CVCL_W887
SY WM-1321
DR Cosmic; 1155566
RX PubMed=18632627;
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM1341B
AC CVCL_A396
SY WM-1341B; WM 1341B
DR Cosmic; 1303062
RX PubMed=2068080;
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6787 ! WM1341D
SX Male
CA Cancer cell line
//
ID WM1341D
AC CVCL_6787
SY WM1341-D; WM-1341D; WM 1341D; WC00096
DR Coriell; WC00096
DR Cosmic; 1477407
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
WW http://www.rockland-inc.com/Product.aspx?id=51691
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00096; probable.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 14,15
ST D19S433: 12,14
ST D21S11: 31.2,32.2
ST D2S1338: 16,18
ST D3S1358: 15
ST D5S818: 10
ST D7S820: 9,11
ST D8S1179: 12,14
ST FGA: 19,22
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A396 ! WM1341B
SX Male
CA Cancer cell line
//
ID WM1346
AC CVCL_W886
SY WM-1346; WM 1346; WC00121
DR Coriell; WC00121
DR Cosmic; 1155538
DR GEO; GSM185170
DR GEO; GSM185171
DR GEO; GSM185172
DR GEO; GSM185173
RX PubMed=18632627;
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00121; probable.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM1361A
AC CVCL_6788
SY WM-1361A; WM 1361A; WC00075; EST69
DR Coriell; WC00075
DR Cosmic; 686402
DR Cosmic; 1047649
DR Cosmic; 1155284
DR Cosmic; 1155540
DR Cosmic; 1303063
DR Cosmic; 1507599
DR Cosmic; 1669263
DR Cosmic; 2163799
DR Cosmic; 2233686
DR ESTDAB; ESTDAB-069
DR GEO; GSM156022
DR GEO; GSM185174
DR GEO; GSM185175
DR GEO; GSM185176
DR GEO; GSM185177
DR GEO; GSM952593
RX PubMed=2068080;
RX PubMed=17260012;
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
WW http://www.rockland-inc.com/Product.aspx?id=51698
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Discontinued: Coriell; WC00075; probable.
ST Source(s): ESTDAB; Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 14
ST D19S433: 13,14
ST D21S11: 30,31.2
ST D2S1338: 25
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 12,13
ST FGA: 22,25
ST TH01: 7,8 (ESTDAB)
ST TH01: 7 (Wistar)
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6993 ! WM1361B
OI CVCL_6994 ! WM1361C
SX Male
CA Cancer cell line
//
ID WM1361B
AC CVCL_6993
SY WM-1361B; WM 1361B
DR Cosmic; 686403
DR Cosmic; 1155555
RX PubMed=18632627;
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Skin.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6788 ! WM1361A
OI CVCL_6994 ! WM1361C
SX Male
CA Cancer cell line
//
ID WM1361C
AC CVCL_6994
SY WM-1361C; WM 1361C
DR Cosmic; 686404
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Skin.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6788 ! WM1361A
OI CVCL_6993 ! WM1361B
SX Male
CA Cancer cell line
//
ID WM1366
AC CVCL_6789
SY WM-1366; WM 1366; WC00078; EST70
DR Coriell; WC00078
DR Cosmic; 1047650
DR Cosmic; 1155539
DR Cosmic; 1665010
DR Cosmic; 2163800
DR ESTDAB; ESTDAB-070
DR GEO; GSM185178
DR GEO; GSM185179
DR GEO; GSM185180
DR GEO; GSM185181
DR GEO; GSM188064
DR GEO; GSM188116
DR GEO; GSM188189
DR GEO; GSM188204
DR GEO; GSM188217
DR GEO; GSM188231
DR GEO; GSM188261
DR GEO; GSM188280
DR GEO; GSM188289
DR GEO; GSM188320
DR GEO; GSM952594
DR SKY/M-FISH/CGH; 4947
RX PubMed=17260012;
RX PubMed=18632627;
RX PubMed=28196595;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51722
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Array-based CGH.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Misspelling: 'Wn1366' in Cosmic 1665010.
CC Discontinued: Coriell; WC00078; probable.
ST Source(s): ESTDAB; Wistar
ST Amelogenin: X
ST CSF1PO: 12 (ESTDAB)
ST CSF1PO: 11,12 (Wistar)
ST D13S317: 8,13
ST D16S539: 12,13
ST D18S51: 12,16
ST D19S433: 14,15
ST D21S11: 28,30
ST D2S1338: 20,22
ST D3S1358: 15,18
ST D5S818: 13 (ESTDAB)
ST D5S818: 12,13 (Wistar)
ST D7S820: 12 (ESTDAB)
ST D7S820: 11,12 (Wistar)
ST D8S1179: 13,14
ST FGA: 21,22
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM1382
AC CVCL_6790
SY WM-1382; WM 1382; WC00055
DR Coriell; WC00055
DR Cosmic; 1155542
DR Cosmic; 1669264
RX PubMed=18632627;
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00055; probable.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM139
AC CVCL_C266
SY WM-139; WM 139; EST71
DR Cosmic; 1047651
DR Cosmic; 2163801
DR ESTDAB; ESTDAB-071
DR GEO; GSM156024
RX PubMed=17260012;
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Array-based CGH.
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D3S1358: 14,17
ST D5S818: 9,11
ST D7S820: 9,11
ST FGA: 20,25
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM1552C
AC CVCL_6472
SY WM-1552C; WM 1552C; WM-1552; WM1552; EST73
DR CLO; CLO_0009614
DR ATCC; CRL-2808
DR BioSample; SAMN03471792
DR Cosmic; 886833
DR Cosmic; 1047652
DR Cosmic; 1303064
DR Cosmic; 1995664
DR Cosmic; 2159426
DR Cosmic; 2163802
DR Cosmic-CLP; 1299078
DR ESTDAB; ESTDAB-073
DR GDSC; 1299078
DR GEO; GSM156020
DR GEO; GSM186469
DR GEO; GSM186470
DR GEO; GSM555186
DR GEO; GSM952582
DR GEO; GSM1670577
DR LINCS; 50568
RX PubMed=17260012;
RX PubMed=27397505;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50673
CC Part of: Wistar Institute melanoma cell line collection.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: ATCC; CRL-2808; true.
ST Source(s): ATCC; Cosmic-CLP; ESTDAB; Wistar
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12,14 (ATCC)
ST D13S317: 12 (Cosmic-CLP; ESTDAB; Wistar)
ST D16S539: 9,11
ST D18S51: 15
ST D19S433: 14
ST D21S11: 30
ST D2S1338: 24,25
ST D3S1358: 14
ST D5S818: 12
ST D7S820: 10,11,12 (ATCC)
ST D7S820: 10,12 (Cosmic-CLP; ESTDAB; Wistar)
ST D8S1179: 11,12
ST FGA: 22
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM1575
AC CVCL_L027
SY WM-1575; WM 1575
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM1617
AC CVCL_6791
SY WM-1617; WM 1617; WC00076
DR Coriell; WC00076
DR Cosmic; 686409
DR GEO; GSM952583
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00076; probable.
CC Derived from metastatic site: Right axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6473 ! WM278
SX Female
CA Cancer cell line
//
ID WM164
AC CVCL_7928
SY WM-164; WM 164
DR Cosmic; 888857
DR Cosmic; 897481
DR Cosmic; 928684
DR Cosmic; 1155550
DR Cosmic; 1187586
DR Cosmic; 1303065
DR GEO; GSM186471
DR GEO; GSM186472
DR GEO; GSM952584
DR PRIDE; PXD004343
RX PubMed=2156614;
RX PubMed=2918552;
RX PubMed=8342600;
RX PubMed=15009714;
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
WW http://www.rockland-inc.com/Product.aspx?id=50688
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Deep proteome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 13
ST D18S51: 12,21
ST D19S433: 13
ST D21S11: 28,31.2
ST D2S1338: 19
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 20
ST TH01: 9
ST TPOX: 8,10
ST vWA: 14,15
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM165-1
AC CVCL_L033
SY WM-165-1; WM 165-1
RX PubMed=3856042;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50693
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 15,17
ST D19S433: 13
ST D21S11: 29
ST D2S1338: 19
ST D3S1358: 15,18
ST D5S818: 13
ST D7S820: 8
ST D8S1179: 13,15
ST FGA: 21,23
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0040 ! WM115
OI CVCL_6795 ! WM239A
OI CVCL_2765 ! WM266-4
SX Female
CA Cancer cell line
//
ID WM1650
AC CVCL_D555
SY WM-1650; WM 1650
DR ATCC; CRL-2810
RX PubMed=2068080;
RX PubMed=8342600;
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: ATCC; CRL-2810; true.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM1716
AC CVCL_AP82
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50715
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 14
ST D19S433: 13,13.2
ST D21S11: 31,32
ST D2S1338: 19,24
ST D3S1358: 16
ST D5S818: 10
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 22
ST TH01: 7
ST TPOX: 8,12
ST vWA: 18,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM1727A
AC CVCL_A339
SY WM-1727A; WM 1727A
DR Cosmic; 1155559
DR Cosmic; 1303066
DR GEO; GSM186473
DR GEO; GSM186474
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50723
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 14
ST D19S433: 14
ST D21S11: 28,33.2
ST D2S1338: 20,23
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 11,13
ST D8S1179: 13,14
ST FGA: 22
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM1789
AC CVCL_6792
SY WM-1789; WM 1789; WC00080
DR Coriell; WC00080
DR Cosmic; 686395
DR Cosmic; 1477416
DR GEO; GSM186475
DR GEO; GSM186476
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51724
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00080; probable.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 11,13
ST D21S11: 29,30
ST D5S818: 9,13
ST D7S820: 8,9
ST TH01: 7
ST TPOX: 10,11
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM1791A
AC CVCL_C267
SY WM-1791A; WM 1791A; WM 1791-A; EST74
DR Cosmic; 1047653
DR ESTDAB; ESTDAB-074
DR GEO; GSM156013
RX PubMed=17260012;
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Array-based CGH.
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,12
ST D3S1358: 16,17
ST D5S818: 10,11
ST D7S820: 10
ST FGA: 19,22
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6793 ! WM1791C
SX Male
CA Cancer cell line
//
ID WM1791C
AC CVCL_6793
SY WM-1791C; WM 1791C; WM 1791-C; WC00086
DR Coriell; WC00086
DR GEO; GSM952585
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51737
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00086; probable.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,12
ST D16S539: 11,13
ST D18S51: 17
ST D19S433: 12,16.2
ST D21S11: 30
ST D2S1338: 17,25
ST D3S1358: 16,17
ST D5S818: 10,11
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 19,22
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C267 ! WM1791A
SX Male
CA Cancer cell line
//
ID WM1799
AC CVCL_A341
SY WM-1799; WM 1799
DR CCLE; WM1799_SKIN
DR Cosmic; 888851
DR Cosmic; 1155560
DR Cosmic; 1303067
DR GEO; GSM186477
DR GEO; GSM186478
DR GEO; GSM887736
DR GEO; GSM888831
RX PubMed=15009714;
RX PubMed=18632627;
RX PubMed=22460905;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50734
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 13,16
ST D19S433: 16,16.2
ST D21S11: 30
ST D2S1338: 18
ST D3S1358: 14,15
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 12,14
ST FGA: 19,24
ST TH01: 9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM1819
AC CVCL_0B65
SY WM-1819
DR Cosmic; 1303068
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50760
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 11,14
ST D18S51: 12,16
ST D19S433: 15
ST D21S11: 29
ST D2S1338: 17,18
ST D3S1358: 14,15
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 11,12
ST FGA: 23
ST TH01: 8
ST TPOX: 8,9
ST vWA: 18,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM1852
AC CVCL_0L86
SY WM-1852
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
WW http://www.rockland-inc.com/Product.aspx?id=50775
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 9,13
ST D13S317: 8,12
ST D16S539: 11
ST D18S51: 13
ST D19S433: 14,15
ST D21S11: 28,33.2
ST D2S1338: 17,25
ST D3S1358: 16,17
ST D5S818: 12
ST D7S820: 9,13
ST D8S1179: 12,15
ST FGA: 21,23
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM1862
AC CVCL_C268
SY WM-1862; WM 1862; EST75
DR Cosmic; 972270
DR Cosmic; 1047654
DR Cosmic; 2163803
DR ESTDAB; ESTDAB-075
DR GEO; GSM156010
RX PubMed=17260012;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50784
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Array-based CGH.
ST Source(s): ESTDAB; Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 13
ST D18S51: 12,17
ST D19S433: 13,14
ST D21S11: 28,29
ST D2S1338: 24,25
ST D3S1358: 16,18
ST D5S818: 11,14
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 20,21
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM1922
AC CVCL_6794
SY WM-1922; WM 1922; WC00093
DR Coriell; WC00093
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00093; probable.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM1942
AC CVCL_DI27
SY WM-1942; WM 1942
DR GEO; GSM482482
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WM1960
AC CVCL_AP76
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50796
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Left axillary lymph node.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 8
ST D18S51: 19
ST D19S433: 13,14
ST D21S11: 29
ST D2S1338: 18,21
ST D3S1358: 14,18
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 10,16
ST FGA: 22,24
ST TH01: 6,8
ST TPOX: 8
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AP77 ! WM2013
OI CVCL_6796 ! WM3060
SX Male
CA Cancer cell line
//
ID WM1963
AC CVCL_0B66
DR GEO; GSM952603
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50822
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 9,11
ST D21S11: 28,30
ST D5S818: 10,11
ST D7S820: 9,12
ST TH01: 9
ST TPOX: 9
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM1985
AC CVCL_0B67
DR GEO; GSM185182
DR GEO; GSM185183
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50819
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 12
ST D21S11: 28,30
ST D5S818: 9,12
ST D7S820: 8,10
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM2013
AC CVCL_AP77
DR GEO; GSM952595
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50837
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Left axillary lymph node.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 8,12
ST D18S51: 19
ST D19S433: 13,14
ST D21S11: 29
ST D2S1338: 18,21
ST D3S1358: 14,18
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 10,16
ST FGA: 22,24
ST TH01: 6,8
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AP76 ! WM1960
OI CVCL_6796 ! WM3060
SX Male
CA Cancer cell line
//
ID WM2032
AC CVCL_0B68
DR GEO; GSM952596
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50848
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 8,11
ST D18S51: 25
ST D19S433: 13,15
ST D21S11: 28,30
ST D2S1338: 17,23
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 9,11
ST D8S1179: 12
ST FGA: 20,21
ST TH01: 10
ST TPOX: 11
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AP86 ! WM3000
SX Sex undetermined
CA Cancer cell line
//
ID WM2044
AC CVCL_0B69
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50862
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 20
ST D19S433: 14,15
ST D21S11: 29,30
ST D2S1338: 18
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 13
ST FGA: 23,24
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM2067
AC CVCL_0L85
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM209
AC CVCL_C269
SY WM-209; WM 209
DR GEO; GSM952604
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
WW http://www.rockland-inc.com/Product.aspx?id=50900
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 10,13
ST D21S11: 28,31
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 17,20
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM2090
AC CVCL_0B70
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50892
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11
ST D18S51: 12,16
ST D19S433: 13,14
ST D21S11: 30,31
ST D2S1338: 24,25
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 12,13
ST FGA: 23
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM218
AC CVCL_L029
SY WM-218; WM 218
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM239A
AC CVCL_6795
SY WM-239A; WM-239-A; WM 239-A; WM 239A; WM-239; WM239; WM 239; WC00044
DR BTO; BTO:0003474
DR Coriell; WC00044
DR Cosmic; 888850
DR Cosmic; 928690
DR Cosmic; 972260
DR Cosmic; 1155288
DR Cosmic; 1155564
DR Cosmic; 1303069
DR Cosmic; 1477413
DR GDSC; 1240225
DR GEO; GSM188232
DR GEO; GSM188262
DR GEO; GSM188321
RX PubMed=3020539;
RX PubMed=3856042;
RX PubMed=15009714;
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51751
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
CC Discontinued: Coriell; WC00044; probable.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D21S11: 28,29
ST D5S818: 12,13
ST D7S820: 7,8
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0040 ! WM115
OI CVCL_L033 ! WM165-1
OI CVCL_2765 ! WM266-4
SX Female
CA Cancer cell line
//
ID WM245
AC CVCL_J513
SY WM-245; WM 245
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM262
AC CVCL_AP85
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50906
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,9
ST D16S539: 9,11
ST D18S51: 20,25
ST D19S433: 12.2,13
ST D21S11: 28,29,32.2
ST D2S1338: 23,24
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 8,11
ST D8S1179: 15,16
ST FGA: 20
ST TH01: 6,9
ST TPOX: 9,12
ST vWA: 14,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM266-4
AC CVCL_2765
SY WM-266-4; WM 266-4; WM-2664; WM2664; WM 2664; WM266; WM-266-mel; WM266mel; WC00097
DR BTO; BTO:0001595
DR CLO; CLO_0009612
DR CLO; CLO_0009615
DR EFO; EFO_0006774
DR CLDB; cl4726
DR ATCC; CRL-1676
DR CCLE; WM2664_SKIN
DR CGH-DB; 9312-4
DR Coriell; WC00097
DR Cosmic; 687444
DR Cosmic; 905225
DR Cosmic; 932718
DR Cosmic; 972276
DR Cosmic; 1022277
DR Cosmic; 1054856
DR Cosmic; 1155273
DR Cosmic; 1238103
DR Cosmic; 1295343
DR Cosmic; 1303070
DR Cosmic; 1458970
DR Cosmic; 1459638
DR Cosmic; 1477409
DR Cosmic; 1507624
DR Cosmic; 1949557
DR Cosmic; 2163804
DR Cosmic; 2233687
DR ECACC; 91061233
DR ESTDAB; ESTDAB-076
DR GEO; GSM827418
DR GEO; GSM887737
DR GEO; GSM888832
DR GEO; GSM1138792
DR GEO; GSM1670578
DR KCLB; 21676
DR Lonza; 1375
RX PubMed=3020539;
RX PubMed=3856042;
RX PubMed=15467732;
RX PubMed=17308088;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51768
WW http://tcpaportal.org/mclp/
CC Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: Coriell; WC00097; probable.
CC Discontinued: ECACC; 91061233; probable.
CC Derived from metastatic site: Right thigh skin.
ST Source(s): ATCC; ESTDAB; KCLB; Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 11,12
ST D18S51: 21
ST D19S433: 13
ST D21S11: 29
ST D2S1338: 19
ST D3S1358: 15,18
ST D5S818: 13
ST D7S820: 8
ST D8S1179: 13,15
ST FGA: 21,23
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0040 ! WM115
OI CVCL_L033 ! WM165-1
OI CVCL_6795 ! WM239A
SX Female
CA Cancer cell line
//
ID WM278
AC CVCL_6473
SY WM-278; WM 278; WC00054
DR BTO; BTO:0005480
DR CLO; CLO_0009616
DR ATCC; CRL-2809
DR BioSample; SAMN03471796
DR Coriell; WC00054
DR Cosmic; 686401
DR Cosmic; 972271
DR Cosmic; 1155544
DR Cosmic; 1995665
DR Cosmic; 2159427
DR Cosmic; 2163805
DR Cosmic-CLP; 1240226
DR ESTDAB; ESTDAB-077
DR GDSC; 1240226
DR GEO; GSM186479
DR GEO; GSM186480
DR GEO; GSM555172
DR GEO; GSM1670579
RX PubMed=18632627;
RX PubMed=27397505;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
WW http://www.rockland-inc.com/Product.aspx?id=51777
CC Part of: Wistar Institute melanoma cell line collection.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2809; true.
CC Discontinued: Coriell; WC00054; probable.
ST Source(s): ATCC; Cosmic-CLP; ESTDAB; Wistar
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 12
ST D16S539: 10,13
ST D18S51: 12,15
ST D19S433: 15,16
ST D21S11: 27,30
ST D2S1338: 19,25
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 12,13
ST FGA: 19,22
ST TH01: 6
ST TPOX: 8
ST vWA: 18,20
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6791 ! WM1617
SX Female
CA Cancer cell line
//
ID WM28
AC CVCL_L034
SY WM-28; WM 28
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3000
AC CVCL_AP86
DR GEO; GSM185184
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50922
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 8,11
ST D18S51: 14,16
ST D19S433: 13,15
ST D21S11: 28,30
ST D2S1338: 17,23
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 9,11
ST D8S1179: 12
ST FGA: 20,21
ST TH01: 9.3
ST TPOX: 11
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0B68 ! WM2032
SX Sex undetermined
CA Cancer cell line
//
ID WM3004
AC CVCL_DG75
SY WM 3004
DR GEO; GSM185185
DR GEO; GSM185186
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WM3060
AC CVCL_6796
SY WM-3060; WM 3060; WC00126
DR Coriell; WC00126
DR Cosmic; 2159440
DR Cosmic; 2230118
DR GEO; GSM186481
DR GEO; GSM186482
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51811
CC Part of: Wistar Institute melanoma cell line collection.
CC Misspelling: 'VM3060' in Cosmic 2230118.
CC Discontinued: Coriell; WC00126; probable.
CC Derived from metastatic site: Left axillary lymph node.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 8,12
ST D18S51: 19
ST D19S433: 13,14
ST D21S11: 29
ST D2S1338: 18,21
ST D3S1358: 14,18
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 10,16
ST FGA: 22
ST TH01: 6,8
ST TPOX: 8
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AP76 ! WM1960
OI CVCL_AP77 ! WM2013
SX Male
CA Cancer cell line
//
ID WM3061
AC CVCL_AP87
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51546
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3066
AC CVCL_C270
SY WM-3066; WM 3066
DR GEO; GSM185187
DR GEO; GSM185188
DR GEO; GSM952597
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3077
AC CVCL_DG76
SY WM 3077
DR GEO; GSM185189
DR GEO; GSM186483
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WM3130
AC CVCL_C271
SY WM-3130; WM 3130
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WM3152
AC CVCL_A340
SY WM-3152; WM 3152
DR Cosmic; 1477414
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3208V
AC CVCL_L028
SY WM-3208V; WM 3208V; WM3208; WM 3208
DR GEO; GSM185190
DR GEO; GSM185191
DR GEO; GSM185192
DR GEO; GSM185193
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3211
AC CVCL_6797
SY WM-3211; WM 3211; WC00045; EST79
DR Coriell; WC00045
DR Cosmic; 972286
DR Cosmic; 1047655
DR Cosmic; 1155289
DR Cosmic; 1155541
DR Cosmic; 1284919
DR Cosmic; 1303071
DR Cosmic; 2144978
DR Cosmic; 2159443
DR Cosmic; 2163806
DR ESTDAB; ESTDAB-079
DR GEO; GSM156008
DR GEO; GSM185194
DR GEO; GSM185195
DR GEO; GSM188070
DR GEO; GSM188122
DR GEO; GSM188195
DR GEO; GSM188210
DR GEO; GSM188216
DR GEO; GSM188233
DR GEO; GSM188263
DR GEO; GSM188286
DR GEO; GSM188295
DR GEO; GSM188322
RX PubMed=17260012;
RX PubMed=18632627;
RX PubMed=22578220;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51798
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: Coriell; WC00045; probable.
CC Derived from metastatic site: Lymph node.
ST Source(s): ESTDAB; Wistar
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 12
ST D16S539: 12
ST D18S51: 12
ST D19S433: 13,14
ST D21S11: 29,31.2
ST D2S1338: 20,24
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 10,11
ST FGA: 20
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3214
AC CVCL_0L87
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3246
AC CVCL_AP88
DR GEO; GSM952605
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50958
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Adrenal gland.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 13,14
ST D16S539: 11,14
ST D18S51: 13,22
ST D19S433: 14
ST D21S11: 29
ST D2S1338: 20,22
ST D3S1358: 14
ST D5S818: 13
ST D7S820: 11,12
ST D8S1179: 13
ST FGA: 20,23
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3248
AC CVCL_6798
SY WM-3248; WM 3248; WC00081
DR Coriell; WC00081
DR Cosmic; 1155546
DR Cosmic; 1303073
DR GEO; GSM185196
DR GEO; GSM185197
DR GEO; GSM188066
DR GEO; GSM188118
DR GEO; GSM188191
DR GEO; GSM188206
DR GEO; GSM188215
DR GEO; GSM188234
DR GEO; GSM188264
DR GEO; GSM188282
DR GEO; GSM188291
DR GEO; GSM188323
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51826
CC Part of: Wistar Institute melanoma cell line collection.
CC Misspelling: 'WM-3428' in Cosmic 1303073.
CC Discontinued: Coriell; WC00081; probable.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM3258
AC CVCL_0L88
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3268
AC CVCL_L031
SY WM-3268; WM 3268; WM3268V; WM-3268V; WM 3268V; WM3268A
DR Cosmic; 1155561
DR Cosmic; 1303072
DR GEO; GSM185198
DR GEO; GSM185199
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
WW http://www.rockland-inc.com/Product.aspx?id=50952
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 11
ST D18S51: 15,18
ST D19S433: 12,13
ST D21S11: 29,32.2
ST D2S1338: 17,18
ST D3S1358: 13,16
ST D5S818: 9,10
ST D7S820: 9,12
ST D8S1179: 13,14
ST FGA: 22,23
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3282
AC CVCL_0B71
SY WM 3282
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50973
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,14
ST D16S539: 11,13
ST D18S51: 13
ST D19S433: 13,14
ST D21S11: 29,33.2
ST D2S1338: 25
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 12
ST D8S1179: 12,14
ST FGA: 25,26
ST TH01: 7,9.3
ST TPOX: 9,11
ST vWA: 20
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3301
AC CVCL_AP89
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=50998
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10
ST D16S539: 11,12
ST D18S51: 12,16
ST D19S433: 14,15
ST D21S11: 29,30
ST D2S1338: 17
ST D3S1358: 16,18
ST D5S818: 9,13
ST D7S820: 12,13
ST D8S1179: 13,16
ST FGA: 21
ST TH01: 8,9
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3311
AC CVCL_0B72
SY WM-3311; WM 3311
DR GEO; GSM952606
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51008
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 11,12
ST D18S51: 11,17
ST D19S433: 12,14
ST D21S11: 31
ST D2S1338: 19,23
ST D3S1358: 14,17
ST D5S818: 12,13
ST D7S820: 12
ST D8S1179: 13
ST FGA: 23,25
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3406
AC CVCL_AP90
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51028
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 12,14
ST D16S539: 11,13
ST D18S51: 16
ST D19S433: 13,16
ST D21S11: 30.2
ST D2S1338: 19,26
ST D3S1358: 16
ST D5S818: 10,11
ST D7S820: 13
ST D8S1179: 14,15
ST FGA: 25
ST TH01: 6,9
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3438
AC CVCL_C272
SY WM-3438; WM 3438
DR GEO; GSM952607
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51025
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 12,14
ST D18S51: 12,14
ST D19S433: 14,14.2
ST D21S11: 32.2
ST D2S1338: 17,19
ST D3S1358: 14
ST D5S818: 13
ST D7S820: 9,11
ST D8S1179: 13,15
ST FGA: 21,23
ST TH01: 9.3
ST TPOX: 10,11
ST vWA: 16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3451
AC CVCL_C273
SY WM-3451; WM 3451
DR Cosmic; 1303074
DR GEO; GSM482483
DR GEO; GSM952598
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 10,11
ST D18S51: 12,13
ST D19S433: 12,12.2
ST D21S11: 29,30
ST D2S1338: 20,26
ST D3S1358: 12,16
ST D5S818: 12,13
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 21,23
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AP91 ! WM3456
SX Sex undetermined
CA Cancer cell line
//
ID WM3456
AC CVCL_AP91
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51060
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 10,11
ST D18S51: 12,13
ST D19S433: 13,14
ST D21S11: 29,30
ST D2S1338: 20,26
ST D3S1358: 16,17
ST D5S818: 12,13
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 21,23
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C273 ! WM3451
SX Sex undetermined
CA Cancer cell line
//
ID WM3482
AC CVCL_AP92
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51075
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,13
ST D16S539: 11,13
ST D18S51: 13,14
ST D19S433: 15
ST D21S11: 27
ST D2S1338: 25
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 9,13
ST FGA: 21,22
ST TH01: 8
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM35
AC CVCL_0580
SY WM-35; WM 35; WC00060
DR BTO; BTO:0003475
DR CLO; CLO_0009617
DR MCCL; MCC:0000486
DR ATCC; CRL-2807
DR BioSample; SAMN03471793
DR Coriell; WC00060
DR Cosmic; 686396
DR Cosmic; 886834
DR Cosmic; 1155548
DR Cosmic; 1187584
DR Cosmic; 1247866
DR Cosmic; 1303075
DR Cosmic; 1507600
DR Cosmic; 1995666
DR Cosmic; 2159431
DR Cosmic-CLP; 1299080
DR GDSC; 1299080
DR GEO; GSM186484
DR GEO; GSM186485
DR GEO; GSM188068
DR GEO; GSM188120
DR GEO; GSM188193
DR GEO; GSM188208
DR GEO; GSM188213
DR GEO; GSM188284
DR GEO; GSM188293
DR GEO; GSM555188
DR GEO; GSM952586
DR GEO; GSM1670580
DR Lonza; 583
RX PubMed=2068080;
RX PubMed=18632627;
RX PubMed=23039341;
RX PubMed=27087056;
RX PubMed=27397505;
CC Part of: Wistar Institute melanoma cell line collection.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2807; true.
CC Discontinued: Coriell; WC00060; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=27087056; Wistar
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 20
ST D19S433: 15,16
ST D21S11: 29,32.2
ST D2S1338: 18,25
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 10,13
ST D8S1179: 11,13
ST FGA: 19
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM35-P1N1
AC CVCL_A806
SY 35-P1-N1
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0580 ! WM35
SX Female
CA Cancer cell line
//
ID WM35-P1N2
AC CVCL_A807
SY 35-P1-N2
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0580 ! WM35
SX Female
CA Cancer cell line
//
ID WM35-P1N3
AC CVCL_A808
SY 35-P1-N3
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0580 ! WM35
SX Female
CA Cancer cell line
//
ID WM35-P2N1
AC CVCL_A809
SY 35-P2-N1
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0580 ! WM35
SX Female
CA Cancer cell line
//
ID WM35-P2N2
AC CVCL_A810
SY 35-P2-N2
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0580 ! WM35
SX Female
CA Cancer cell line
//
ID WM35-P2N3
AC CVCL_A811
SY 35-P2-N3
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0580 ! WM35
SX Female
CA Cancer cell line
//
ID WM3506
AC CVCL_AP93
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51091
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 12,13
ST D18S51: 14,18
ST D19S433: 13,14
ST D21S11: 30
ST D2S1338: 19,23
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 10,12
ST D8S1179: 14,15
ST FGA: 24,25
ST TH01: 8
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM3533
AC CVCL_0B73
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51088
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9,12
ST D18S51: 13,16
ST D19S433: 13,14.2
ST D21S11: 30
ST D2S1338: 25,26
ST D3S1358: 15,17
ST D5S818: 10,12
ST D7S820: 9,12
ST D8S1179: 10,15
ST FGA: 22,24
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 15,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3540
AC CVCL_AP94
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51108
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 9
ST D13S317: 9
ST D16S539: 12
ST D19S433: 12,13
ST D21S11: 27,32
ST D2S1338: 17,19
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 9,13
ST FGA: 20,24
ST TH01: 8,9
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM3618F
AC CVCL_0B74
SY WM3618
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51135
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Right axillary lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 13
ST D18S51: 13,14
ST D19S433: 13,14
ST D21S11: 28,31
ST D2S1338: 20,25
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 10,13
ST D8S1179: 10,15
ST FGA: 20
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0B81 ! WM3772F
SX Female
CA Cancer cell line
//
ID WM3619
AC CVCL_0B75
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51136
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 12
ST D18S51: 12,15
ST D19S433: 13
ST D21S11: 28,32.2
ST D2S1338: 20,21
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 9,14
ST FGA: 23
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 14
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3622
AC CVCL_AP95
DR GEO; GSM952599
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51149
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 11
ST D18S51: 10,19
ST D19S433: 14
ST D21S11: 28,33.2
ST D2S1338: 17,25
ST D3S1358: 14,15
ST D5S818: 12
ST D7S820: 7,8
ST D8S1179: 12,14
ST FGA: 21
ST TH01: 6
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3623
AC CVCL_C274
SY WM-3623; WM 3623
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51156
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Right lymph node.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12,13
ST D16S539: 11
ST D21S11: 28
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM3629
AC CVCL_C275
SY WM-3629; WM 3629; WC00117; WC00117A
DR Coriell; WC00117
DR Cosmic; 1812179
RX PubMed=28196595;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51178
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Discontinued: Coriell; WC00117; probable.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 12,13
ST D16S539: 9,12
ST D18S51: 11,12
ST D19S433: 13,15
ST D21S11: 31,32
ST D2S1338: 32
ST D3S1358: 15
ST D5S818: 10,11
ST D7S820: 10
ST D8S1179: 8,13
ST FGA: 22
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 18,20
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3630
AC CVCL_0B76
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51548
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,13
ST D16S539: 9,11
ST D18S51: 14
ST D19S433: 13,14
ST D21S11: 28,31.2
ST D2S1338: 24,25
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 13
ST FGA: 19
ST TH01: 7,8
ST TPOX: 8
ST vWA: 16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3670
AC CVCL_6799
SY WM-3670; WM 3670; WC00119; WC00119A
DR Coriell; WC00119
DR Cosmic; 1812180
DR Cosmic; 2159436
RX PubMed=28196595;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=52026
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Discontinued: Coriell; WC00119; probable.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 14,19
ST D19S433: 14,17
ST D21S11: 30
ST D2S1338: 17,25
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 13
ST FGA: 18,19
ST TH01: 6,9
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3681
AC CVCL_C276
SY WM-3681; WM 3681
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51200
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Liver.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 11
ST D18S51: 13,19
ST D19S433: 13,14
ST D21S11: 29,33.2
ST D2S1338: 19,25
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 13
ST FGA: 24,25
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3682
AC CVCL_AP78
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51217
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 13,14
ST D18S51: 14,15
ST D19S433: 14,15
ST D21S11: 28,29
ST D2S1338: 17,23
ST D3S1358: 14,17
ST D5S818: 13
ST D7S820: 9,10
ST D8S1179: 11,12
ST FGA: 22
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0B77 ! WM3702
OI CVCL_AP79 ! WM3758
SX Male
CA Cancer cell line
//
ID WM3702
AC CVCL_0B77
DR Cosmic; 2159432
DR GEO; GSM952600
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51235
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 13,14
ST D18S51: 14,15
ST D19S433: 14,15
ST D21S11: 28,29
ST D2S1338: 17,23
ST D3S1358: 14,17
ST D5S818: 12,13
ST D7S820: 9,10
ST D8S1179: 11,12
ST FGA: 22
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AP78 ! WM3682
OI CVCL_AP79 ! WM3758
SX Male
CA Cancer cell line
//
ID WM3704
AC CVCL_0B78
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51242
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 13
ST D16S539: 13
ST D18S51: 21
ST D19S433: 13
ST D21S11: 31.2
ST D2S1338: 16,19
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 13,15
ST FGA: 22
ST TH01: 7,9.3
ST TPOX: 8,12
ST vWA: 16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM373
AC CVCL_C277
SY WM-373; WM 373
DR Cosmic; 928687
RX PubMed=3856042;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51267
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Skin.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 14,16
ST D19S433: 12,14
ST D21S11: 29
ST D2S1338: 17
ST D3S1358: 14
ST D5S818: 11
ST D7S820: 8
ST D8S1179: 13
ST FGA: 20
ST TH01: 6
ST TPOX: 9,11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7156 ! WM75
SX Male
CA Cancer cell line
//
ID WM3734
AC CVCL_6800
SY WM-3734; WM 3734; WC00090
DR Coriell; WC00090
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51895
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00090; probable.
CC Derived from metastatic site: Brain.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 13
ST D21S11: 30
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3743
AC CVCL_0B79
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51285
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 8,11
ST D18S51: 16,18
ST D19S433: 13,14
ST D21S11: 31,31.2
ST D2S1338: 19,21
ST D3S1358: 14,16
ST D5S818: 10,12
ST D7S820: 9,10
ST D8S1179: 8,12
ST FGA: 21,26
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 14,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM3749
AC CVCL_AP80
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51280
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 14
ST D16S539: 12
ST D18S51: 16,17
ST D19S433: 14,15
ST D21S11: 30.2
ST D2S1338: 24,25
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 8,9
ST D8S1179: 13,14
ST FGA: 20,24
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM3755
AC CVCL_0B80
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51287
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 12
ST D16S539: 11,13
ST D18S51: 15
ST D19S433: 13,16
ST D21S11: 29
ST D2S1338: 17,20
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 12
ST D8S1179: 11,13
ST FGA: 23
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
- 公告/新闻
